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CHAPTER I 
INTRODUCTION 
1.1 EVOLUTION OF OCCUPATIONAL LEAD EXPOSURE 
Lead is one of the longest-known metals. Archeological findings have been made 
of leaden objects that are about 7,000 years old [Woolley (1984)]. Nowadays, lead 
still is one of the most extensively applied non-ferrous metals. The total world 
production in the 1980's was estimated to be about 25.10' tons, making it the fifth 
used metal. Not surprisingly, in many professions workers come into contact with 
lead or lead-containing materials. The Occupational Safety and Health 
Administration in the U.S.A. has identified over 120 occupations in which lead is 
applied. varying from the manufacturing of lead storage batteries to printing and 
the production of glazed pottery [OSHA (1978)]. 
Although during the last decades in a number of industrial branches and for 
certain applications the use of lead has undoubtedly decreased, there still are a 
great number of workers potentially exposed. From 1981 to 1983 the National 
Institute for Occupational Safety and Health conducted a survey in the U.S.A. and 
estimated that almost 1.4 million workers were exposed to inorganic lead or lead 
compounds [NIOSH (1988)]. In 1992 the TNO Medical Biological Laboratory' 
(MBL) carried out a survey amongst Occupational Health Services in the Nether-
lands with regard to the number of workers possibly exposed to various heavy 
metals. Lead scored highest with 5,000-10,000 workers. The large majority were 
males [MBL, internal report 92-15, in Dutch]. In the period 1973-1983 the Institute 
of Occupational Health in Helsinki performed over 55,000 analyses of lead in 
blood samples in order to screen male workers for exposure to lead. Also about 
7500 analyses were conducted in samples obtained from women [Taskinen (1988)]. 
In the 19'" century serious health effects, such as wrist drop, colics and anaemia, 
often occurred in workers occupationally exposed to lead. A 'lead line' on the 
gums was frequently observed and was considered evidence of extremely high 
exposure. However, in this century improvement of hygiene and working 
conditions, as well as adaptations of industrial processes have resulted in gradually 
declining levels of exposure and in decreasing numbers of cases of occupational 
lead poisoning [Davies (1984)]. 
Nowadays, lead poisoning mainly occurs in a limited number of occupations. 
Industrial activities with traditionally high levels of exposure are primary and 
• As from January 1st. 1994 the laboratory has merged in TNO Nutrition and Food Research 
Institute. Zcist. the Netherlands. 
secondary lead smelting, manufacture of storage batteries and production of lead-
containing pigments. Also welding, thermal cutting and sand-blasting of lead-
coated constructions may result in lead toxicity [NIOSH (1992)]. However, Froines 
et al. (1990) identified altogether 52 types of indUStry which during inspection 
showed more than 1/3 of the levels of lead-in-air samples greater than the 
permissible exposure limit. 
In the last decades substantial progress has been made with regard to the 
knowledge of adverse health effects induced by lead in man. Formerly, 
investigations were mainly directed to overt clinical aspects of lead exposure such 
as anaemia. But the application of molecular-biological tests and the advancement 
in screening methods has focused attention on more subtle adverse effects to 
systems and organs as on reproduction and kidney function. It has become clear 
that these effects in man may occur at much lower levels of exposure than initially 
supposed. 
To avoid adverse effects in the general population, various measures have been 
taken to terminate or decrease the application of lead in several widely used 
products such as petrol and paints, and to reduce the concentration of lead in food 
and drinking water. These improved conditions may be illustrated by figures for 
the intake of lead by the population in the Netherlands. The 'Commission for the 
Co-ordination of Measurements of Radioactivity and Xenobiotic Compounds' 
calculated that the average total intake of lead from food, water and air decreased 
from about 107 flg/day in 1976178 to about 37 flglday in 1984/86 [CCRX (1990)]. 
Health surveillance of lead workers, aimed at preventing the occurrence of adverse 
health effects, is traditionally based on monitoring the concentration of lead in 
environmental air (PbA) at the workplace (stationary air sampling, SAS) or in the 
breathing zone of the workers (personal air sampling, PAS) and/or on biological 
monitoring (BM) of lead-in-blood (PbB). Sometimes additional analyses are carried 
out in order to detect possible early effects induced by lead (Chapter 2). However, 
it has become gradually evident that such programmes do not always meet require-
ments as to the prevention of health impairment in occupationally exposed workers. 
Therefore, existing programmes for health surveillance of lead workers have been 
reconsidered in the light of the results of the present study. 
The MBL, where this study was carried out, initiated and performed research in 
the field of occupational health for the purpose of protecting workers in industry 
and agriculture from adverse health effects caused by exposure to chemical 
substances. In this context, health surveys have been performed in which data was 
collected on the exposure to lead of workers in Dutch lead-processing industries 
in order to get insight into the prevalence of health risks and the need of 
preventive measures. The surveys were restricted to metallic lead and inorganic 
lead compounds. The toxicology of organic lead compounds and the health risks 
of exposure to these are completely different. Moreover, industrial application of 
2 
organic lead compounds is limited. Lead salts that ionize and are soluble in water 
(e.g. lead acetate) are generally considered as inorganic compounds. 
1.2 OBJECTIVE AND OUTLINE OF THE PRESENT STUDY 
The objective of the present study was improvement of the quality of health 
surveillance of lead workers. To that end, the following themes were given 
attention: 
A. The quality of the assay of lead in blood. 
B. The significance of the measurement of blood pressure and of haemoglobin in 
the health surveillance of lead workers. 
C. The meaning of BM of lead in blood of workers exposed to insoluble lead 
chromate. 
D. The use of zinc protoporphyrin as a pre-screening method to identify persons 
for exposure to lead. 
E. The usefulness of PbB as an indicator of changes in exposure. 
F. The haematological and biochemical effects of chronic exposure to lead acetate 
according to a study in rabbits. 
Ad A. In daily practice, decisions to minimize or even stop further exposure of 
lead workers, generally are taken on the basis of PbB. Erroneous analytical data 
may lead to unjustified decisions, which may have radical implications for the 
employees, as well as for the employer. Therefore, the insufficient quality of the 
analyses of PbB performed in many laboratories has given reasons for concern and 
has contributed to the organization of quality-control programmes in several 
countries. This has enabled participants to improve the performance of their 
analysis. In order to investigate the quality of the analysis of PbB in the 
Netherlands, two 'round robin' exercises were carried out. The results are discussed 
in Chapter 3. 
Ad B. Effects of lead on blood pressure have frequently been reported. However, 
they mainly occurred at higher levels of exposure. It was investigated whether the 
presently observed levels of exposure in the Netherlands make it appropriate. to 
check blood pressure as part of health surveillance of lead workers regularly. The 
conclusions are presented in Chapter 4. 
-
Anaemia is one of the earliest noticed adverse health effects induced by exposure 
to lead. In order to establish whether the determination of haemoglobin should be 
part of the protocol for health surveillance, the relation between haemoglobin and 
PbB in three groups of male Dutch and foreign lead workers was assessed 
(Chapter 5). 
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Ad C. The role of the solubility of lead chromate, zinc chromate, and potassium 
chromate on the rate of absorption of lead in the lungs of rats is discussed in 
Chapter 6. In the respiratory tract, metallic lead and many of its salts behave as 
soluble matter and are readily absorbed into the blood. However, absorption of 
inhaled lead chromate, which is almost completely insoluble in aqueous solution 
at neutral pH and in the alveoli, is slow and incomplete. This results in a deposit 
in lung tissue. The level of PbB remains low, and thus reflects an underestimation 
of exposure. This and the presence of the deposit may have consequences for the 
health surveillance of the workers concerned. 
Ad D. The assay of PbB is time-consuming and demands qualified personnel and 
sophisticated equipment. In contrast, the analysis of zinc protoporphyrin (ZPP) in 
blood is easily performed, might even be done at the workplace and the results are 
available immediately. For this reason the determination of ZPP has found wide 
application not only as a useful effect parameter, but also as a pre-screening 
method to establish whether an increased PbB can be expected in people. In this 
way unnecessary work and costs are avoided. In Chapter 7 a method is presented 
to use ZPP as an alternative for PbB in screening lead workers. 
Ad E. In Chapters 8 and 9 the level of exposure to lead and the results of 
technical and hygienic measures in two different types of working conditions, 
aimed to reduce the intake, are reported. It is proposed to apply other 
measurements, in addition to PbB, to estimate the internal exposure of workers 
who are exposed to extremely high levels of lead. 
The rate of decline of PbB after termination of exposure (Chapter 8) or after 
improvement of working conditions (Chapter 9) depends on the duration of 
previous exposure and on the half-time of Pb in the deposits in the body. This 
implies that a reduced intake of lead by prolongedly exposed workers is not 
necessarily reflected at short notice in a decrease of PbB. Therefore, in estimating 
the effect of hygienic or technical measures in the intake of lead in these workers, 
other measurements are required. 
Ad F. In health surveillance of lead workers, PbB is almost exclusively applied as 
the indicator of exposure. Additionally, responses of the haematopoietic system to 
lead, such as an increased level of ZPP in erythrocytes or of 8-aminolaevulinic acid 
in urine, may be used. In Chapter 10 the results of a study of chronic exposure of 
rabbits to lead acetate are presented. The aim of this study was to identify 
haematological or clinical parameters which could be used as biological-effect 
parameters for health surveillance of lead workers, in addition to those already 
available. 
A general discussion on the data in Chapters 3-10 and conclUding remarks are 
presented in Chapter n. As the Chapters, are based on separate articles, an 
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overlap is sometimes inevitable. In the Annex a possible protocol for health 
surveillance of lead workers is outlined. It is based on available protocols into 
which the relevant results of the studies presented in the Chapters 3-10 and some 
additional data from reports in literature are incorporated. 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
2.1 TOXICOKlNETICS OF INORGANIC LEAD 
Absorption 
Lead is a toxic metal that accumulates in the human body. It may be absorbed via 
the lungs and the gastrointestinal tract. Lead and inorganic lead compounds are not 
absorbed through the skin, although a slight absortion of lead soaps and of lead 
naphtenate has been reported [Van Peteghem and De Vos (1974)]. 
The deposition of lead in the respiratory tract of man exposed to lead dust for two 
tidal volumes was studied by Nozaki (1966). The concentration of the inhaled 
fumes was 10 mg/m'. Figure 2.1 shows that a smaller air tidal. e.g. during exertion 
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as in work, results in a decreased retention, The results were similar to those of 
Kehoe (1961) who exposed volunteers to levels of 10-150 flg lead oxide/m'. The 
extensive balance studies of Kehoe, which were carried out between 1937 and 
1972, have been summarized by Gross (1981). Under an average alveolar 
ventilation of 15 m'/day for the general population, the retention of inhaled lead 
particles <5 flITl was about 30%. Under occupational conditions, deposition may 
differ appreciably because depth and frequency of ventilation as well as particle 
size differ strongly between workers and the general population. 
Particles with an aerodynamic diameter <0.1 flm are deposited mainly by 
diffusion in the gas exchange region of the lung [Heyder et al. (1986)]; these 
parricles are transported to the blood with an efficiency of almost 100% [Hodgkins 
et al. (1991)]. Deposition ofparricles >5 flITl occurs mainly in the upper respiratory 
tract, where they are removed to the gastrointestinal tract by mucociliary clearing. 
This may cause further absorption in the gut. Kehoe (1961) reported that exposure 
of a volunteer to aerosols of large particles of lead oxide resulted in a substantial 
increase in faecal excretion of lead. There is no evidence of accumulation of lead 
in the alveolar part of the lung. In experiments with humans, lead isotopes were 
found to be transferred almost completely to the blood within 24 h [Chamberlain 
(1985)]. Thus, lead deposited in the lungs is further absorbed into the blood or is 
transferred to the gastrointestinal tract. 
Gastrointestinal absorption of ingested lead and soluble lead salts is usually less 
than 10%. The absorption is influenced by factors such as age and the 
physiological and nutritional status of the subject. In young children it may be as 
high as 50% [Alexander et al. (1973)]. 
Absorption by the body does not solely depend on the amount of lead presented 
to the routes of entry per unit of time, but also on composition and particle size. 
However, the solubility of lead compounds is by far the most important source of 
the observed variability in absorption. Therefore, this must in any case be taken 
into account when considering uptake, distribution and excretion. In Chapter 6 this 
aspect is discussed for soluble and insoluble chromates. However, it is also 
important to note that the solubility of lead compounds in water or buffers is not 
always representative of the solubility in biological fluids with their abundance of 
chelating ligands. In many types of industry, exposure to lead is mainly in the form 
of lead oxide dust. 
Absorption of lead is greatly reduced by simultaneous intake of calcium and 
phosphate [Heard and Chamberlain (1982)]. This may explain the empirical 
practice for over a century of drinking milk to prevent the symptoms of lead 
poisoning. However, Stephens and Waldron (1975) concluded that the overall 
effect of drinking milk is rather promoting absorption of lead from the gut. 
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Distribution 
Lead that is deposited in the alveoli and in the gastrointestinal tract is absorbed 
into the blood plasma. Within minutes about 94% is taken up by the red blood 
cells. About 80% is bound to haemoglobin, and about 14% is associated with the 
erythrocyte membranes [Moore (1988)]. Because of its greater bioavailability, the 
remaining 6% exerts greater influence on the concentration in other compartments 
and, thus, influences effects in various organs more than lead bound to 
haemoglobin. Therefore, the level of lead in plasma should be considered a better 
estimate of the 'biologically active' fraction than the level in whole blood 
[CavalIeri et al. (1978)]. 
From the blood plasma lead is transported to other organs. Although on 
theoretical grounds between two and seven compartments have been argued, from 
a practical point of view a two-compartment model may suffice to describe the 
kinetics of PbB [Schutz et al. (1987)]. The skeleton contains more than 90% of the 
body burden of lead; in workers occupationally exposed to lead this fraction may 
even be higher. In this compartment lead is not evenly distributed. There is a pool 
contained in cortical bone with about 70% of the deposit and another one in 
trabecular bone [Barry (1975)]. The turn-over of lead in trabecular bone is more 
rapid than that in cortical bone. The half-time of lead in finger bone, which was 
considered representative of the whole skeleton, was estimated to be a decade or 
more. But also a half-time of seven years has been reported. The turn-over in the 
skeleton causes a continuous release of endogenous lead. Depending on the extent 
and duration of earlier exposure, it may have an impact on PbB as large as 1 
flmollL [Schutz et al. (1987')]. 
Blood, tissue fluids and some organs, particularly the kidneys and the liver, 
contain about 8% of the body burden. The half-time of these deposits amounts to 
20-40 days. 
Lead passes the placental membrane and to some extent the blood-brain barrier. 
It is also transported to the male reproduction system [Barry (1975)]. 
Excretion 
Lead that enters the blood stream and is not deposited, is excreted almost 
exclusively through the renal system and the gastrointestinal tract. Balance studies 
have shown that 54-78% of the daily excreted lead leaves the body with urine 
[Rabinowitz et al. (1976)]. Excretion into urine occurs by glomerular filtration, 
followed by partial tubular reabsorption [Araki and Aono (1989)]. During exposure 
to lead the level of Pb in urine (PbU) increases more than in blood, possibly 
because PbU depends more strongly on the level of lead in plasma. The latter 
increases more than PbB at higher level of exposure. 
Excretion of lead in faeces occurs via hepatic bile and pancreatic juice and 
amounts to about 16% of the absorbed quantity [Ishihara et al. (1987)]. 
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There are some other routes of elimination of lead from the body, such as via 
nails, hair and sweat However, these are without practical relevance for the 
assessment of exposure [WHO (1977)], 
In Figure 22 a scheme is presented of the uptake, distribution and excretion of 
inorganic lead in man. The toxicokinetics of lead has recently been reviewed by 
Skerfving (1993). 
2.2 (ADVERSE) HEALTH EFFECTS OF LEAD IN MAN 
Lead has found extensive use since classical times. Its high malleability and low 
melting point, which makes processing relatively easy, and the high resistance to 
corrosion contributed much to its application. It was used for water pipes, 
containers, coins, sieves. cosmetics. etc. Nowadays, lead is mainly used for battery 
grids, tank linings, soldering, roofing material and as sound and vibration damping 
material. 
The consequences of the ignorance of the toxic properties of the metal have 
been dramatic. Although health hazards associated with the usage of lead were 
already recognized in the Roman period, widespread and frequently fatal 
epidemics, usually caused by lead-contaminated drinking water and foods, and by 
lead-adulterated wines, have occurred repeatedly throughout history [Woolley 
(1984)]. 
This potentially toxic metal probably has no useful physiological function 
[Nolan and Shaikh (1992)]. Organs and systems that are affected by lead are the 
haematopoietic system, the central and peripheral nervous systems, and the 
kidneys. Also the male reproduction organ and the foetus are very sensitive to 
impairment The effects may range from relatively mild and reversible harm to 
overt damage and chronic diseases. 
The objective of the present Section is to provide an overview of the (adverse) 
effects induced by lead in man. Since the literature on this subject is voluminous, 
the review will be limited to the more important data with respect to health 
surveillance of lead workers. It aims also to support the recommendations in the 
protocol presented in the Annex. 
Effects on the gastrointestinal tract 
Gastrointestinal symptoms caused by lead are constipation or diarrhoea, epigastric 
pain and indigestion. In a study of Hanninen er al. (1979), 45 lead workers whose 
mean PbB at the time of the survey was 1.6 ± 0.6 flmollL, experienced more 
subjective symptoms than a control group. PbB of none of the former had ever 
been higher than 3.4 flmollL. 
Colic is considered an early warning of potentially more serious effects likely 
to occur during continuous industrial exposure. Its occurrence at relatively low 
exposure levels of PbB is well known. Beritic (1971) reported that in a cohort of 
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Figure 2.2 Scheme of intake. distribution and excretion of lead in humans. 
Based on a scheme by Zielhuis (1959). 
64 lead workers suffering from colics, 13 had PbB levels between 1.9 and 3,9 
flmollL 
Effects on the central and peripheral nervous systems 
Inorganic lead may cause severe effects on the central and peripheral nervous 
systems. Symptoms such as dullness, restlessness, irritability, muscular tremor, and 
loss of memory may result from chronic high lead exposure. However, these early 
changes in the nervous system do not produce clinical effects. 
Hanninen et al. (1978) reported for 49 otherwise asymptomatic workers with 
a mean PbB of 1.5 ± 0.5 flmol/L a diminished neuropsychological performance, 
as compared with 24 controls. PbB of none of the workers ever exceeded 3.4 
flmollL. The functions impaired most were those dependent on visual intelligence 
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and visual motor co-ordination. Effects on the central nervous system of 90 
secondary lead smelters (average PbB levels about 2.5 ~01JL) Were reported by 
Valciukas et al. (1978). In a 2-years follow-up study Seppaliiinen et al. (1983) 
showed that effects of lead in the peripheral nerves start at levels of PbB of 1.4 
~01lL. They recommend to monitor these effects in prospective screenings. Rosen 
et al. (1983) established significant sub-clinical effects on conduction velocities in 
motor and sensory nerves of the lower limbs of lead workers with mean PbB levels 
in the range 1.8-2.4 !lmollL. 
In 133 workers at a battery plant, Triebig et al. (1984) found a negative relation 
between PbB and the conduction velocity of the sensory nerves in the forearm only 
in workers with PbB levels exceeding 3.4 !lmollL. Baker et al. (1984) showed that 
in workers with PbB levels between 1.9 and 2.9 ~01lL effects on the central 
nervous system appeared well before effects on the peripheral nervous system 
became manifest. Compared with a control group, Jeyaratnam et al. (1986) 
observed a poorer performance in several neuropsychological tests for 49 lead 
workers with a mean PbB level of 2.35 ± 0.7 ~01lL. 
Muijser et al. (1987) tentatively concluded that exposure to high levels of lead 
(mean PbB was 4.0 !lmollL) for a few months resulted in a partly reversible 
decrease in motor conduction velocity, whereas sensory conduction velocities were 
not depressed (details of exposure levels of the workers are described in Chapter 
8). Exposure for more than six months may result in a decrease in motor 
conduction velocity, which recovers only several years after termination of the 
exposure [Corsi et al. (1984)]. 
Conclusion. Although in several studies no effects of lead on the central and 
peripheral nervous system were established, the results of many other studies show 
that impairment may already occur at levels of PbB of about 1.5-2 I'mollL. 
The studies on effect of lead on the nervous system have been reviewed by 
SeppaIiiinen (1988). 
Nephropathy and effect on blood pressure 
Nephropathy, ultimately leading to kidney failure, has been recognized as an effect 
of relatively high exposure to lead since long [Landrigan (1989)]. 
Effects of lead on renal function have been assessed by applying various 
parameters as indices of tubular or glomerular function. However, clinical signs, 
such as the level of urea in blood or creatinine in serum, or a decreased basal 
glomerular filtration rate, are only suitable for detecting effects on the kidneys 
when the greater part of the renal function has already been impaired [Bernard and 
Becker (1988)]. 
Frequently, proteinuria is considered an early and sensitive indicator of renal 
damage, but the measurement of excreted specific proteins is more indicative of 
kidney damage than measurement of total protein. Examples are the increased 
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excretion of retinol-binding protein and of ~2-microglobulin in urine as early 
indications of tubular or glomerular function impairment, respectively [Lauwerys 
and Bernard (1987)], 
In 25 lead workers Buchet et aL (1980) found no relationship between renal 
function and level of PbB in the range 1,6-3 flmol/L, Verschoor et aL (1987) 
examined in 244 workers the influence of lead exposure on the urinary excretion 
of several proteins. They concluded that some changes in tubular parameters may 
exist at levels of PbB below 3 flmollL and that at these levels tubular parameters 
are more affected than glomerular parameters. 
In a study of renal function in the general population, Staessen et al. (1992) 
found that in males creatinine clearance was inversely correlated with PbB 
(geometric mean 0.55 flmollL) and ZPP levels. There were also positive 
correlations between creatinine in serum and the levels of PbB and ZPP. Compared 
with control groups, Gerhardsson et al. (1992) found no signs of tubular or 
glomerular malfunction in 70 active (PbB between 0.24 and 2.3 flmollL) and 30 
retired lead workers who experienced long-term exposure. 
Conclusion. The extent to which low to moderate exposure to lead contributes to 
impairment of renal function is not clear, as available data are conflicting and not 
sufficient in number to allow a proper judgement. 
It has long been hypothesized that hypertension is a consequence of nephropathy 
[Bernard and Becker (1988)]. Until recently, epidemiological and experimental 
results were inconsistent. However, there is now evidence that lead has direct 
effects on kidney arterioles and processes related to calcium metabolism, resulting 
in hypertension. 
Harlan (1985) analysed data from a National Health and Nutrition Examination 
Survey in the U.S.A. A Significant relationship was found between PbB (levels 
<1.4 flmollL) and blood pressure in the general population. After correction for 
several confounding factors, Weiss et al. (1986) established a relationship between 
systolic blood pressure and PbB in three groups of males with mean PbB levels of 
<1,1-1.4 and >1.4 flmollL, respectively. In a study carried out in the Netherlands, 
De Kort et al. (1987) found an increased prevalence of potential hypertension in 
53 lead workers with PbB levels between 2.1 and 2.5 flmollL. PbB of the control 
group was about 0.4 flmollL. 
The studies on nephrotoxicity and hypertension have recently been reviewed by 
Bernard and Becker (1988) and by Nolan and Shaikh (1992). 
Reproduction toxicity 
Evidence of the deleterious effects of lead on human reproduction dates back to 
ancient Rome. It has been suggested that lead in wine and food even caused the 
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declining of populations. Lead has long been known as a spermicidal agent and as 
an abortifacient. 
Compared with a control group, Wildt et aI. (1983) observed subtle adverse 
effects on the sperm quality in 14 workers with an average PbB level of 2.2 
flmollL (range 1.6-3.2 flIDollL), indicating a decreased function of the genital 
glands. 
Assennato et aI. (1986) compared the sperm production or sperm transport in 
18 battery workers (mean PbB: 3.0 flIDOIlL; SD: I flIDOIlL) and 18 cement workers 
(mean PbB: <1 flIDollL). Possibly confounding factors (smoking, alcohol and 
coffee consumption, frequency of intercourse) were not significantly different 
between the two groups. The levels of the various sex hormones in both groups 
were similar. However, compared with the control group, a significantly different 
sperm count or sperm transport was found in the exposed group. 
Coste et aI. (1991) performed a cohort study on 229 workers at a battery 
factory (mean PbB: 2.2 flIDollL; 19% of the workers had a PbB >2.9 flIDollL) and 
a control group of 125 non-occupationally exposed males. In a foJlow-up of about 
five years lead exposure did not appear to be significantly associated with a 
reduction in fertility as expressed in live births for couples. The negative results 
were explained by the moderate levels of exposure, but also by the low predictive 
value of several semen abnormalities for pregnancy outcome. In the study no 
confounding factors with regard to the women were considered. 
The effect of lead on the fertility of 74 workers at a battery plant (mean PbB: 
2.3 flIDollL; range 1.1-3.6 flmollL) was assessed by Gennart et al. (1992). 
Compared with a matched control group, in the study a tendency toward decreased 
fertility with increasing period of exposure, evaluated as birth experience of their 
wives was observed. However, a significant relation between PbB levels and 
fertility could not be identified. 
Conclusion. Koeter et al. (1989) reviewed the literature on effects of lead on 
human reproduction capacity. They concluded that there was sufficient causal 
evidence that lead negatively affects spermatogenesis. Aberrations may occur in 
sperm volume, sperm count and morphology. These effects appear to be reversible. 
The average no-adverse-effect level of PbB is about 1.7 f.J11'LollL. Studies on effects 
of lead on the endocrine system related to spermatogenesis were considered 
inadequate. 
As lead passes unimpededly through the placental membrane from mother to child, 
the lead burden of the foetus is determined by the lead burden of the mother 
[OSHA (1978)]. 
In several longitudinal epidemiological studies it has been established that foetal 
neurological damage may occur at levels of PbB only slightly higher than those in 
the general popUlation, in particular during the first weeks of pregnancy. Bellinger 
et al. (1984) studied the relationship between lead levels in umbilical cord blood 
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and both the Mental Development Index (MDI) and Psychomotor Development 
Index in six month old infants ('The Boston Study'). At birth PbB levels were 
between 0.5 and 1.4 flmol/L. PbB in cord blood is about 80% of that in maternal 
blood, implying that PbB of the mothers was between 0.6 and 1.8 flffiol/L. Higher 
levels of PbB in cord blood were associated with lower MDI. In follow-up studies 
of the same children atthe age of 6, 12, 18 and 24 months, the differences in MDI 
appeared to persist. This suggests that the impairment had already occurred in the 
early stages of pregnancy. 
Dietrich et al. (1986) studied the behavioural development and PbB levels in 
185 new-born children. As in the Boston study, adverse effects in the MDI test 
were observed at the age of 6 and 12 months at mean levels of PbB of 0.4 ± 0.2 
flmol/L. It was concluded that pre-natal exposure had a greater effect than exposure 
after birth and that the effects in male children were much greater than in female 
children. 
Conclusion. There was convincing causal evidence of subtle damage to the central 
nervous system in offspring of women with levels of PbB, that were only slightly 
higher than those in non-occupationally exposed women [Koeter et al. (1989)]. 
Therefore, pregnant women and women in reproductive age should be con.sidered 
as a group at risk. 
Genotoxic effects!carcinogenicity 
Thomas and Brogan (1983) reviewed studies on the effects of lead on the 
prevalence of chromosomal damage. In ten studies an increased incidence of 
chromosomal damage was found. However, six other studies failed to establish 
such an association. Therefore, the question as to whether chromosomal abnormali-
ties are induced by lead cannot be answered yet [WHO (1987)]. 
There is only limited information available with regard to carcinogenicity of 
lead and lead compounds in humans. The WHO classifies lead and lead 
compounds in group 2B (,inadequate evidence of carcinogenicity for humans, but 
sufficient evidence in experimental animals') [WHO (1987)]. However, in a review 
article, Magos (1991) suggested that the small increased risk observed in some 
human studies gives rise to concern about human carcinogenicity. 
The adverse effects of lead which have been discussed in this Section so far, often 
reveal themselves as a result of past exposure at levels of intensity and duration 
which nowadays do not occur any more. This implies that the data of present 
exposure need not merely be applicable to establish valid response/effect 
relationships with PbB. 
Effects on the haematopoietic system 
The parameters involved in the interference of lead with haemoglobin synthesis are 
discussed in Section 2.3 and in Chapter 5. 
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2.3 MONITORING OF LEAD-EXPOSED WORKERS 
Monitoring of lead in environmental air 
Berlin et al. (1984) defined environmental air monitoring (EM) as ·the measure-
ment and assessment of agents in air at the workplace and evaluation of 
environmental exposure and health risks to an appropriate reference". 
EM of lead aims at estimating the exposure by measuring levels of lead dust 
or aerosols in air at the workplace. These measurements may be performed in two 
ways. 
Firstly, air is sampled at fixed spots at the workplace. This is called 'stationary 
air sampling'. The method is mainly applied to identify sources of emission and 
to investigate trends in concentrations at particular places and in time. However, 
it gives little information on the actual exposure of a worker. 
Secondly, air is sampled in the breathing zone of a worker. This method 
(personal air sampling, PAS) estimates the actual intake of lead but takes also into 
account the mobility and the working style of the subject. These largely affect the 
concentration in the breathing zone and thus the intake of lead. Therefore. PAS has 
the advantage that it provides an estimate of the exposure of the individual worker. 
Biological monitoring of lead in blood 
Biological monitoring (BM) has been defined as 'the measurement and assessment 
of workplace agents or their metabolites either in tissues, secreta, expired air or any 
combination of these to evaluate exposure and health risk compared to an 
appropriate reference' [Berlin et al. (1984)]. 
It is the biologically active fraction of the body burden, i.e. the lead in plasma, 
which is considered to cause most of the (adverse) health effects. However, 
practical reasons do not allow the reliable determination of Pb in plasma. 
Therefore, the level of PbB is generally applied as an indicator for the assessment 
of the exposure and estimation of health risks. PbB reflects both recent and past 
external exposure. In a steady state exposure a relationship exists between external 
exposure, and thus intake, and the body burden or internal dose. 
Relations between PbB levels and the occurrence of several types of adverse 
effect, particularly on the haematopoietic system, have been established [Zielhuis 
and Wibowo (1978); Alessio and Foa (1980)]. Consequently. biologically 
permissible levels of exposure are generally expressed in PbB. 
An advantage of applying PbB, instead of other parameters to estimate intake 
of lead, is that its level depends on all sources, including leisure, smoking and 
hand-to-mouth contact. Sources outside work, like food, traffic and hobbies, are 
generally negligible compared with occupational exposure. People living in urban 
communities show only slightly higher levels than those living in rural areas. The 
level of PbB in non-occupationally exposed populations (the reference value) is 
generally lower than 0.75 !lmoVL. 
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A limitation of BM of lead in blood is that the sampling requires an invasive 
intervention. This may form an ethical problem and an inconvenience and, albeit 
very small, a health risk to the subject. 
When a lead worker is no longer exposed, his PbB level decreases with a rate 
which depends on the kinetics of lead in the deposits. O'Flaherty et al. (1982) 
concluded that the decay depends on the length of exposure and on the value of 
PbB at the time of suspension of exposure. Schlitz et al. (1987) estimated that 
newly employed workers may display a decay of PbB from 3.0 to 2.0 flmol/L in 
less than a month, whereas in workers with much longer times of employment, and 
thus larger deposits of lead in the body, it will take more than a year to reach such 
a level. 
Biological monitoring of lead in urine 
As has been mentioned before, part of the absorbed lead is excreted in urine. Thus, 
levels of lead in urine (PbD) may be used in biological monitoring, particularly to 
detect recently absorbed lead. It is surprising, however, that in health surveillance 
of lead workers PbD is hardly used as an index of lead intake. 
During prolonged exposure, PbD rises to reach a steady state after about two 
weeks [Tola et al. (1973)]. A short heavy exposure of volunteers to lead dust 
results in an exponential correlationship between PbB and log PbD [Schlitz and 
Skerfving (1976)]. PbD remains increased for a long time after termination of 
exposure. 
There is a considerable interindividual variation in PbD at a certain PbB level. 
The PbD level seems inversely related to the urine flow. But also a circadian 
rhythm has been established in the excretion [Aono and Araki (1988)]. To adjust 
for these effects on the urinary concentration of Pb, the analysis should preferably 
be carried out in samples collected over a period of 24 h. Also normalization with 
regard to specific gravity or the concentration of creatinine* may be required. 
In practice, BM of PbD should preferably be used as a screening method in 
addition to the analysis of PbB. The latter being the first choice [Lerner (no year)]. 
A problem is that urine samples may be easily contaminated by hands and 
clothing, particularly when voiding occurs at the workplace. 
Monitoring of lead, whether environmental air monitoring or biological monitoring, 
plays a crucial role in health surveillance and health maintenance of man at the 
workplace. It is also important for the assessment of personal hygiene and the 
efficacy of healthy work practices. 
An important goal of EM is the determination of the levels of emission near 
sources. Also the compliance to permissible limit values may be monitored. The 
The quantity of creatinine which is excreted in urine per unit of time is grosse modo constant 
and largely independent of the volume of the urine. 
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method yields the actual concentration present at the time of measurement. BM is 
more directly related to adverse health effects because it indicates the 
bioavailability of the metal in the body, instead of the potential external exposure 
which is estimated by EM, It is clear that EM and BM should not be regarded as 
alternatives, They are in fact complementary and should preferably be carried out 
in parallel to assess both exposure and potential health effects. 
Biological-effect monitoring 
In addition to monitoring of lead, particular parameters may be measured to assess 
biological effects on organs and systems. This approach is known as biological-
effect monitoring (BEM). 
Zielhuis and Henderson (1986) defined BEM as 'the measurement and assess-
ment of early biological effects, of which the relationship to health impairment has 
not yet been established, in exposed workers, to evaluate exposure andlor health 
risk compared to an appropriate reference'. 
A number of tests are available to measure various haematological and 
biochemical effects induced by lead. In establishing the relationship between PbB 
and these effects several definitions may be appropriate [Zielhuis (1977)]. 
'Effect' refers to a particular biological phenomenon in an individual, induced 
at a specified PbB level. The 'no-detected-effect level' is the threshold level below 
which such an effect has not been reported. 'Response' refers to the relative 
frequency of occurrence of a specified reaction in a group of subjects at a given 
dose of PbB. At increasing exposure the intensity of the effect increases and also 
the percentage of people in a population at risk showing such an effect. 
The term' critical effect' has frequently been used to denote the earliest adverse 
or undesirable effect in an organ. A 'critical organ' is defined as that organ which 
first shows critical effects under specified circumstances of exposure. The critical 
organ for effects of lead in the haematopoietic system is bone marrow [TGMT 
(1976)]. At exposure levels lower than those resulting in critical effects, other 
effects may appear that do not impair functions and are not considered as adverse 
but which are still evident in biochemical or other tests. 
Individuals differ in dose-effect/response relationships with regard to threshold 
level and slope, i.e. there is a considerable interindividual variation in effects at 
certain PbB levels [Gibson et aI. (1968)]. In Figure 7.1 (Chapter 7) this is 
illustrated for the effect parameter zinc protoporphyrin. Thus, subjects may show 
symptoms or even signs of toxicity at relatively low PbB, while others show hardly 
any symptoms at relatively high PbB. It has been suggested that these differences 
are caused by variations in the binding of lead to a particular protein in the red 
blood cell and in the capacity for synthesizing this protein [Raghavan et al. (1980, 
1981)]. Also, in hereditary porphyrias an increased sensitivity to lead, reflected in 
a decreased level of o-aminolaevulinic acid dehydratase (see below), has been 
observed [Batlle et al. (1987)]. 
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Because exact dose-response relationships and no-response levels cannot be 
determined, one has to rely on practical approaches [Zielhuis (1975)], In practice 
dose-effect/response curves are only applicable when they meet requirements as to 
sensitivity, Le. the slope of the curves should not be too small. In this respect, it 
should also be mentioned that these relationships should not be used in incidental 
or short-term exposure but only after an equilibrium between intake and uptake has 
been attained. 
In the following, the characteristics and dose-response/effect relationships are 
discussed of the parameters related to effects of lead on the haematopoietic system. 
These relationships have been studied extensively. 
Most studies on effects of lead on the haematopoietic system date from the 
1970's and earlier. More recent publications on this subject are scarce, however, 
its data are not in defiance of older results. Extensive reviews have been published 
by Zielhuis (1959); WHO (1977) and Moore (1988). 
Already in the 19th century haematoporphyrinuria was observed in leadpoisoned 
rabbits [Stokvis (1895)]. Following absorption, a small part of the lead is trans-
ported to bone marrow where it interferes with several enzymatic steps of the bio-
synthesis of haem and globin in young erythrocytes. In particular, cytoplasmatic 
enzymes with functional sulphydryl (-SH) groups are highly sensitive to inhibition 
by lead. These effects are currently considered as the first signals in man associated 
with an increased body burden of lead. Several of the effects can be detected 
readily, prior to the onset of other, more serious symptoms. Figure 5.1 in Chapter 
5 shows a rough scheme of the interference of lead with haemoglobin synthesis. 
Inhibition of o-aminolaevulinic acid dehydratase (AlAD) 
The inhibition of ALAD in erythrocytes is currently considered the most sensitive 
indicator of human exposure to lead [Bernard and Lauwerys (1987)]. Only 
excessive consumption of alcohol and smoking of cigarettes gives a comparable 
effect. The logarithm of the ALAD activity is negatively and linearly related to the 
PbB level. Under good analytical conditions correlation coefficients are between 
-0.8 and -0.9 [Tola (1973)]. In Table 2.1 dose-response relationships are presented 
of a cohort of 221 male lead workers. 
TABLE 2.1 PERCENTAGE OF ADULTS WITH >40% AND >70% INHIBITION OF THE 
AVERAGE ALAD ACTIVlTY IN CONTROLS (PbB 0;;0.70 ~oVL)' 
PbB (~oVL) n >40% >70% 
';0.70 
0.71·1.20 30 13 3 
1.21·1.65 26 62 12 
1.66·2.15 32 97 22 
2.16·2.60 53 100 92 
2.61-3.10 37 100 92 
3.11-3.57 43 100 95 
a. From Zielhuis (1975). 
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Berlin and Schaller (1974) standardized the method of Bonsignore et aL (1965) 
for the assay of ALAD in blood. In contrast with the original method of 
Bonsignore, this 'European Standardized Method' is applicable to levels of PbB 
as high as 3 flmol/L. Despaux-Pages et al. (1986) developed another method for 
the analysis of ALAD which also may be used in screening lead workers. Both 
modifications allow measurement of ALAD inhibition by lead over a wider range 
of PbB than the original method. A disadvantage of the analysis of ALAD is that 
it has to be carried out within hours after blood sampling [Berlin et al. (1977»). 
Haeger-Aronsen et al. (1974) showed that in subjects who have been exposed to 
lead to a moderate degree, ALAD rises only slowly to normal levels after 
termination of exposure. 
Increased excretion of '6-aminolaevulinic acid in urine (ALAU) 
Inhibition of ALAD leads to a metabolic block and accumulation of ALA in blood 
plasma. As a result the substrate is excreted in urine. The concentration of ALAU 
has been used as an effect parameter in occupational lead exposure for a long time, 
because the increased concentration of ALAU correlates with the level of lead in 
blood. However, there is a threshold for the increase of ALAU at a level of PbB 
of about 2 flmol/L [WHO (1977»). Therefore, measurement of this parameter is 
only appropriate at higher levels of exposure. The correlation coefficient between 
PbB and ALAU is low, about 0.4 [Tola et al. (1973»). 
In a cohort of 207 male workers, the percentage with ALAU >5 mglL urine 
(the upper limit of the reference value) and with ALAU > I 0 mglL (considered the 
acceptable value for lead workers) was calculated. The results are shown in Table 
2.2. 
In recently exposed subjects, there is a latency period of about two weeks 
before ALAU increases [Benson et al. (1976»). After cessation of exposure, the 
level of ALAU shows a similar decrease as PbB. Therefore, this parameter does 
not reflect any previous exposure that is not also detectable by means of 
measurement of PbB [Alessio et al. (1981»). 
TABLE 2.2 DOSE-RESPONSE RELATIONSHIP BETWEEN PbB AND ALAU IN ADULT 
MALES' 
PbB CfllllOVL) ALAU Cmg/L) 
n >5 >10 
0.53-1.0 17 0 0 
1.01-1.49 27 0 0 
1.50-1.95 36 14 3 
1.96-2.45 55 33 11 
2.46-2.93 38 74 37 
2.94-3.38 34 88 50 
a. From Ziclhuis (1975). 
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Accumulation of zinc protoporphyrin in erythrocytes (ZPP) 
As a result of the interference of lead with iron transport in the bone marrow, 
accumulation of the substrate protoporphyrin IX takes place in erythrocytes, as the 
complex zinc protoporphyrin. This, and the application of ZPP as an effect 
parameter to screen people for an increased level of PbB, is discussed in more 
detail in Chapter 7 [see also Labbe and Rettmer (1987)]. 
In males the level of ZPP starts to increase clearly at levels of PbB around 1.5-
2 flmollL. Females show an increase already at levels of PbB of about 1.3-1.5 
flmol/L, and thus are more vulnerable than males. Therefore, to observe a change 
in concentration of ZPP at these low levels, the determination should preferably be 
carried out in a longitudinal programme. Also one has to reckon with the lower 
sensitivity and specificity of ZPP at lower PbB levels (see Chapter 7). 
Lilis et al. (1977) postulated that ZPP reflects the average exposure to lead over 
several months, whereas PbB reflects also short-term exposure. In workers with 
a long history of lead exposure, ZPP may remain high for many years. It has been 
suggested that this is caused by a continued negative effect on haem synthesis by 
lead released from deposits into the blood. Therefore, ZPP is considered a better 
estimate of the 'active' body deposit of lead than PbB. In fact, when there is no 
anaemia induced by iron shortage or by a disturbance in the utilization of iron, 
high levels of ZPP in subjects with past exposure to lead are evidence of a still 
active lead deposit [Alessio et al. (1981)]. After cessation of exposure, ZPP returns 
to normal more slowly than other effect parameters. 
There are indications that ZPP correlates better with particular effects on kidney 
function [Lilis et al. (1980)] and on the nervous system [Lilis et al. (1985)] than 
does the PbB level. However, the toxic effects of lead on the nervous system are 
unrelated or only secondarily related to alterations in haem synthesis [Moore et al. 
(1987)]. 
Increased excretion of coproporphyrin in urine (CPU) 
The inhibition of coproporphyrinogen oxidase within the mitochondria by lead 
results in an increased excretion of the substrate coproporphyrin (CP) in urine. This 
excretion parallels that of ALA. But the specificity of CPU to predict the level of 
PbB is more modest than that of ALAU, making its application as a screening test 
of limited value [Alessio et al. (1976)]. So measurement of CPU does not result 
in additional information relative to monitoring ALAU. However, Omae et al. 
(1988) reported that after separation by chromotography of the CP isomers CP-I 
and CP-III, analysis of CP-III is sufficiently sensitive and specific for the early 
detection of lead exposure. The excretion of CP-III in urine induced by alcohol 
abuse should be taken into account. 
Decreased concentration of haemoglobin (Hb) 
It is well known that anaemia, which in adults is of the normocytic type, may 
occur in lead poisoning (Chapler 5). Several mechanisms are involved in its 
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development. Lead induces a marked inhibition of haem and globin synthesis and 
also shortens the survival of red cells [Moore et al. (1980)]. 
In many studies a decrease of the Hb concentration was observed in workers 
with PbB levels >2 flmollL. But the failure to find a dose-response relationship 
between the PbB and Hb levels in several investigations may also reflect the non-
specificity of this parameter, as well as the great interindividual variation in its 
sensitivity [Moore (1988)]. 
Inhibition of pyrimidine 5'-nucleotidase in erythrocytes (PsN) 
Lead inhibits the activity of the enzyme P,N which is present in erythrocytes and 
catalyses the dephosphorylation of pyrimidine 5' -monophosphate. This disturbance 
of porphyrin metabolism is considered useful for detecting exposure to lead over 
a wide range as the inhibition is proportional to the level of PbB. It starts at about 
0.5 flIDollL and is complete at about 5 flIDollL. Ichiba and Tomokuni (1988) 
established a correlation coefficient of -0.82 in a study of 77 lead workers with 
PbB levels between 0.8 to 4.6 flmollL. In a study on the inhibition of P,N in 16 
lead workers and a control group, Cook et al. (1986) observed a similar correlation 
as between PbB and ZPP. 
Lead usually affects systems and organs gradually. Moore and Goldberg (1985) 
consider a single effect on the haematopoietic system only as an indication of a 
change in function. All factors together may, however, represent a more serious 
health impairment. 
Table 2.3 presents an overview of the onset of haematological and other adverse 
effects which have been discussed in this Section and in Section 2.2. The wide 
variations in individual sensitivity and the non-specific character of these 
parameters render it difficult to define exact PbB levels for the appearance of these 
effects. Thus, if it is suspected that they are induced by lead, this must be 
confirmed by an increased level of PbB andlor by additional measurements. This 
implies also that the PbB level of a subject does not reflect hislher condition of 
health, but only the risk to health impairment. 
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TABLE 2.3 NO-EFFECT LEVELS OF LEAD IN BLOOD OF ADULTS' 
PbB 
(filllollL) 
3.5 
3 
2.5 
2 
1.5 
o 
Effects 
Effects on gastrointestinal tract 
(Colics. constipation. diarrhoea) 
Nephropathy 
Anaemia 
Hypertension? 
Effects on central nervous system 
Increased excretion of ALAU 
Increased excretion of CPU 
Impaired spermatogenesis 
Increased level of ZPP in blood 
(males) 
Decreased conduction velocity in 
peripheral nerves 
Effects on central nervous system 
of foetus 
Increased level of ZPP (females) 
Inhibition of PsN 
Inhibition of ALAD 
References 
Hanninen ct a1. (I978) 
Verschoor et a1. (I 987) 
Moore (1988) 
See also Chapter 5 
De Kort et al. (1987) 
Baker et al. (1984) 
WHO (1977) 
WHO (1977) 
Kocter et al. (1989) 
Zie1huis (1975) 
Sec also Chapter 7 
SeppaUiinen ct al. (1983) 
Kocter et a1. (1989) 
Zie1huis (1975) 
Ichiba and Tomokuni (1988) 
Ba10h (1974) 
* The values are approximated 'no-response levels', i.c. the effects arc observed in <5% of the 
population studied. 
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CHAPTER 3 
QUALITY CONTROL IN THE ASSAY OF LEAD IN BLOOD 
The extent of exposure to lead and the concomitant occurrence of risks to health 
of people is generally based on the level of lead in blood (PbB). In this respect, 
the legislation in the Netherlands, as well as in other countries of the European 
Community, of the so-called 'Lead Decree' requires, among other things, the 
regular measurement of lead in blood of occupationally exposed workers. Also for 
the establishment of the relation between exposure and adverse responses/effects 
in lead workers the measurement of PbB is decisive. Therefore, there is an 
increased necessity for a reliable assay of this parameter. To obtain insight into the 
quality of the assay of PbB in the Netherlands, two interlaboratory surveys were 
organized. Almost all laboratories that determine PbB more or less regularly took 
part. The outcome of these inspections was that, on the whole, the quality of the 
analysis needed improvement in terms of precision and accuracy. 
3.1 INTRODUCTION 
In the last decades the interest in scientific studies on the relationship between 
(increased) exposure to metals and the associated health hazards has grown 
considerably. However, extensive investigations have clearly shown that the 
analytical equipment available today does not guarantee correct results of the 
determinations of metals in biological samples. These analyses are an essential part 
of the studies. Sometimes determinations in identical samples, within one 
laboratory or in different laboratories, yield widely different results [Parsons 
(1992)]. This fact has been recognized earlier for clinical-chemical determinations 
[Jansen et al. (1977)]. Possible causes are the complex and often inhomogeneous 
composition of the samples to be analysed as well as the application of different 
methods and inadequate analytical techniques. 
In various countries the problem concerning has led to the setting up of round 
robin programmes for clinical-chemical analyses. These programmes aim at 
standardize and improve the quality of the results of the participating laboratories 
by comparing their results. In the United States, the Centers for Disease Control 
in Atlanta has a central role in such extensive programmes [Cooper (1975)]. In the 
Netherlands, quality control programmes for e.g. haematological, serological and 
clinical-chemical determinations are cartied out by the 'Stichting Kwaliteitsbewa-
king Ziekenhuislaboratoria' (SKZL, Quality Control Foundation for Hospital 
Laboratories). Some suppliers of diagnostics also organize quality programmes 
aiming in principle at their own products. 
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It is estimated that in the Netherlands each of 15-20 laboratories performs on 
the average 250-300 analyses of PbB per year. However. only a few laboratories 
participate in continuously running external quality control programmes. 
Incidentally, samples are exchanged between laboratories, or concise programmes 
organized. In most laboratories, however, the necessary continuity in external 
quality control is lacking. 
It is desirable that this situation is improved. In particular for the assay of lead 
in blood, because in the Netherlands, as well as in the other countries of the 
European Community, an EC-directive has become legally binding [EC (1982); 
Labour (1988)]. This so-called 'Lead Decree' indicates which measures should be 
taken in lead-processing industries in order to prevent health hazards to employees 
by exposure to lead and its inorganic compounds. One of the measures comprises 
the determination of the concentration of lead in blood. Depending on the 
particular lead concentration found in a group of workers or in an individual 
worker, additional measures should be taken, i.e. repetition of the determinations, 
or reduction (or where appropriate suspension) of the exposure. 
The introduction of the Lead Decree implies that the results of assays of lead 
in blood may sometimes have radical and far-reaching financial and social 
consequences for employer and employee. If too high PbB values are reported, it 
may lead to drastic measures, such as technical changes or adaptations of processes 
and ultimately to unnecessary removal of the worker from his job. In the reverse 
case that values are reported too low, measures to decrease exposure will probably 
be omitted, possibly leading to hazardous situations. Although generally valid, the 
Lead Decree makes it even more imperative that the results of the determinations 
meet standards with regard to reproducibiliry and accuracy. In the United States the 
Occupational Safety and Health Administration has issued criteria for approving 
laboratories for PbB analysis. These include the requirement that the result of a 
PbB control analysis is performed within 0.3 J.lffiol of the mean of all results (under 
the condition that the mean is less than 1.9 ~molJL) [OSHA (1991)]. 
In this perspective, two interlaboratory surveys into the quality of the 
determination of lead in blood as it was carried out in the Netherlands were 
organized in 1986/87. Including the MBL, almost all Dutch laboratories performing 
the analysis more or less regularly took part. 
3.2 QUALITY CONTROL OF METAL DETERMINATIONS 
The purpose of internal control of metal determinations in a laboratory is to spot 
erroneous results and trends in good time. It is not strictly necessary that the 
concentration of the element to be determined in the samples is known accurately. 
External quality control is carried out on samples in which the concentration of 
the element to be determined is not known (in advance) in the laboratory. This 
method allows a retrospective check of the results. Abroad, external quality 
inspections (so-called interlaboratory surveys or intercomparison programmes) of 
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procedures for metal determinations are carried out regularly. Some of these 
surveys run continuously. 
Paulev et al. (1978) reported the results of an interlaboratory comparison of lead 
and cadmium in blood, urine and aqueous solutions in which five laboratories 
participated. The coefficient of variation (CV) of the results of lead measured in 
two samples were 12.3 and 24.7%. 
Saltzman (1985) collated the results of three programmes for lead 
determinations carried out in the United States between 1973 and 1983. At a mean 
lead concentration of about 2.5 flmollL the results of 28, 54 and 237 laboratories 
fell within a CV of 10, 13 and 19%, respectively. In another round robin 
programme with approximately 30 participants, the mean interlaboratory CV of the 
analysis of PbB decreased between 1975 and 1985 from 19.2 to 5.5% [Taylor and 
Briggs (1986)]. 
In an international interlaboratory survey two bovine blood samples were 
analyzed by 25 participants. The average results (0.27 and 1.2 f.lffiollL, 
respectively) deviated about 10% of the reference values obtained by mass 
spectrometric isotope dilution analysis [Subramanian and Stoeppler (1986)]. 
Sugita et al. (1991) reported results of a quality control programme with 153 
participants. Between 1980 and 1987 the standard deviation of the mean 
'evaluation score' (a measure of the technical level of the analysis of PbB) 
decreased from about 25 to 17%. In an internal quality control programme of the 
analysis of PbB, running over a period of five years, Schaller et aL (1990) obtained 
a CV of 6.7%. 
Parsons (1992) reported that the overall performance of the assay of PbB has 
improved steadily since the 1970's. Among other things, this is attributed to 
participation in external quality control programmes. 
At present continuously running quality control programmes for heavy metals 
are organized in several countries. In Europe these programmes are available from: 
- Danish National Institute of Occupational Health. Copenhagen, Denmark. 
- German Society of Occupational and Environmental Medicine. Erlangen, 
Germany. 
- Queen Elizabeth HospitaL Birmingham, England. 
- Robens Institute of Industrial and Environmental Health and Safety, 
University of Surrey. Guildford, England. 
Since 1973, the Clinical Chemistry Department of the Queen Elizabeth Hospital 
jointly with the Health and Safety Executive in London, carries out the 'U.K. 
External Quality Assessment Scheme' (UK EQAS), among others for the 
determination of lead in blood. Between 1979 and 1985 the number of participants 
in the programme increased from 50 to 120; in this period the mean CV of the 
results of the participating laboratories decreased from about 12% to about 6% 
[Bullock et aL (1986)]. 
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3.3 DESIGN OF THE SURVEYS 
The fourteen Dutch participants in the first survey received six lead-enriched 
human blood samples, at intervals of several weeks. The samples had been put at 
our disposal by dr. D.G. Bullock (Queen Elizabeth Hospital, Birmingham), who 
used identical samples in the UK EQAS. Therefore, it was possible to compare the 
results of the MBL survey with those of the 66 to 95 English participating 
laboratories. The Dutch participants were requested to carry out the determinations 
according to their usual procedures and to process the samples in routine fashion 
with own standard solutions. The majority used the technique of ftameless atomic 
absorption spectrophotometry. 
The second survey was carried out with samples prepared by the MBL The 
sixteen participants received eight times, with intervals of several weeks, a sample 
of lead-enriched human blood and once a solution of lead in I % nitric acid. Half 
a litre of blood from a single person, lysed with EDTA (1.5 gIL), was divided into 
two portions (A and B). To portion A, a solution of lead in I % nitric acid was 
added up to 4.83 fllTIolJL, after which samples of both portions were mixed in 
varying proportions and subjected to ultrasonic vibrations. The blood was then 
sterilized with X rays (7 hours, 60 Gray). In this way samples with the desired lead 
concentration were obtained. These mixtures were distributed over lead-free tubes 
in 2-ml portions under sterile conditions. As in the first survey, the receivers of the 
samples were asked to carry out the determinations in routine fashion according 
to their usual method of analysis and with their own standard solutions. 
It cannot be excluded that determination of lead in blood to which lead has 
been added (so-called 'spiked' blood) yields different results from those obtained 
with blood into which the same concentration of lead has come by 'natural', i.e. 
occupational exposure. In order to test this, a mixture of blood from persons 
occupationally exposed to lead was sent twice to the participants in the first survey. 
The samples consisted of lysed blood distributed over lead-free tubes without any 
further treatment. 
3.4 RESULTS AND DISCUSSION 
In the first survey, two laboratories did not send in any results. In all, determi-
nations in 75% of the samples distributed were received. In Table 3.1 the results 
obtained by both the English and Dutch participants are reported. 
According to the two-tailed Welch test the means of the English and Dutch 
participants are not significantly different. Although for sample 5 P, = 0.019 (iffor 
a single result P2 <0.05, there is a statistically significant difference with a 
confidence limit of 95%), the chance that all six P;s >0.05 is only 73.5%. It is 
only at a P, <0.008 that the difference may be considered significant in this 
experimental design. 
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TABLE 3.1 RESULTS OF LEAD DETERMINATIONS CflMOLlL) BY DUTCH" AND ENGLISH' 
LABORATORIES IN THE FIRST SURVEY 
Dutch laboratories, sample number 
Lab.c 2 3 4 5 6 
2 1.77 3.18 1.97 2.51 3.92 2.19 
3 1.53 2.88 2.02 2.92 2.86 2.42 
4 2.13 3.83 3.22 
5 2.10 3.60 4.60 1.80 
7 1.72 2.70 1.93 2.53 3.54 2.43 
8 1.94 3.27 2.60 
9 1.28 2.05 2.75 5.17 2.22 
11 1.93 3.43 2.25 2.48 4.25 2.93 
12 2.40 3.10 2.30 2.40 4.30 2.90 
14 3.04 2.64 2.23 3.19 4.25 2.43 
15 1.85 2.90 1.80 3.62 3.60 3.62 
16 1.74 1.77 1.82 2.51 3.41 2.31 
Aritbm. 
mean 1.94 2.83 2.04 2.70 3.92 2.59 
Cacff. of 
variation (%) 24 20 10 16 16 19 
English laboratories 
Number 95 66 78 71 85 66 
Arithm. 
mean 1.72 2.84 1.98 2.57 3.41 2.48 
Coeff. of 
variation (%) 9.7 8.4 7.4 7.1 9.1 7.5 
p/ 0.15 0.96 0.43 0.37 0.019 0.47 
a. Among the Dutch results there were none that deviated from the mean by more than three times 
the standard deviation (SD). 
b. After elimination of results that deviated from the mean by more than three times the SD. 
c. In the text and the tables the various laboratories arc referred to by the same code numbers. 
d. According to the two-tailed Welch test of the difference between the Dutch and the English mean. 
Except for sample 3 the coefficient of variation (CV). and therefore the range 
of the Dutch results, is far wider than that of the English. This points to a smaller 
accuracy of the Dutch lead determinations, as compared with the English results. 
This appears also from the results plotted in Figures 3.1a-b. 
Most of the values measured by laboratories II and 12, minus the mean of all 
laboratories, are significantly >0 (P 2 <0.05), which means that these results are 
systematically too high (Hest). 
It is clear from this survey that the quality of the results of the lead 
determination by the Dutch participants is on the average far poorer than that of 
the English participants. For four out of six samples the CV is more than twice that 
ofthe corresponding English results (Table 3.1). The individual results in Table 3.1 
also show this unacceptable variation around the mean. In three out of six samples 
the highest concentration measured is more than double the lowest one. 
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Figure 3.1a Results of lead determinations in samples 1~3 by English (closed bars) and 
Dutch (open bars) laboratories in the first interlaboratory survey. 
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Figure 3.lb Results of lead determinations in samples 4-6 by English (closed bars) and 
Dutch (open bars) laboratories in the first interlaboratory survey. 
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In the second survey, results of 99% of the samples sent were received. In Table 
3.2 the results are reported. Sample 10 was the blood to which no lead had been 
added. The mean value therefore represents the 'natural' concentration. Sample 11 
consisted of the solution of lead in nitric acid that had been used to enrich the lead 
concentration in samples 12 through 18. The concentration of lead in these samples 
therefore amounts approximately to the mean found in sample 10, increased by the 
added quantity, also indicated in Table 3.2. 
TABLE 3.2 RESULTS OF LEAD DETERMINATIONS ()!.MOUL) BY DUTCH LABORATORIES 
IN THE SECOND SURVEY 
Sample number 
Lab. 10 II' 12 13 14 15 16 17 18 
1 1.11 2.03 1.51 1.30 1.70 1.23 2.89 3.07 3.50 
2 0.98 2.28 1.15 1.06 1.21 1.25 2.62 3.87 4.01 
3 1.32 1.82 1.54 1.87 1.36 2.27 2.63 2.90 3.89 
4 1.16 2.64 1.11 0.84 1.88 0.73 2.23 3.60 3.25 
5 1.50 2.80 1.60 1.40 1.70 0.80 1.20 2.20 4.20 
6 1.45 1.81 1.74 0.82 1.75 1.79 4.64 8.50b 4.73 
7 2.86 0.94 1.00 0.89 1.23 2.42 3.36 3.61 
8 1.06 0.06 1.15 1.05 0.96 1.12 2.23 3.66 3.31 
9 1.01 1.45 1.06 0.97 0.68 1.09 2.61 2.95 
10 1.26 0.94 1.35 1.40 1.40 1.45 2.27 2.61 2.56 
II 1.13 2.16 1.45 1.30 1.26 1.25 3.42 3.79 3.63 
12 0.61 2.39 0.80 1.10 1.50 1.26 1.97 2.70 3.00 
13 1.32 2.51 1.32 1.33 1.38 1.49 3.01 5.62 3.91 
14 0.76 2.48 1.01 1.00 0.98 1.02 2.51 3.43 3.99 
15 0.65 1.98 1.30 1.14 1.40 1.30 3.04 3.77 3.38 
16 1.01 2.48 1.14 1.00 1.22 1.37 2.45 3.34 4.01 
Arithm. 
me:m 1.09 2.04 1.26 1.16 1.33 1.29 2.64 3.39 3.67 
Cocff. 
of var. 
(%) 25 36 21 22 26 28 28 23 14 
Lead 
added 0 2.41 0.25 0.10 0.15 0.25 1.69 2.66 2.90 
a. Solution of lead in 1 % nitric acid. 
b. X > mean + 3 SD. not included in calculation of the mean. 
The expected values and the corresponding means found do not differ significantly 
(t-test). The range of the results, however, is unacceptably wide, as appears from 
the coefficient of variation. In most samples the highest and lowest values 
measured differ by a factor of 2 or more. The results from laboratory 9 are 
systematically too low (t-test). 
In imitation of the Queen Elizabeth Hospital the results of the assays were 
calculated for each sample with the indices of variation (N) according to the 
method of Whitehead (1977). 
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IV = X-X. 100 . 100 
X C 
in which: IV= index of variation 
X = individual result 
X = mean of all results (in the first survey 
the mean of the English results) 
C = selected coefficient of variation of 15% 
The CV of 15% in the formula implies that deviation of a result of that size of the 
mean of all results gives an IV of 100. By means of the IV both the quality of the 
laboratories' results for one sample and the variation in quality with different 
samples in time within one laboratory can be compared. 
Table 3.3 shows the results of the first survey after analysis according to the 
method of Whitehead. For this analysis not the mean of the Dutch results but that 
of the English ones was used. This mean has been obtained from far more results 
and is, therefore, more likely to represent the correct lead concentration in the 
samples than the Dutch mean. 
TABLE 3.3 INDEX OF VARIATION (IV) AND ARITHMETICAL MEAN OF THE LEAD 
DETERMINATIONS BY DUTCH LABORATORIES IN THE FIRST SURVEY 
Lab. I 2 3 4 5 6 Mean 
2 19 80 3 16 100 78 49 
3 74 9 13 91 108 16 52 
4 II4 82 199 132 
5 147 178 233 183 185 
7 0 33 17 10 25 13 16 
8 85 27 32 48 
9 171 185 47 344 70 163 
II 81 138 91 23 164 121 103 
12 264 61 108 44 174 II3 127 
14 400' 47 84 101 164 13 145 
IS 50 14 61 272 37 306 123 
16 8 251 54 16 0 46 63 
a. When IV >400 a value of 400 is used. 
In Table 3.4 the IV values and the mean IV of the results obtained in the second 
survey are presented, calculated according to the method of Whitehead. 
The English authorities accept only results of lead determinations when these 
have been carried out by a laboratory that takes part in the UK EQAS. 
Furthermore, they demand that the CV, as calculated from the last ten results, is 
12% or less (this means a IV of 80 or less). If this norm is applied to the Dutch 
results, in each survey five laboratories meet this demand (Tables 3.3 and 3.4). 
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TABLE 3.4 INDEX OF VARIATION (IV) AND ARITHMETICAL MEAN OF THE LEAD 
DETERMINATIONS BY DUTCH LABORATORIES IN THE SECOND SURVEY 
Lab. 10 11 12 13 14 15 16 17 18 Mean 
I 12 3 132 80 185 31 63 63 31 67 
2 67 78 58 57 60 21 5 94 62 56 
3 141 72 148 400u 15 400u 3 96 40 146 
4 43 196 79 184 276 289 104 41 76 143 
5 251 248 180 138 185 253 364 234 96 217 
6 220 75 254 195 211 258 400' 400(1 193 245 
7 268 169 92 221 31 56 6 11 107 
8 18 400u 58 63 185 88 78 53 65 112 
9 49 193 106 109 326 103 8 87 123 
10 104 359 48 138 35 83 93 153 202 135 
11 24 39 101 80 35 21 197 79 7 65 
12 294 114 243 34 85 16 169 136 122 135 
13 141 154 32 98 25 103 93 400u 44 121 
14 202 144 132 92 175 140 33 8 58 109 
15 269 20 21 11 35 5 101 75 53 66 
16 49 144 63 92 55 41 48 10 61 63 
a. When IV >400 a value of 400 is used. 
However, it should be noted that in the surveys the mean IV has been calculated 
from nine or fewer values. 
According to the Bartlett test there is no difference between the variances of the 
lead determinations in blood to which lead has been added and those in blood into 
which the lead has come by exposure (P = 0.099) (Data not shown). This means 
that the ranges of the results of the two series of samples do not differ 
significantly. So there is no reason to suppose any influence from the way in which 
the lead came into the blood on the accuracy of the results. 
In the first survey five laboratories achieved an IV lower than 80 and in the 
second survey again five. Of the latter, four had also participated in the first 
survey. Only two laboratories showed a mean IV lower than 80 in both surveys. 
Out of twelve laboratories participating in both surveys, four had a higher mean 
IV in the second survey. Thus, in the second survey their results deviate more from 
the mean values, so the quality of their determinations has deteriorated. Another 
four laboratories had a smaller mean IV, in these the quality of the determinations 
has improved. Four laboratories achieved an approximately equal IV in both 
surveys. 
3.5 CONCLUSIONS AND RECOMMENDATIONS 
Almost all Dutch laboratories that carry out lead determinations in blood took part 
in the two interlaboratory surveys. In the first surVey with six samples the mean 
deviation of the arithmetical mean was less than 10% in five out of twelve 
participants and in the second survey with nine samples in five out of sixteen 
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participants. Only two participants out of twelve that took part in both surveys 
deviated in both surveys on average less than 10% from the mean. 
The small number of participants in the surveys did not allow judgement of the 
results with respect to the analytical method used. However, based on the results 
of the UK EQAS, Bullock et al. (1986) concluded that owing to the improved 
overall performance, small differences between the methods of analysis had 
disappeared since 1983. In the present surveys there were no indications that the 
accuracy of the results was influenced by the manner in which the lead had come 
into the blood. 
On the whole the performance of the determination of lead in blood in respect 
to precision and accuracy is in need of improvement. In order to improve the data 
it is suggested that the analyses should be carried out in qualified laboratories by 
technicians who have comprehensive experience in measurements of low-level 
trace elements in biological samples, and which carry out these analyses regularly. 
Also a detailed, validated protocol can contribute to the quality. Furthermore, in 
daily routine reproducibility must be checked by analysis of so-called 'internal 
control samples' along with each series of actual determinations, The results help 
in identifying any trends in the intralaboratory performance which occur in course 
of time and aim also to keep precision within acceptable limits. Such (certified) 
samples are available commercially, among others from the Community Bureau of 
Reference of the European Community in Brussels, Belgium, and from the 
National Institute for Standards and Technology, Gaithersbury, U.S.A. Finally, 
participation of laboratories in external quality control programmes, preferably with 
a large number of participants, is strongly recommended. This allows the analysis 
of samples with unknown concentrations of lead, together with many other 
laboratories and thus estimation of the deviation of obtained results from the 'true' 
value. In these quality control programmes, the true value of Pb in a sample is 
usually considered the mean of the results of all participants, after the removal of 
extreme deviant results. 
These recommendations may result in a coefficient of variation of the PbB 
analysis of about 6% [Bullock et aI. (1986)], instead of the values obtained in the 
present surveys, which ranged between 10 and 36%. 
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CHAPTER 4 
BLOOD LEAD AND BLOOD PRESSURE: SOME IMPLICATIONS FOR 
THE SITUATION IN THE NETHERLANDS' 
W.L.A.M. de Kort and W.C.M. Zwennis 
Studies performed earlier have shown a positive relation between blood lead (a 
parameter for lead body burden) and blood pressure, whereas such a relation 
between urine cadmium (a parameter for cadmium body burden) and blood 
pressure could not be shown. Median (i.e. 50th percentile, P 50) blood lead levels in 
the general population in the Netherlands are in the range of 80 to 150 flglL··. 
Persons occupationally exposed to lead show median blood levels that may exceed 
400 flg/L. To study causality, a prospective study among lead workers is desired. 
4.1 INTRODUCTION 
In the literature, a positive, rather than a negative relation between lead and blood 
pressure is more often cited. Furthermore, experimental (animal) studies render 
some support to this relation, although a satisfactory explanation by some 
underlying mechanism is not yet at hand. Recently, the U.S. Environmental 
Protection Agency published an extensive report on lead, which contained a review 
on this topic [EPA (1986)]. Apart from the fact that positive results are more easily 
reported than negative results, the actual existence of a positive relation should be 
seriously considered. 
The relation between occupational lead exposure and blood pressure was 
studied in the Netherlands [De Kort et al. (1987)]. After a brief review of this 
study, some results are presented of studies on the blood lead values in the general 
population in the Netherlands. An attempt will be made to evaluate the 
consequences of these results. 
4.2 LEAD WORKER STUDY 
A group of 53 occupationally exposed workers (from a plant processing lead and 
cadmium compounds) was compared with a group of 52 workers not occupa-
Published in Environmental Health Perspectives 78:67-70 (1988) . 
.. Note added: 100 !lg lead corresponds to 0.48 )lffiol. 
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tionally exposed (from a plant where insulation materials are produced). For the 
results to be included in the analysis, the worker had to have been employed for 
more than I year and not be under treatment for hypertension. Further details 
concerning the methods used in this study have been described previously [De Kort 
et al. (1987)]. The groups were comparable with regard to their socio-economic 
background, physical exertion, workplace conditions (apart from exposure), place 
of residence, and some lifestyle characteristics. A statistically significant difference 
existed concerning their age and their duration of employment (Table 4.1). 
The average values of systolic and diastolic blood pressure were found to be 
higher in the exposed group (Table 4.2). Because the workers were exposed to 
both lead and cadmium and because the exposed group was on the average older 
TABLE 4.1 AGES AND DURATION OF EMPLOYMENT' 
n 
Age 
Years at work 
Pb-exposed 
53 
42.1 ± 1.2b 
12.5 ± 1.2 
a. From de Kort et a1. (1987). 
b. Values are means ± SEM. 
Controls 
52 
38.2 ± 1.1 
8.6 ± 0.8 
TABLE 4.2 BLOOD PRESSURE AND HEART RATE' 
n 
Systolic blood 
pressure, rom Hg 
Diastolic blood 
pressure, mm Hg 
Heart rate. 
beats/min 
Pb-exposed 
53 
86 ± 2 
78 ± 2 
a. From de Kort ct al. (1987). 
b. Values are means ± SEM. 
c. NS. non-significant. 
Controls 
52 
131 ± 3 
80 ± 2 
81 ± 2 
Significance 
p <0.05 
p <0.01 
Significance 
p=O.DI 
p = 0.01 
NS' 
than the control group, further statistical analyses were performed. Calculation of 
the correlation coefficients revealed significant results for the correlation between 
blood lead and blood pressure while controlling for age and heart rate; additional 
adjusting for urine cadmium (only feasible for a smaller number of complete data 
sets) revealed a non-significant result at the 0.05 level. On the other hand, no 
significant result was obtained for the correlation between cadmium and blood 
pressure if age effects were controlled for (Tables 4.3 and 4.4). 
The following regression equation was obtained for systolic blood pressure using 
multiple linear regression analysis: 
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P"" (~H,l = 73.8 + 0.018 x PbB (~glL) + 0.52 x age (years) + 
+ 0.45 x heart rate/min 
The regression equation for diastolic blood pressure contained no significant 
contribution from blood lead (the coefficient in the equation being 0.010, P >0.10). 
Kidney function parameters (serum creatinine, blood urea nitrogen, retinol binding 
protein in urine, relative uric acid clearance, and total protein) revealed no 
significant differences between the groups. From the study, which had its 
limitations (small groups, insufficient data on body mass index), it was concluded 
that a positive relationship may exist between blood lead level and blood pressure 
(notably systolic blood pressure). A relationship between urine cadmium and blood 
pressure appeared to be linked with age. 
TABLE 4.3 ZERO·ORDER CORRELATION COEFFICIENTS FOR SYSTOLIC BLOOD 
PRESSURE' 
Parameter 
Blood lead 
Urine cadmium 
Age 
Heart rate 
a. From de Kort ct a1. (1987). 
0.29 
0.22 
0.34 
0.34 
p 
0.003 
0.04 
0.001 
0.001 
TABLE 4.4 PARTIAL CORRELATION COEFFICIENTS FOR SYSTOLIC BLOOD PRESSURE' 
Parameter 
Blood lead, adjusted 
for age. heart rate 
Urine cadmium. adjusted 
for age. heart rate 
Blood lead. adjusted 
for age. heart rate, 
urine cadmium 
a. From de Kort ct a1. (1987). 
r p 
0.22 0.02 
0.13 0.22 
0.20 0.07 
4.3 BLOOD LEAD LEVELS IN THE NETHERLANDS 
Several studies have been performed to gain a clearer insight into the average 
blood lead levels in the Dutch population [PHC (1984)]. Some studies were 
particularly aimed at assessing blood lead levels in children [Zielhuis et al. (1979); 
Ligeon et al. (1981)]. In other studies samples from draftees, which are being 
gathered at regular intervals, were examined for heavy metal contents such as lead 
and cadmium [Ellen et al. (1984)]. Another study reported on blood lead levels and 
other trace metal levels in elderly men [Kromhout et al. (1985)]. Occupationally 
exposed persons frequently have been the subject of epidemiological studies. Some 
of the results are presented here. 
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Blood lead levels in children 
In 1984, a committee of the Public Health Council in the Netherlands has 
published recommendations for air quality criteria for lead [PHC (1984)], The 
committee has also taken into consideration accepted limits for blood lead levels 
in children as recommended by Zielhuis et aL (1979) (Table 45). 
In co-operation with the European Community, blood lead levels were assessed in 
children under the age of 6 years, in several small and large cities, in 1979 and in 
1981 [Ligeon et aL (1981)]. The results showed that the limit values were generally 
not exceeded, with median (50th percentile, Pso) values declining over the years, 
being at a level of 130 J.1g/L in 1981 (Table 4.6). 
TABLE 4.5 DUTCH PUBLIC HEALTH STANDARDS FOR CHILDREN' 
Percentile Blood lead (~g!L) 
P50 200 
P90 250 
P98 300 
a. From Zielhuis ct al. (1979). 
TABLE 4.6 BLOOD LEAD LEVELS IN CHILDREN. AGE 6 YEARS' 
City 
Rotterdam-centre 
(n ± 99) 
The Hague 
(n ± 88). 
a. From Ligcon ct al. (1981), 
Blood lead levels in draftees 
Blood lead (~g!L. P501P98) 
1979 
160/330 
180/320 
1981 
130/220 
1301230 
The National Institute of Public Health and Environmental Protection in the 
Netherlands has reported on blood lead levels in draftees [Ellen et al. (1984)]. In 
random samples (of at least I % of all draftees in one year) blood lead levels of 
draftees in several years have been assessed (Table 4.7). The results in 1980 and 
1982 showed markedly lower values when compared with those of earlier years 
(1976). Furthermore, trend analyses showed a significant downward trend over time 
within the 198011982 groups. The investigators suggested that reducing the 
gasoline lead content in 1978 might have played a role. 
TABLE 4.7 BLOOD LEAD LEVELS IN DRAFTEES' 
n 
Blood lead (~glL, 
P501P98) 
a. From Ellen ct aI. (1984). 
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1976 
1170 
140/350 
1980 1982 
175 150 
901210 80/200 
Blood lead levels in lead workers 
It is estimated that in the Netherlands (14.5 million inhabitants) less than 10,000 
and approximately 5,000 workers are occupationally exposed to lead, a figure that 
is expected to become smaller. In the near future, a directive from the European 
Community will be implemented in Dutch legislation, including action levels and 
threshold values for blood lead levels of occupationally exposed workers (Table 
4.8)'. 
TABLE 4.8 PROPOSED ACTION LEVELS AND THRESHOLD LEVELS OF PbB FOR 
OCCUPATIONALLY EXPOSED PERSONS 
Blood lead level C!-lgIL) 
>300 
>500 
>600 
700 (threshold) 
or 700 - 800. provided 
Zppb <20 ~g1g Hb 
:l. Applies only to the worker concerned. 
b. ZPP, blood zinc protoporphyrin content. 
Requirements 
Information to workers 
Hygienic measures 
Opportunity to undergo medical examination 
Medical surveillance 
Information to workers 
Hygienic measures 
Opportunity to undergo medical examination 
Intensive medical 
examinationa 
Medical surveillance 
Information to workers 
Hygienic measures 
If occurring twice within 3 months. 
withdrawal from exposure 
Supported by the Directorate General of Labour, the TNO Medical Biological 
Laboratory performed a health and health hazard survey in branches of industry, 
where occupational exposure to lead is an important factor. The blood lead levels 
obtained in this survey were pooled, and the results (Table 4.9 and Fig. 4.1) show 
that median (Pso) values vary between 288 Ilg/L and 339 IlglL for Dutch workers 
and between 381 Ilg/L and 451 IlglL for workers of mediterranean origin. 
However, it must be emphasized that the workers exantined in this survey probably 
do not constimte a group that is representative for all lead workers. More likely 
they represent those who are exposed to relatively high levels of lead, as the 
survey was preferentially performed in workplaces with levels of exposure 
expected to be higher than average . 
. Notc added: The Directive is legally binding from 1988. 
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TABLE 4.9 BLOOD LEAD LEVELS IN MALE LEAD WORKERS IN THE NETHERLANDS" 
Dutch workers 
Age n P50 P90 
<30 149 302 725 
30-39 136 288 588 
40-49 128 339 635 
;'50 138 292 675 
a. Blood lead levels in J,.lg/L. 
700 
60 0 
" .; 50 0 
~ 
o 
o 
" o 
~ 40 0 
o 
-" 
30 0 
20 0 
10 0 
0 
;; 
~ ~ ;; ;; ~ ;; ~ ~ ~ ~ ~ V:: V:: 
<30 30 39 
149 81 136 75 
P98 
929 
795 
774 
886 
Mediterranean workers 
n 
81 
75 
65 
24 
~ % ~ ~ % ~ ~ 
40 49 
128 6S 
P50 P90 P98 
381 662 762 
451 689 772 
389 704 863 
424 710 927 
;;; ~ ~ ~ V:: 
~50 age 
138 24 
number of 'Workers 
-
Figure 4.1 Average lead~inwblood values ± SD of Dutch lead workers (open bars) and mediterranean 
lead workers (hatched bars) in the Netherlands. 
4.4 DISCUSSION 
The study of lead workers indicates the possibility of a positive relation between 
blood lead and blood pressure. The effect on systolic blood pressure is in the order 
of magnitude of an 1.8 mm Hg increase per 100 flg/L increase in blood lead level 
when a linear relation is assumed. If a relationship between blood lead level and 
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diastolic blood pressure exists, then here the increase per 100 /lgIL increase in 
blood lead level would amount to approximately 1.0 mm Hg. These figures are 
lower than those found in the NHANES II study [Pirkle et al. (1985)], but well in 
accordance with the results found by Kirby and Gyntelberg (1985). However, it 
must be kept in mind that linearity of a relation is merely an assumption, provided 
an effect does exist. In particular, at lower blood lead levels (i.e. values <100 
/lgIL), deviation from linearity would not be a surprising result. Nevertheless, since 
median blood lead levels of persons not occupationally exposed in general do not 
exceed 200 /lgIL, reducing this level to zero could imply an average lowering of 
systolic blood pressure with 3.6 mm Hg and perhaps an average lowering of 
diastolic blood pressure of 2.0 mm Hg. 
In most studies median blood levels are lower than 200 /lgIL, and reducing this 
level to zero will probably not be possible. As a result, detecting an effect of the 
lowering of blood lead levels will not be an easy task: population standard 
deviation in blood pressure measurements can vary from 15 to 25 mm Hg (for 
systolic blood pressure). Thus, if a difference of 1.8 mm Hg is to be detected, 
using first and second type error probabilities of 0.05 (two-sided and one-sided, 
respectively), groups of at least 3200 persons each have to be examined. The 
detection of such differences will be further impaired because of the many factors 
(lifestyle, genetic, environmental, etc.), which may influence the outcome of blood 
pressure measurements. In statistical terms, the stability of blood pressure 
measurements might even decrease further if many factors are controlled for, 
demanding even larger groups to be examined. 
Because the half-time of blood lead is rather long, a follow-up study will 
necessarily have to be performed over several years if one chooses to use a 
longitudinal study. Also, it is not known if a blood pressure-raising effect of lead 
is at all reversible. If cross-sectional studies are preferred, one might have to take 
into account the additional disadvantage of a cohort effect, which could hide an 
effect or erroneously reveal one. A prospective study of lead workers may yield 
more conclusive results, because the occupational level of lead exposure is higher 
than the level of exposure in the general population. 
In conclusion, the expected reduction of environmental pollution with lead due 
to the reduction of the gasoline lead content and the expected reduction of 
occupational exposure due to hygienic measurements make a reduction of body 
burden in the general population, as well as in the occupationally exposed 
population, likely. In the Dutch situation, further epidemiologic evaluation of an 
effect on blood pressure will be difficult to perform. Prospective studies, e.g. in an 
occupational setting, are desired. 
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CHAPTER 5 
OCCUPATIONAL EXPOSURE TO LEAD AND THE INCIDENCE 
OF ANAEMIA' 
W.C.M. Zwennis and A.Ch. Franssen 
In a study on the occupational exposure to lead of industrial workers in the 
Netherlands, the concentration of lead and haemoglobin was determined in blood 
of 494 Dutch, 59 Moroccan and 18 Turkish male employees. In the Dutch group 
a small but significant negative correlation was observed between the 
concentrations of lead (maximum 5 J.ImollL) and haemoglobin (a = 0.05, one-sided 
testing). In the Morrocan and Turkish groups no statistically significant correlation 
was found. In Dutch employees with a low-to-normal haemoglobin value, 
occupational exposure to lead may therefore cause anaemia. 
Key words: lead, anaemia, haemoglobin concentration, occupational exposure 
5.1 INTRODUCTION 
Biological monitoring constitutes an important part of health control programmes 
for employees exposed to lead (compounds) during their work. The determination 
of the concentration of lead in blood (PbB), which is now in general use, gives an 
insight into the recent and total lead uptake of the individual employee. 
In the near future a European Community Directive controlling the protection 
of employees against the health hazard of exposure to lead will become operative 
(Directive 82/605IEEC)". This Directive indicates under which circumstances, 
and how often, the concentration of airborne lead dust at the work site, andlor the 
concentration of lead in blood of the exposed employees, must be measured. 
Furthermore, the Directive indicates that in certain circumstances clinical 
surveillance of speCified parameters may also be required, e.g. zinc protoporphyrin 
in blood, o-aminolaevulinic acid dehydratase in blood, or o-aminolaevulinic acid 
in urine . 
. Published in 'Tijdschrift voor Socialc Gczondhcidszorg' 65:601~604 (1987). (In Dutch. 
English summary available) . 
.. ~ See note page 47. 
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In the past the determination of lead in blood involved practical problems, and 
other parameters were used to judge the uptake of lead; parameters which are 
based on the effects of lead on the haematopoietic system. In this paper their 
biochemical base is discussed. The results of an investigation into the correlation 
between the lead concentration in blood and the haemoglobin concentration (Hb) 
are also reported. 
5.2 EFFECTS OF LEAD ON THE HAEMATOPOIETIC SYSTEM 
As early as the end of the last, and the beginning of this century, experiments with 
rabbits and observations of patients suffering from lead intoxication revealed 
symptoms pointing at effects of lead on haem synthesis [Stokvis (1895); Gotzl 
(1911)). Binnendijk [cited by Stokvis (1895)) was the first to note an increased 
porphyrin concentration in urine of intoxicated patients. In 1927 Liebig suggested 
that lead-induced anaemia is caused by the destruction of the erythrocytes. In 1957 
Haeger noted an increased excretion of o-aminolaevulinic acid in the urine of 
workers exposed to lead. 
Figure 5.1 shows a simplified scheme of haem biosynthesis and the effects of 
lead on it. 
In the first step the coupling of glycine and succinyl-CoA is catalysed by 0-
aminolaevulinic acid synthetase, under formation of o-aminolaevulinic acid (ALA). 
Then, under the influence of o-aminolaevulinic acid dehydratase (ALAD), from 
two ALA molecules porphobilinogen (PBG) is formed. In the third step four PBG 
molecules are coupled by the enzymes uroporphyrinogen-1-synthetase and 
uroporphyrinogen cosynthetase to form uroporphyrinogen (URO). By subsequent 
decarboxylation and oxidative transformation effected by the enzymes uro-
porphyrinogen decarboxylase, coproporphyrinogen oxidase and protoporphyrinogen 
oxidase, protoporphyrin IX is formed. 
In the last step of the pathway iron is incorporated into this molecule, leading 
to the formation of the haem group. This group is used for the formation of 
haemoglobin, but it is also a component of some enzymes, e.g. cytochrome P-450 
and catalase [Moore et aL (1980)). 
Lead may form complexes with chemical compounds containing sulphydryl-, 
amino-, carboxyl-, phenoxy- or imidazole-groups. When this complex formation 
concerns functional groups of enzymes it is often associated with inhibition of 
enzyme activity. A number of enzymes involved in the biosynthesis of the haem 
group are thus more or less inhibited by lead. Most of the research in this 
connection has been carried out with ALAD. The almost complete inhibition of 
this enzyme by an increased lead concentration blocks the further conversion of 
ALA, resulting in an increased excretion with the urine. There are no indications 
that this inhibition affects health. ALAD inhibition and ALA excretion are now, 
at least in the Netherlands, only used to a limited extent in connection with lead 
exposure. 
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I o-AMINOLAEVULINIC ACID (ALA) I 
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• ferrochelatase 
I HAEM I 
excreted in urine 
excreted in urine as 
coproporphyrin 
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Figure 5.1 Haem biosynthesis. Lead inhibits tvlo enzymes (horizontal drawn arrows) and possibly 
inhibits two morc (horizontal dotted arrows), 
Coproporphyrinogen oxidase is also inhibited by lead, which leads to an 
increased excretion of coproporphyrin with the urine. The by now obsolete 
determination of Donath (1956) is based on this principle. Lastly, the inhibition of 
ferrochelatase, the enzyme that catalyses the incorporation of iron into 
protoporphyrin IX, should be mentioned. The inhibition results in the incorporation 
of zinc instead of iron into the substrate. 
Beside the above-mentioned effects on haem biosynthesis, exposure to lead also 
induces increased fragility and associated accelerated destruction of the 
erythrocytes. 
5.3 ANAEMIA DUE TO LEAD EXPOSURE 
A decreased haemoglobin concentration in blood due to occupational lead exposure 
is often observed. According to Zielhuis (1959) 13 out of 21 workers (62%) at 
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small accumulator factories had a Hb value lower than 8.5 ~mol/L and 17 a Hb 
lowerthan 9.1 ~mol/L (81%). These percentages were higher than those measured 
in industries with no or little lead in the atmosphere. In this study lead in blood of 
the workers was not measured. 
Tola et al. (1973) reported that in persons exposed to lead for the first time an 
increased PbB up to about 2.4 ~mollL was associated with a small but significant 
decrease in Hb after several months (1 ~ol PblL = 207 ~glL = 207 ppb). 
Out of 46 lead workers having a PbB between 1.9 and 3.8 ~mol/L. 37% had 
a Hb lower than 8.5 mmollL [Lilis et al. (1977)]. Fischbein et al. (1978) 
established a significant difference between the mean Hb of 34 lead workers (PbB 
levels <3.8 ~mol/L) and that of 34 controls: 47% of the workers had a Hb lower 
than 8.6 mmol/L against 12% of the control group. 
Examination by Grandjean (1979) of 202 male workers with levels of PbB up 
to about 4 ~01JL, showed a statistically significant correlation between Hb and 
PbB, but the median of the Hb values remained within the reference range (8-11 
mmol/L; 1 mmol HblL = 16.125 gIL, Hb/4). 
In two secundary lead smelteries and in a factory producing lead-containing 
pigments, in 27 out of 129 persons examined a Hb concentration lower than 8.7 
mmollL was found. These 27 persons had a significantly higher PbB than the other 
collaborators: 20 persons having a PbB higher than 3.9 ~mol/L, six a PbB between 
2.9 and 3.8 ~mol/L and one a PbB less than 2.9 ~molJL [Baker et al. (1979)]. 
In twelve secondary lead smeltery workers who were checked regularly for PbB 
and Hb for twelve years, no statistically significant difference was found between 
mean Hb at the beginning and at the end of that period. The highest PbB value 
found in this period was 4.2 ~011L, while the mean PbB ranged from 1.3 to 2.7 
~mollL [Valentine et al. (1982)]. 
5.4 STUDY DESIGN 
Within the scope of a health hazard survey in the lead-processing industry, carried 
out by the TNO Medical Biological Laboratory by order of the Directorate General 
of Labour, lead and haemoglobin concentrations were determined in blood samples 
of a large number of persons working in several branches of industry. 
Lead was determined by means of atomic absorption spectrophotometry 
following the method of Schaller (1983). The coefficient of variation in time, 
obtained by analyzing identical control samples, was 7%. For the determination of 
haemoglobin the photometric method of Van Kampen and Zijlstra (1961) was used. 
The coefficient of variation in time, determined with identical control samples, was 
2%. 
Because of the extent of the survey, which involved several thousands of 
persons working in dozens of industries of different character, a good insight into 
the levels of lead in blood of occupationally exposed employees in the Netherlands 
was obtained. On the strength of an inventory of the use of lead and lead 
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compounds in the Dutch industry, it is justified to conclude that higher values than 
found are unlikely in the Netherlands. 
In this paper the correlation between the lead and haemoglobin values found in 
male employees working for five years or more in the same jobs are reported. Part 
of the men were exposed to dust or aerosols of metallic lead, the others to dust of 
lead compounds like lead oxide or insoluble inorganic lead salts. The purpose of 
the study was to determine whether the present levels of exposure to lead in the 
Dutch lead-processing industry may cause a decrease in haemoglobin concentration 
in employees. The reference values of haemoglobin used were 8.6 - 10.9 mmoVL. 
These values are based on a large number of Hb values in adult Dutch men 
considered as healthy [Helleman et al. (1973)]. 
5.5 RESULTS AND DISCUSSION 
The population under study consisted of employees with Dutch, Morrocan or 
Turkish nationaliry. In general, clinical laboratories in the Netherlands base the 
reference values of haemoglobin for ethnic minorities on those of Dutch people 
(personal communication, P.H. Trienekens). The influence of age, race, nutritional 
habits and geographical origin on the concentration of Hb of adults is small. As no 
data are known on possible differences in the influence of lead on Hb in 
Dutchmen, Morrocans and Turks, the results for the three groups of employees 
were calculated separately. 
Figure 5.2 gives the correlation between PbB and Hb in 494 Dutchmen and 
Figure 5.3 that in 59 Morrocans and 18 Turks. For the Dutchmen the slope of the 
regression line is -0.0586, with a standard error of 0.0307. In a one-tailed test, the 
null hypothesis that the Hb concentration does not decrease with increasing lead 
concentration is rejected at a level of significance of 5% (PI = 0.032; upper limit 
of slope -0.006). Tested similarly, the slope found for the Morrocans does not 
differ significantly from zero (upper limit slope 0.124). The observations in the 18 
Turkish employees do not meet the assumptions of the linear regression model. 
They do not show a significant Spearman rank correlation between PbB and Hb 
either. 
The slope found in the Dutchmen corresponds to a decrease in Hb of 0.28 
mmollL over the Pb range of 0-5 J.lmoVL. Using a confidence interval of 95% the 
maximal decrease over this range is 0.59 mmoVL. Although this decrease is small, 
it can lead to anaemia in those employees who have a Hb approaching the lower 
limit of the reference range (8.6 mmoVL) at the start of their work in the lead-
processing industry. The linear regression line in the Dutchmen gives a 95% 
confidence interval of 9.2 to 9.5 at a PbB value of 5 J.lmoVL. 
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Figure 5.2 Correlation between lead concentration in blood and haemoglobin in 494 Dutchmen. 
The lines indicate reference values for Duteh men according to HeIleman et aI. (1973). 
5.6 CONCLUSIONS 
In a group of 494 Dutchmen who stayed in their industrial jobs for five years or 
longer and were exposed to metallic lead and/or inorganic lead compounds. 
resulting in lead concentrations in the blood between 0.3 and 5.5 ~mollL, one-sided 
statistical testing showed a negative correlation between the concentration of lead 
in blood and haemoglobin concentration. The slope of the line corresponds to a 
decrease in Hb of 0.28 mmol over the Pb range of 0-5 ~mollL. Using a confidence 
interval of 95%, this means that maximally the decrease may be 0.59 mmollL. In 
persons who at the start of their work in the lead-processing industry have a Hb 
value around the lower limit of the reference range, this value can lead to anaemia. 
Therefore, it is recommended to check Hb in (future) employees in the lead-
processing industry. 
In a group of 59 Morrocan men and in a group of 18 Turkish men who had 
also been working for several years in the same industries and who had concentra-
tions of lead in blood lower than 4.5 ~mol/L and 3.5 ~mollL, respectively, no 
correlation between the lead and haemoglobin concentrations was found. 
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CHAPTER 6 
BIOLOGICAL MONITORING OF EXPOSURE TO CHROMIUM(VI) 
SALTS: THE ROLE OF SOLUBILITY' " 
P.C. Brag(", W.C.M. Zwennis and A.Ch. Franssen 
6.1 INTRODUCTION 
Biological monitoring of chromium in urine is a useful instrument for the 
evaluation of possible health risks as a result of exposure to soluble chromium(VI) 
compounds (Cr(VI». The Cr concentration in post-shift urine and the increase of 
the Cr concentration during a workday are correlated linearly with the time-
weighted average exposure during the shift, especially when a correction is made 
for creatinine excretion (,dilution of urine') [Mutti et al. (1979)]. 
Allergic sensitization of the skin and lungs and renal tubular damage are the 
main health effects associated with long-term exposure to soluble Cr(VI) [Langard 
and Norseth (1986)]. A number of sparsely soluble and insoluble Cr(VI) 
compounds are suspected of carcinogenicity in animals and man, the most 
prominent compounds being chromite ore roast, calcium chromate, lead chromate, 
and strontium chromate [IARC (1980)]. The ferro-chromium industry, the chromate 
production industry, and the chrome-pigment industry have been associated with 
an enhanced risk of lung cancer for the workers involved [Leonard and Lauwerys 
(1980); Norseth (1981)]. 
In previous experiments in rats [Bragt and Van Dura (1983)] we have shown 
that intratracheally administered zinc chromate (moderately soluble in water) is 
absorbed via the lungs and excreted into the urine in sufficiently large amounts to 
allow biological monitoring. Lead chromate (practically insoluble in water) was 
only absorbed very slowly and incompletely. Even a high intratracheal dose did not 
result in appreciably enhanced blood and urinary chromium concentrations. This 
implies that these concentrations will not reflect exposure. 
The study comprises lead chromate. 
Published in 'Biological monitoring of exposure to chemicals: metals'. pp. 119-126 (1991). 
Eds. H.K. Dillon and M.H. Ho. John Wiley & Sons, Inc .. New York. U.S.A. 
Present adress: Inspectorate for Health Protection. Ministry of Welfare. Health and Cultural 
Affairs. Rijswijk. the Netherlands. 
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The aim of this study was to investigate whether Cr concentrations in blood or 
urine are indicative of exposure to chromates of different solubilities. The study 
was performed because exposure by inhalation is a more adequate model of 
exposure in the work environment than intratracheal administration. 
6.2 METHODS 
Design of the experiment 
Five groups of 10 male Wistar rats (150-200 g) were exposed to sodium chromate 
in a whole body exposure chamber, during 4 h per day for 1-4 days. Similar 
experiments were also carried out with zinc chromate and lead chromate. The 
exposure schedule is visualized in Figure 6.1. 
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Figure 6.1 (A) Schedule of animal treatment and collection of samples during the day of exposure. 
(B) Exposure levels of sodium chromate. zinc chromate. and lead chromate (bars: daily 
exposure, dashed line: mean exposure level of 4 days with SD). 
Ninety-five percent of the particles had a diameter of 1.5-4.2 flm, and all particles 
had a diameter less than 6 flm. The mean daily chromium concentrations (± SO) 
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were 15.5 ± 2.9 mg Cr/m', 17.0 ± 6.4 mg/m', and 5.3 ± O.S mg/m', for sodium 
chromate, zinc chromate, and lead chromate, respectively. Venous blood (tail vein) 
was obtained half an hour before and after each exposure period. For the separate 
collection of urine and faeces, the rats were placed into stainless-steel metabolic 
cages for IS h after each exposure period. An unexposed control group of 30 rats 
was treated similarly. Subsequently, groups of rats were sacrificed after the 
collection of urine and faeces; arterial blood samples were taken and the lungs 
were dissected. The samples were frozen immediately and kept at -25°C. 
Chemicals 
Sodium chromate and lead chromate were purchased from E. Merck (Darmstadt, 
Germany) and zinc chromate (4ZnCrO,-K,O'3H,O) was a kind gift of Mr. J. de 
Winter, Sikkens B.V., Sassenheim, the Netherlands. 
Determination of chromium and lead 
For the determination of Cr and lead (Pb), the method of Davidson and Secrest 
(1972) was followed in essence. Blood and urine samples were digested in nitric 
acid (65%). Lung tissues and faeces samples were digested in nitric acid (65%) and 
hydrogen peroxide (30%). After dilution with water, Cr and Pb were determined 
at the respective wave!enghts of 357.9 and 283.3 nm with a Perkin-Elmer AAS 
4000IHGA 500 atomic absorption spectrophotometer with graphite furnace. The 
metals were quantified by the standard addition method. Under the conditions of 
this experiment, the interday coefficient of variation was less than 10%. The 
detection limits were 5 fIg CrlL blood or urine, 2 fIg PblL blood, and 7 fIg PblL 
urine. 
6.3 RESULTS AND DISCUSSION 
Chromium in the lungs 
The chromium concentration in the lungs of 29 control animals was 4.6 ± 4.9 ng/g 
wet tissue weight (mean ± SD). No speciation was made with respect to the 
valence of chromium. Exposure to sodium chromate, zinc chromate, or lead 
chromate resulted in a dramatically enhanced chromium concentration in the lungs, 
as shown in Figure 6.2. 
Sodium and lead chromate showed marked accumulation after repeated 
exposure, whereas zinc chromate did not, possibly as a result of the decreasing 
exposure level during the 4-day period (see Figure 6.1). The high chromium 
concentrations in the lungs, even after an exposure-free period of 4 days, indicated 
that the half-time of clearance from the lungs is relatively long. In the experiments 
with intratracheal exposure, we found values of 2.4, 1.9, and I.S days for the 
respective chromates in the early phase of lung clearance [Bragt and Van Dura 
(1983)]. For sodium bichromate dust, a half-time of 30.5 days has been reported 
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Figure 6.2 Total amount of chromium in rat lungs as a result of 1-4 exposures (exp.). or 4 exposures 
followed by 4 days recovery (day 8). Values arc means:!:: SD of 10 animals. 
for the second phase of lung clearance [Suzuki et al. (1984)]. At necropsy in six 
former chromate workers and at surgery in two workers, an average chromium 
concentration of 36.7 flglg wet weight (range 0.5-130) was found in peripheral lung 
tissue. This indicates that chromium was retained long after the cessation of 
exposure, because in a formerly unexposed patient a concentration of 0.21 J.lg/g 
lung tissue was found [Tsuneta et al. (1980)]. 
Chromium in blood 
In 30 control rats, the mean chromium concentration was lower than 9 flg/L (range 
<5-59). Figure 6.3 shows that after the first exposure episode to sodium chromate 
and zinc chromate, the chromium concentration in blood increased rapidly. 
After 2-3 exposures, an equilibrium between absorption and elimination was 
established. The chromium concentration in blood was only slightly elevated as a 
result of repeated exposure to lead chromate. From the exposure-free period a half-
time of chromium in blood was roughly estimated at 5-9 days. As shown in Figure 
6.3, the increase of the chromium concentration in the blood as a result of the 
second to fourth exposures is not indicative of the respective exposure levels. 
Chromium in urine 
The chromium concentration in the urine of 30 unexposed animals was 94 ± 134 
flg CrlL (mean ± SO, range 7-680) or 30 ± 31 flglg creatinine (range 3.6-123.2). 
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Figure 6.3 Chromium concentration in the blood of rats (log scale) as a consequence of repeated 
inhalatory exposure (exp.) to three chromatcs. The range of chromium concentrations in 
the blood of unexposed animals was <5-59 ng/ml (n ::;;: 30). An arrow indicates that 
individual values are below the limit of detection (i.c. 5 ng/mt). Each point is the mean 
± SD of 10 animals. 
The first exposure episode resulted in greatly enhanced chromium concentrations 
in the urine with either chromate (Figure 6.4). An exposure-free period of 4 days 
resulted in a significantly decreased chromium concentration (P <0.001, two-sided 
Wilcoxon test). 
The estimated half-time of chromium in the urine was 2.4-6.2 days. The pattern 
of chromium excretion in the urine did not resemble the pattern of exposure 
(Figure 6.1), possibly because an equilibrium between uptake and elimination had 
not yet been established. As a consequence of the high exposure levels the urinary 
chromium concentrations were significantly elevated (P <0.02, two-sided Wilcoxon 
test) even with lead chromate. The present (1988) lintit value for lead chromate in 
the Netherlands is 0.05 mg Cr/m' (maximum accepted concentration, 'MAC-
value'): which is more than a hundredfold lower than the lead chromate 
concentration inhaled by the rats in the present study. This implies that urinary 
chromium concentrations in workers exposed to lead chromate are expected not to 
be increased significantly. Relevant human data are lacking, however . 
• No,e added: In the 1994 MAC-list the MAC-value for lead chromate has been reduced to 0.Q25 
mg/m3 (TWA-IS min), 
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Figure 6.4 Chromium concentration in the urine of rats. corrected for creatinine excretion. after 1-4 
exposure periods (days 1-4), and after 4 exposures followed by an exposure·free period 
of 4 days (4 + 4 rcc.). Control animals had a mean concentration (± SD) of 30 ± 31 J.lglg 
creatinine (n ;:::; 30). Each bar represents the mean ± SD of 10 rats. 
Chromium in faeces 
In unexposed rats the mean chromium concentration in the faeces was 33.3 ± 21.2 
flglg dry material (range 17.547.9, n = 30). After exposure to the three chromates, 
the faecal chromium concentration was strongly increased, as shown in Figure 6.5. 
After the exposure-free period of 4 days, the concentrations decreased by more 
than 85% when compared with the concentration after four subsequent exposure 
periods. This means that the chromium concentration in the faeces is indicative of 
recent exposure. The faecal chromium concentrations are the result of distal 
depOSition in the respiratory tract, transport by the mucociliary escalator, and 
passage through the gastrointestinal tract. However, ingested chromium caused by 
the rats licking their fur might have contributed to the faecal chromium 
concentration, because whole-body exposure took place [Langard and Nordhagen 
(1980)]. 
Lead in blood, urine, and faeces from lead chromate exposed animals 
The average concentration in the blood from 10 unexposed rats was lower than 60 
flg/L (range: not detectable-267 flglL). After the first exposure episode, the lead 
concentration increased to 197 ± 151 flglL (mean ± SO of five rats), and to 416 
± 133 flglL after four exposures. The exposure-free period resulted in an average 
lead-in-blood concentration of <120 flg/L (range: <2-325 flg/L). 
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Figure 6.5 Faecal chromium concentration after 14 periods of exposure (days 1-4). and after 4 
exposures followed by an exposure-free period of 4 days (4 + 4 rec.). Control rats had 
a concentration (mean ± SD) of 33.3 ± 21.2 J.lg Crlg dry faeces. Each bar represents the 
mean ± SO of 10 animals. 
In 10 unexposed rats the urinary and faeca11ead concentrations were 456 ± 62 
flglL and 19.3 ± 6.2 flglg dry material, respectively. After four exposures to lead 
chromate, the lead concentrations increased to 510 ± 319 flg/L urine and 4800 ± 
2900 flglg dry faeces, followed by a marked decrease as a result of the exposure-
free period to 228 ± 112 flg/L urine and 719 ± 112 flglg dry faeces (n = 5). 
The atomic ratio of chromium and lead in the faeces was 7.6 in unexposed 
animals and 1.0 in animals with four exposure episodes with and without the 
recovery period of four days. This means that lead chromate in the faeces of 
exposed animals is most probably the result of secondarily (and primarily) ingested 
material and not of selective excretory mechanisms (e.g. chromium in the bile). 
Furthermore, the data show that the lead concentration in the blood of 
repeatedly exposed rats is not dramatically increased, as might be expected from 
the high levels of exposure to lead chromate. This is consistent with the results of 
the chromium analyses. 
6.4 CONCLUSIONS 
Sodium chromate (solubility in water: 81 gIL) is readily absorbed after inhalation 
and this results in an increased chromium concentration in blood, even after one 
exposure. Excretion of chromium into the urine is greatly enhanced after exposure. 
In fact, the same is true for zinc chromate (solubility about 0.6 gIL), although the 
blood and urinary concentrations are lower at the same exposure level. 
Lead chromate, which is practically insoluble in water (only 58 flg/L) 
accumulates in the lungs after repeated exposure. Dissolution in the lungs is most 
probably a rate-limiting factor for absorption, in view of the low chromium and 
lead concentrations in blood and urine even at a high level of exposure. Excretion 
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via the faeces was pronounced with all three chromates. An important factor may 
be ingestion of chromates when rats lick their fur. 
If these results are extrapolated to man, the suggestion emerges that biological 
monitoring of chromium in urine is indicative of a recent exposure to chromates 
having solubilities in between that of sodium chromate and zinc chromate. The 
concentration of chromium in the urine decreases with decreasing solubility, at the 
same exposure level. 
At the present (1988) occupational exposure limit for lead chromate of 0.05 mg 
Cr/m',' lead-in-blood and chromium-in-urine concentrations are too low to be 
indicative of exposure. However, a major advantage of biological monitoring is that 
it may reflect internal exposure. Thus, the low concentrations of lead in blood and 
chromium in urine may indicate that the risk of systemic health effects after 
exposure to lead chromate (e.g. nephrotoxicity), is considerably lower than after 
comparable exposure to the more soluble chromates. 
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CHAPTER 7 
USE OF ZINC PROTOPORPHYRIN IN SCREENING INDIVIDUALS 
FOR EXPOSURE TO LEAD' 
W.C.M. Zwennis, A.Ch. Franssen and M.J. Wijnans 
We studied the relation between the concentrations of lead in blood (PbB) and zinc 
protoporphyrin in blood (ZPP) in a group of 801 men occupationally exposed for 
more than one year to lead or inorganic lead compounds. Linear regression of PbB 
on log ZPP provided 95% tolerance intervals for PbB values for a given ZPP 
value. The intervals we found are too large to warrant the estimation of PbB on the 
basis of ZPP measurements in health surveillance of lead workers. Instead we 
propose a procedure in which ZPP can be used as an indicator to decide which 
individuals exposed to lead need further investigation of PbB in light of existing 
actionllimit values for PbB. The procedure is applicable only for PbB values of 2.4 
flmol/L or more but may reduce considerably the costs for screening individuals 
or groups of people exposed to lead. 
Additional keyphrases: reference values ~ receiver-operating characteristic curves 
7.1 INTRODUCTION 
Exposure to lead and its inorganic compounds leads to an increased concentration 
of lead in blood (PbB). It has now generally been accepted that, under conditions 
of more or less constant and prolonged exposure, PbB reflects the quantity of 
'biologically active' lead in the body [WHO (1977); Zielhuis and Wibowo (1978); 
Alessio and Foa (1980); NRC (1980)]. Analysis of PbB is, therefore, the first 
choice for the assessment of internal exposure of lead. Moreover, assessment of 
health risks due to exposure to lead is generally based on the concentration of lead 
in blood. However, determination of PbB is expensive and time-consuming, 
especially if large groups of people have to be screened. 
As early as the 19m century, patients suffering from lead intoxication were 
recognized as showing symptoms of effects by lead on the formation of haem 
[Stokvis (1895)]. These effects have been investigated extensively [Moore et al. 
(1980)]. Lead inhibits at least two enzymes that are essential for the formation of 
haem, namely, o-aminolaevulinic acid dehydratase (ALAD; EC 2.6.1.43) and 
ferrochelatase (EC 4.99.1.1). Both the inhibition of ALAD in erythrocytes and the 
. Published in Clinical Chemistry 36:1456-1459 (1990). 
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resulting increase in excretion of the substrate 8-aminolaevulinic acid in urine are 
used for early detection of the biological responses to lead, and indirectly as a 
measure of increased internal exposure of lead, Because of the interaction of lead 
with ferrochelatase in bone marrow, no iron is inserted into the substrate 
protoporphyrin IX, so that the concentration of the latter is increased in erythro-
cytes, Lamola and Yamane (1974) showed that instead of iron, zinc is incorporated 
into this free erythrocyte protoporphyrin to form zinc protoporphyrin (ZPP), ZPP 
thus reflects an effect of lead on the haematopoietic system, mainly resulting from 
the deposits of lead in the bone marrow, PbB, on the other hand, reflects both 
recent and earlier exposure. Numerous authors [see review by Wildt et al. (1987)] 
have shown that under steady-state conditions of exposure the logarithm of ZPP 
is linearly related to PbB. Iron-deficiency anaemia may also result in an 
accumulation of ZPP, whereas in erythropoietic protoporphyria, a rare inborn error 
of metabolism, the increased protoporphyrin in erythrocytes remains mainly 
unchelated. 
The concentration of ZPP can be measured directly in a smear of blood, which 
can be drawn from an ear lobe or obtained by a finger prick. Because of the 
simplicity of the measurement, which does not require specially qualified 
personnel, determination of ZPP has been applied as another method to screen lead 
workers for a biological response to an increased exposure to lead [Grandjean and 
Lintmp (1978); Alessio and Foa (1980); Herber (1980); Wildt et al. (1987)]. Here 
we further contribute to the discussion on the validity of using the concentration 
of ZPP to estimate PbB. We propose using the ZPP value and the statistical 
correlation between PbB and ZPP to decide, on an individual basis, whether 
additional analysis of PbB is necessary to assess if someone has an increased 
health risk due to lead exposure. 
7.2 SUBJECTS AND METHODS 
We studied 801 men (ages 16-64 years) employed in lead-processing industries and 
exposed to lead or inorganic lead compounds for at least one year. Of this group, 
555 were Dutch by birth, the others were of mediterranean origin. The men were 
involved in the production of batteries, pigments, or soldered cans or were 
employees of metal-recycling industries. Most of them have been checked for lead 
in blood several times over the last few years; for those cases, we used the first 
measurement in this study. In general, the individual PbB values showed relatively 
little variation over time. In view of the nature and time of exposure (more than 
a year), steady-state concentrations of lead in the bone marrow are likely. 
Venous blood was collected in 5-mllead-free tubes containing 7.5 mg of EDT A 
(Venoject; Temmo, Italy). We mixed 100 fll of blood with 900 fll of I MollL nitric 
acid solution with swirling on a shaker. The precipitate was centrifuged and the 
lead in the clear supernate was determined by atomic absorption spectrophotometry 
(Perkin-Elmer, Model 4000, equipped with a Model 500 graphite atomizer) 
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[Stoeppler et al. (1978)]. The quality of the analysis was checked by participation 
in the U.K. External QUality Assessment Scheme of the Queen Elizabeth Hospital, 
Birmingham, U.K. At three-week intervals, we analyzed lead-supplemented human 
blood samples. On the average, our results differed by 7.7% (range 0 - 22.6%) 
from the average results of about 80 participants, but there was no systematic 
deviation. We determined the concentration of zpp with a direct-reading 
haematofluorometer (Environmental Sciences Associates; Bedford, MA, U.S.A., 
Model 4000) after oxygenation of a 100 fll blood sample by swirling on a shaker. 
The apparatus, which measures the ratio of the fluorescence of ZPP and the 
absorbance of light by oxyhaemoglobin in the sample, was calibrated at a fixed 
concentration of haemoglobin (Hb) of 8.4 mmollL (for men). The coefficient of 
correlation (CV) for 15 analyses of the same sample carried out on five successive 
days was 2.6% at a ZPP content of 95 flmol/mol Hb and about 1.5% at 
concentrations of ZPP between 150 and 625 flmol/mol Hb. 
The 95% tolerance intervals for PbB as calculated for log ZPP (Figure 7.1) are 
the simultaneous tolerance intervals of Lieberman Miller [cf. Miller (1981)], based 
on the regression of PbB on log ZPP. For PbB, I flmol!L corresponds to 207 flglL; 
for ZPP, I flmol/mol Hb corresponds to 0.04 flg/g Hb. 
7.3 RESULTS AND DISCUSSION 
Figure 7.1 shows the relation between PbB and log ZPP. The highest concentration 
of PbB was 6.2 flmol!L and of ZPP 1253 flmol/mol Hb. Assuming a linear relation, 
the regression of log ZPP on PbB gives the following equation: log ZPP = 0.56 
PbB + 0.86 (r = 0.83, P <10-4). This relation is in good agreement with other 
studies [Wildt et al. (1987)]. 
Table 7.1 lists 95% tolerance intervals for PbB at four different concentrations of 
ZPP, obtained by regressing PbB on log ZPP separately for the Dutch workers, the 
mediterranean workers, and the whole group. Given the considerable overlap of the 
interv.als of the Dutch and the mediterranean workers, we decided to treat the three 
groups of workers as a single population. Considering the four occupations studied 
- production of batteries, of pigments or of soldered cans, and metal recycling -
separately only slightly narrows the PbB tolerance intervals. The upper values 
remain more than twice the lower values. 
The large ZPP-related intervals for PbB preclude an acceptable estimation of 
the concentration of PbB on the basis of ZPP. The width of the intervals is partly 
explained by the absence of a strong biological relation between PbB and ZPP. 
Close correlation between PbB and ZPP exists only under steady-state conditions 
of exposure because of the time lag in the formation of ZPP [Hernberg (1980)]. 
Although the exposure of most of the present lead workers meets this requirements, 
as shown by analysis of blood samples over several years, other factors probably 
also influence the width of the intervals, for example: 
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- The kinetics of lead absorption and formation of ZPP may differ among people. 
- Iron deficiency contributes to an increase in ZPP [Lamola and Yamane (1974)]. 
- Interindividual variability affects the kinetics of formation of ZPP. 
- Increased concentrations of bilirubin in serum have a small, positive effect on the 
ZPP reading [Grandjean and Lintrup (1978)]. 
- Analytical variation in the analysis of both analytes, especially PbB, may affect 
the results. The order of magnitude of these variations have already been given. 
S 6 
o 
E 
2 
OJ 5 
D 
a. 
3 
2 
x 
x 
x 
log ZPP (~mol/mol Hb) 
Fig.7.1 Scatter diagram and 95% tolerance intervals of 801 PbB and ZPP pairs. 
In 1982 the Council of Ministers of the European Community issued a 
Directive on the protection of workers from health risks due to exposure to lead 
[EC (1982)]. For PbB, three so-called action levels (1.45, 2.4 and 2.9 flmol/L) and 
a limit value (3.4 flmol/L) have been defined. Concentrations of PbB between 3.4 
and 3.9 flmol/L are considered acceptable if ZPP is <500 flIDollmol Hb. 
Because for many ZPP values the resulting PbB intervals include the action or 
limit values as given in the European Community Directive, giving rise to 
indecisive worker policy, we conclude that an acceptable estimate of PbB by 
measuring ZPP is not possible in health surveillance of individual lead workers. 
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TABLE 7.1 95% TOLERANCE INTERVALS FOR PbB AT DIFFERENT CONCENTRATIONS 
OFZPP 
PbB intervals (flll1ollL) 
Dutch Mcditcrranacn All 
workers workers workers 
ZPP (flll1ollmol Hb) (n = 555) (n = 246) (n = 801) 
250 1.48-4.05 1.44-4.09 1.52-4.02 
500 2.00-4.64 1.88-4.63 2.03-4.58 
750 2.31-4.99 2.13-4.95 2.33-4.92 
1000 2.52-5.23 2.31-5.17 2.54-5.16 
Individual ZPP values may be used only as a very rough indicator of individual 
PbB, and the average ZPP of a group of workers only approximates the average 
PbE. This conclusion is supported by the work of Grandjean and Lintrup (1978) 
and Herber (1980). Accepting PbB as the best marker to estimate health risk 
implies that every worker who is possibly exposed to lead should be monitored for 
PbB at regular intervals. For this reason, in the U.S.A. as well as in the European 
Community assessment of PbB is required in workplace monitoring. However, 
detection of individuals with high PbB concentrations by screening for ZPP would 
be desirable because the latter is considerably less costly. Therefore, we further 
analyzed the relationship between PbB and ZPP. 
Using the PbB and ZPP data of the 801 lead workers, we calculated the 
sensitivity and specificity of different ZPP cutoff points at the five standard values 
of PbB mentioned in the Directive of the European Community_ (Within this 
context, sensitivity and specificity refer to the epidemiological characteristics ofthe 
relationship between PbB and ZPP. That is, the sensitivity is defined as the 
percentage of the cases with ZPP values above a chosen cutoff point, given a PbB 
value above a chosen standard value. The specificity is defined as the percentage 
of the cases with ZPP values below a chosen cutoff point, given a PbB value 
below a chosen standard value. These percentages depend on the characteristics of 
the population under study). 
Appropriate cutoff points for ZPP at the five PbB standard values can be 
derived from plots of sensitivity against I-specificity, the so-called receiver-
operating characteristic (ROC) curves (Figure 7.2) [Metz (1978)]. The optimum 
cutoff point is determined as the point the farthest from the diagonal; this cutoff 
point maximizes the discriminative power of the test by minimizing the fractions 
of false-positive and false-negative results. Table 7.2 gives the optimum ZPP cutoff 
points at the five PbB standard values as derived from Figure 7.2. 
Screening with the aim of meeting the above Directive demands a sensitivity 
of 100% because every person with a PbB concentration exceeding an action level 
or the limit value should be identified. To have a sensitivity of 100%, one must use 
a lower cutoff point of ZPP and thus a lower specificity, leading to suboptimal 
discriminative power (Table 7.2). Table 7.2 shows also that ZPP cannot be used 
as a discriminative indicator for the lowest PbB standard value (specificity = 0%). 
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TABLE 7.2 ZPP CUTOFF POINTS FOR OPTIMUM AND REQUIRED SENSITIVITY. 
AND RELATED SPECIFICITY. AT FIVE VALUES FOR PbB 
ZP!'" Optimum % ZP!'" Required % 
PbBb (flIllO!/ (flIllO!/ 
(flIllo!/L ) mol Hb) Sens. Spec. mo!lHb) Sens. Spec. 
1.45 55 80 87 0 100 0 
2.4 90 95 84 40 100 46 
2.9 170 90 90 45 100 47 
3.4 250 94 88 120 100 77 
3.9 250 100 86 250 100 86 
a. ZPP cutoff points as derived from Figure 7.2. 
b. Action and limit values specified in European Community Directive (see text). 
In that case all samples would have to be analyzed for PbB. This parallels the 
report of Meredith et al. (1979). 
The positive predictive value of a screening result (i.e. the fraction of the 
samples for which PbB exceeds the standard PbB value of all samples for which 
ZPP exceeds the chosen cutoff point) depends not only on sensitivity and 
specificity, but also on the prevalence in the study population of values of PbB that 
exceed the standard value under consideration: the lower the prevalence, the greater 
the number of false-positive tests results. Table 7.3 presents positive predictive 
values of ZPP cutoff points that yield a sensitivity of 100% at different 
prevalences. 
TABLE 7.3 POSITIVE PREDICTIVE VALUE (PPV) OF ZPP CUTOFF POINTS AT DIFFERENT 
PREVALENCES OF FOUR VALUES FOR PbB 
PbB (flIllo!/L) 
2.4 2.9 3.4 3.9 
ZPP (flIllollmol Hb) 40 45 120 250 
- Sens. %:1. 100 100 100 100 
Spec. %b 46 47 77 86 
Prev. PPV Prevo PPV Prev. PPV Prevo PPV 
% % % % 
5 9 2 5 2 7 1 7 
10 17 4 9 5 19 2 13 
15 24 8 17 10 33 5 27 
20 31 10 21 15 43 10 44 
25 38 15 30 20 52 15 56 
30 44 20 37 25 59 20 64 
35 50 25 44 30 65 25 70 
40 55 30 51 40 74 30 75 
60 73 40 61 50 81 40 83 
50 70 
a. Sensitivity as required by the European Community Directive. 
b. Specificity as derived from Figure 7.2. 
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Figure 7.2 Receiver-operating characteristic curves for ZPP at the five standard PbS values of the 
European Community Directive: 1.45 JlmoJJL (_.-._): 2.4 J-lIllol/L (---): 
2.9 ~mollL (----- ): 3.4 ~ollL (--): 3.9 ~ollL ( .......... ). 
The points in the Figures indicate the optimum cutoff points for ZPP and denote the 
values at maximum sensitivity and specificity: A = 55: B = 90: C = 170: D = 250: and 
E = 250 ~mollmol Hb. 
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zPP can be used satisfactorily for pre-screening only if one can estimate 
reasonably accurately the prevalence of the standard PbB values in the population 
under study. Recently, health hazard surveys carried out in several lead-processing 
industries in the Netherlands [Zwennis (1985)] have reported prevalences of 60%, 
33%, 19%, and 10% for PbB >2.4, >2.9, >3.4, and >3.9 IlmollL, respectively, in 
battery works (n = 200); 25%, 14%, 7%, and 3%, respectively, in pigment 
production (n = 556); and 100%, 87%, 87%, and 87%, respectively, in flame 
cutting of lead-painted constructions (n = 9) [this thesis, Chapter 8]. Rifle 
instructors showed no values for PbB >2.4 !lffiollL (n = 125). Hemberg and Tola 
(1979) reported decile distributions and ranges of PbB values found in different 
types of work in Finland. These results allow an estimate of the prevalences in 
groups of lead workers. 
The ultimate goal of the use of ZPP as a screening method is an economical one. 
Does the method save labor and time over screening via PbB? 
Potential savings can be computed with the formula S = nP - (nZ + fp), where 
S = savings, n = the number of samples, P = the cost of a PbB analysis, Z = the 
cost of a ZPP analysis, and f = the number of samples with true- and false-positive 
ZPP values that require additional PbB analysis. 
Figure 7.3 gives the relation between savings and percentage of positive ZPP 
values, assuming that the cost of a ZPP analysis is about 10% of the cost of a PbB 
analysis, which is the case with our laboratory. Savings vary between 10% 
'negative savings' (when all samples have positive ZPP values) and 90% of the 
costs of PbB analysis (when no samples have positive ZPP values). 
In summary, measuring ZPP to screen lead workers for a PbB of 1.45 IlmollL has 
no economical value. All such samples must also be analyzed for PbB. However, 
screening for ZPP to detect the higher action levels and the limit values for PbB 
may save considerable costs. 
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Figure 7.3 Savings in screening with ZPP instead of PbB for exposure to lead, assuming that costs 
of analysis are 10% of that for PbB. 
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CHAPTER 8 
LEAD EXPOSURE DURING DEMOLITION OF A STEEL STRUCTURE 
COATED WITH LEAD-BASED PAINTS 
I. ENVIRONMENTAL AND BIOLOGICAL MONITORING -
T. Spee" and W.C.M. Zwennis 
Demolition of a steel railway bridge was carried out by nine workers using f1ame-
torch cutting. The air in the breathing zone of the workers contained from 2 to 38 
mg of leadlm3• which is a very high level in comparison with the Dutch exposure 
limit of 0.15 mg/m3 (MAC. 8 h time-weighted average). Without very effective 
respiratory protection these concentrations may result in acute lead poisoning. 
Upwind of the flame-torch the exposure level was below the exposure limit, 
whereas downwind lead concentrations of up to a hundred times the exposure limit 
were observed. Although filtering facepieces were used by the workers, average 
blood lead concentrations of about 4.5 flmol/L were rapidly attained. Possibly 
under these work conditions this value represents a maximum concentration 
attainable in blood. After termination of the exposure, there was a fast decrease of 
lead in the blood. This finding indicates that lead was mainly present in rapidly 
exchangeable compartments like blood. No stable correlation between the 
concentration of lead in blood and the concentration of zinc protoporphyrin in 
blood was found. 
Key terms: industrial hygiene, occupational hygiene, zinc protoporphyrin 
8-1 INTRODUCTION 
Although it is known that the flame cutting of lead-painted steel constructions may 
cause severe lead poisoning [Feldman et al. (1977); NIOSH (1980) Fischbein et al. 
(1984)], exposure to lead fumes during this type of work still occurs. Such 
exposure may be due to the fact that the workers are insufficiently aware of the 
risk involved or the fact that the respiratory protection of the workers may be 
insufficient or may turn out to be difficult in practice. 
Published in Scandinavian Journal Work & Environmental Health 13:52-55 (1987). 
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The Dutch Labour Inspectorate has requested the TNO Medical Biological 
Laboratory to monitor lead exposure of workers involved in the demolition of a 
railway bridge. At the same time the health effects due to exposure to lead were 
studied through measurements of the delay and repair of nerve conduction velocity 
in the workers [Muijser et al. (1987)]. 
The arched steel railway bridge. built in 1902, consisted of two fixed bridges 
and a swivel bridge. Its total length was 265 m and the maximum height of the 
arches amounted to about 11.5 m. The bridge had been painted seven times with 
a 0.1 mm coating of a primer containing 60% lead and with a 0.02-mm top coat 
containing green chromium oxide. The bridge was taken down during the period 
October 1983 through February 1984 by flame-torch cutting (oxypropane flame). 
Seven workers cut on the bridge, and two cut parts to smaller pieces. One of the 
latter worked mainly on a deckship, the other mainly on the bank of the canal. 
Several authors have reported on the relationship between the concentration of 
lead in the breathing zone (PbA) and that in the blood (PbB) of occupationally 
exposed workers. According to Coenen and Drasche (1978) and Alessio and Foa 
(1980) there is a linear relationship in groups of workers for PbA up to 0.2 mg/m3• 
However, on an individual basis the PbB concentration cannot be derived from the 
PbA concentration [Gartside et al. (1982)]. Unpublished investigations by us in 
three lead-battery factories support the latter observation. 
8.2 SUBJECTS AND METHODS 
Air sampling 
Air' was sampled from the breathing zone by pumping air through a stainless steel 
filter holder fixed to the lapel of the worker (personal air sampling). The holder, 
with an opening 7 mm in diameter, contained a cellulose nitrate membrane and 
was connected to an air sampling pump (Du Pont P 2500) by Tygon tubing. The 
flow rate was 2 Llmin. With this equipment particles with an aerodynamic 
diameter up to 30 flm are sampled. This method meets the criteria specified in the 
directive on inorganic lead issued by the Council of the European Community [EC 
(1982)]. 
Large air samples were taken by means of portable high-volume samplers 
(Portikon, Sartorius) at a flow rate of 200 Llmin. 
The lead concentrations were determined by atomic absorption spectropho-
tometric analysis (Varian Techtron AA 9751) after the filters were dissolved in 
aqua regia. The measurements were performed during dry weather and wind 
velocities of 1-2 mls. 
Analysis of lead and zinc protoporphyrin in blood 
Venous blood was collected in 5-ml lead-free tubes contammg 7.5 mg of 
ethylenediaminetetraacetate-disodium salt (EDTA-2Na) (Venoject, Terumo). The 
PbB concentration was determined after addition of 100 fll of blood to 900 fll of 
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1 MollL nitric acid and swirling [Stoeppler et al. (1978)]. The precipitate was 
centrifuged, and in the clear supernatant the lead was determined by atomic 
absorption spectrophotometric analysis (Perkin Elmer Model 4000, HGA Model 
500). The day-to-day coefficient of variation of the method was 7% at 2.07 flIllol/L 
and 6% at 3.75 flIllol/L (N = 17). 
The concentration of zinc protoporphyrin (ZPP) was determined with a direct-
reading haematofiuorometer (Environmental Sciences Association, model 4000) 
after oxygenation of a 100 ~l blood sample by swirling on a shaker. 
8.3 RESULTS 
Environmental monitoring 
Table 8.1 shows the concentration of lead in the breathing zone of the workers for 
three periods on the same day, 13 weeks after the start of the demolition. Workers 
1 to 4 were engaged in flame cutting on the bridge. Worker 5 was cutting demo-
lished parts of the bridge into smaller pieces on a deckship. 
Air samples were also taken upwind and downwind ofthe torch simultaneously. 
The results are shown in Table 8.2. 
Biological monitoring 
The PbB and ZPP concentrations were determined in blood collected before the 
work started (between weeks 0 and 2), four times during the demolition (weeks 
TABLE 8.1 LEAD CONCENTRATIONS IN THE BREATHING ZONE OF FIVE WORKERS' 
DURING THE DEMOLITION OF A LEAD-PAINTED STEEL STRUCTURE 
Lead concentration (mglm3) 
Worker Period 1 Period 2 Period 3 
(08.00·09.45) (10.15·12.30) (13.15·14.45) 
10.8 b b 
2 32.3 17.3 5.7 
3 20.5 2.3 3.2 
4 38.1 13.4 6.0 
5 3.1 3.3 3.7 
a. Sumpling on January 20 1984. 
b. Measurement not successful. 
TABLE 8.2 RESULTS OF SIMULTANEOUS SAMPLING UPWIND AND DOWNWIND 
AT A DISTANCE OF 50 CM FROM THE FLAME TORCH. THE SAMPLING 
WAS PERFORMED DURING PERIOD 2 (TABLE 8.1) BY MEANS OF PORTABLE 
HIGH· VOLUME SAMPLERS' 
Worker 
2 
Sampling time 
(min) 
7 
14 
Lead concentration (mglm3) 
Upwind Downwind 
0.08 
0.06 
1.7 
14.0 
a. In order to avoid disturbing effects. only one worker was at work during the sampling. 
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7-20) and two times after the job was finished (weeks 39 or 40 and week 89). Due 
to absence some workers did not participate in the sampling on every occasion. 
The results are presented in Table 8.3 (PbB) and Figure 8.] (ZPP). 
TABLE 8.3 BLOOD LEAD CONCENTRATIONS (flMOUL) OF THE WORKERS DURING 
DEMOLITION OF A RAILWAY BRIDGE 
Week 
Worker o or 2 7 or 8 11<1 14 or 15 20b 39 or 40 89 
1 1.7 4.5 5.1 4.2 5.0 2.6 1.3 
2 2.3 2.7 4.5 3.0 1.5 
3 1.9 4.9 5.5 4.2 4.3 2.4 1.4 
4 1.3 3.8 4.5 3.8 4.2 2.4 l.l 
5 2.5 5.3 3.4 4.7 5.0 3.0 2.7 
6 1.9 4.5 3.8 3.3 2.1 1.2 
7 1.6 3.3 4.4 3.4 3.2 2.3 1.3 
8 1.2 4.8 4.3 3.8 1.8 
9 3.7 3.1 2.4 2.5 1.6 0.7 
Mean 1.80 4.35 4.51 3.61 4.08 2.36 1.40 
SD 0.45 0.68 0.82 0.74 0.94 0.49 0.57 
a. Season holidays during week 12. 
b. The work was completed shortly after week 20. 
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Figure 8.1 Zinc protoporphyrin concentration in the blood of the workers (marked by the number in 
the figure) during demolition of the railway bridge. (The worker numbers correspond 
with those in the tables). 
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8.4 DISCUSSION 
During the first three months of the job the respiratory tract of the workers was 
protected by filtering facepieces. Thereafter half-mask respirators in combination 
with dust filters, class P2, were available. The results of the environmental 
monitoring show that concentrations of 100 times the Dutch exposure limit for lead 
(0.15 mg/m', TWA-8 h) were not exceptional. Other authors have also observed 
high exposure during flame-torch cutting in open air [Feldman et al. (1984); 
Shackleton et al. (1985)]. Even with protection by a half-mask respirator the 
situation was unacceptable, since for this type of mask a protection factor of only 
10 to 12 is specified [NIOSH (1976); Labour (1983)]. The high exposure of 
workers 2 and 4 compared to that of workers 1 and 3 may not only have been due 
to exposure to lead fumes produced by themselves, but also to those produced by 
their colleagues. Workers 2 and 4 worked downwind of workers 1 and 3 at a 
distance of about 10 m. 
It is often stated that, if a worker stays upwind of the torch, the exposure to 
lead fumes should remain at an acceptable level. To determine the validity of this 
statement, we took simultaneous air samples at a distance of 50 cm upwind and 
downwind of the torch. The results in Table 8.2 indicate that indeed upwind the 
exposure is below the exposure limit, the more so because usually the distance 
between the worker and the torch is about 1 m. However, when working on a 30-
cm broad bar, 10m above ground level, a worker is not always able to take the 
right position with respect to the wind. 
All workers had raised PbB levels (normal value <0.75 flmoVL) and most of 
them also had raised ZPP levels (normal value <38 flmollmol Hb) before the work 
started, and therefore they had evidently been exposed to lead previously. 
However, during the first weeks of the demolition of the bridge the PbB 
concentrations increased sharply to 3.5-5.5 flmoVL. 
Shortly after the collection of the blood samples in week 11, the work was 
interrupted for a week of season holidays. After resumption of the work half-mask 
respirators in combination with a dust filter, class P2, were available to the workers 
instead of the filtering facepieces used during the preceding period. The average 
PbB decreased significantly. (Compare weeks 14115 to week 11; (J, = 0.05, multiple 
comparison analysis according to Friedman). This finding indicates that the use of 
the masks resulted in a diminished uptake of lead. Nevertheless the average PbB 
was still above the value of 2.9 flmoVL and therefore suggested that the protection 
provided by the half-masks was also insufficient [Shackleton et al. (1985]. 
However, notwithstanding an exposure that notably exceeded the exposure limit, 
the average PbB did not exceed 4.5 flmoVL. Apparently, at this level a plateau is 
reached where a dynamic equilibrium exists between uptake, storage in deposits, 
and excretion. Such a plateau could explain why worker 5, whose exposure was 
much lower than that of workers 1-4, showed a similar PbB during weeks 7/8 
through 20. No linear relation was found between PbA and PbB. 
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After the job was finished (week 20) the PbB level decreased, the average 
concentration in week 89 differing significantly from that in weeks 0 or 2 (!-test 
for pairs, P, ; 0.022). Apparently, exposure between weeks 20 and 89 was less 
than during the period preceding the demolition. Usually the workers followed by 
us are involved in other types of demolition work, demolition of steel constructions 
being only a minor fraction. 
The PbB values in weeks 0 or 2 show that, during the preceding period, 
exposure to lead was relatively low compared to the exposure during demolition. 
Other compartments, therefore, played a minor part in the decrement of PbB. 
While in week 11 the average PbB reached its maximum, the ZPP concentration 
was still increasing. Since ZPP is formed in the bone marrow and the life-span of 
erythrocytes is about 120 days, the exchange of the entire population of 
erythrocytes requires that length of time. Therefore, at the end of the work in week 
20, the concentration of ZPP was still in an increasing phase. The EC-Directive on 
inorganic lead states a limit value of 3.4 /lmoliL for PbB, but a concentration 
between 3.4 and 3.9 /lmollL is acceptable if the ZPP concentration is lower than 
500 J.lmolimol Hb lEC (1982)]. With the exception of the value of worker 9, the 
PbB level of all workers exceeded the first criterion at one or more times. 
8.5 CONCLUDING REMARKS 
The demolition, by flame-torch cutting, of a steel structure coated with lead-based 
paints resulted in very high concentrations of lead in the breathing zone of the 
workers. Without the use of effective respiratory protection such concentrations 
may result in acute lead pOisoning. 
Exposure to these high concentrations of lead resulted in a fast increase of the 
concentration of PbB. After the exposure was terminated, there was a fast decrease 
in the PbB values indicating that the body burden of lead was mainly present in 
rapidly exchangeable compartments. 
The use of half-mask respirators during the work resulted in significantly lower 
PbB concentrations. In addition working upwind of the torch also provided a 
substantially lower exposure to lead. 
Exposure to PbA concentrations ranging from 3 to 38 mglm3 resulted in average 
PbB concentrati<ms of about 4.5 J.lmollL. This finding might indicate that this value 
represents an equilibrium concentration attainable in blood under the conditions 
given. 
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CHAPTER 9 
EFFECT OF TECHNICAL AND HYGIENIC MEASURES ON 
EXPOSURE TO LEAD IN A LEAD-RECYCLING PLANT: 
A CASE STUDY' 
W.C.M. Zwennis, A.Ch. Franssen, T, Spee .. and A. W. HoI ••• 
9.1 INTRODUCTION 
occupational exposure to lead (Pb) has decreased considerably during recent 
decades. This has been effected by adaptations of technical processes as well as by 
hygienic measures initiated by the increased awareness of the health risks of 
exposure to lead. However, there is still reason for concern, because in several 
branches of industry workers are even yet often exposed to levels of Pb which may 
result in adverse health effects. It has become clear that such effects already may 
occur at levels which were considered without harm a few years ago [Landrigan 
(1989); Davis et al. (1993)]. 
In this study results are presented of technical measures and hygienic provisions 
on the levels of lead in blood (PbB) of the workers at a plant where scrap-lead is 
smelted, refined and made into lead sheet. 
9.2 SUBJECTS AND METHODS 
Housing and production process 
The plant was housed in two adjacent halls. In one (l00x40 m) the foundry and 
the rolling departments were housed in two separate sections and in the other 
(l00x20 m) the storehouse and, separated by a wall, the sawing department. The 
canteen, washing facilities and changing-room were situated next to the rolling 
department (Figure 9.1). 
The stock of scrap-lead (tubings, roof lead, cable lead etc.) was kept in the open 
air until 1985, after which it was stored in a depot open at one side. The scrap was 
conveyed with a shovel to a shredder which was situated in the open air. With a 
conveyor-belt batches of about 100 tons of shredded lead were transported to an 
oven and smelted at 450·C. Dross like sand. copper etc. was allowed to float to the 
To be submitted. 
Prescnt adress: Arbouw Foundation. Amsterdam. the Netherlands . 
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surface. The combustible part was burned by adding diesel oil to the smelt. The 
remaining was skimmed off; larger objects like wire were removed manually. In 
1988 shredding was ended and the scrap was conveyed straight into the smelting 
oven. 
Sixty tons of the smelt was drained along closed gutters into forms where it 
solidified to lead slabs of circa 6 ton. The smelting oven was filled up and the 
process started again. The slabs were cold-rolled to lead sheet. This was 
subsequently rolled up and sawed into the desired lengths. Finally, the rolls were 
weighed, packed in polyethylene foil and transported to the storehouse. 
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Figure 9.1 Ground-plan of the plant. Measures arc not to scale. 
In 1982 a refining oven with a capacity of 100 tons of Pb was installed. About 
60% of the so-called pre-smelt was pumped into this oven and was refined by the 
'Harris procedure' . According to this process sodium nitrate and sodium hydroxide 
are added at circa 500cC. In this way other metals are converted into their oxides, 
forming the 'chemical dross'. This was removed from the surface with an enclosed 
screw conveyor, stored in drums and handled further outside the plant. About 60% 
of the refined lead, which had a purity of >99.9%, was drained to cast slabs. The 
refining oven was filled up from the smelting oven and the cycle restarted. 
The smelting and refining steps were each carried out two times per 24 hours. 
An outline of the production process is given in Figure 9.2. 
( 
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Day Shift: storehouse, office. 
technical ~rvlce 
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CHARGING-SMELTING 
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second Shift 
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Figure 9.2 Outline of the production process, 
::: 
23.30 
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Occupational hygiene survey 
In the survey, exposure of the workers to Pb was estimated by regularly measuring 
the concentration of PbB and of the effect parameter zinc protoporphyrin (ZPP). 
An Occupational Health Service was responsible for these measurements. 
Levels of Pb in the breathing zone were measured by personal air sampling 
(PAS), monitoring some parts of the work with supposedly high exposure 
(removing dross, cleaning) separately. Assumed sources of lead dust were 
monitored by stationary air sampling (SAS). 
Analysis of PbB and ZPP in blood 
Venous blood was collected in 5-rnllead-free tubes containing 7.5 mg of EDTA 
(Venoject, Terumo). The concentration of Pb was determined after mixing 100 rrl 
of blood and 900 rrl of 1 Mol/L nitric acid solution by swirling on a shaker. The 
precipitate was centrifuged and in the clear supernatant Pb was determined by 
atomic absorption spectrophotometry (Perkin Elmer Model 4000, equipped with a 
Model 500 graphite atomizer) [Stoeppler et al. (1978)]. The quality of the analysis 
was checked by participation in the U.K. External Quality Assessment Scheme of 
the Queen Elizabeth Hospital, Birmingham, U.K. At three-weekly intervals lead-
supplemented human blood samples were analysed. On the average, the results 
differed by 7.7% (range 0-22.6%) from the average results of about 80 participants, 
but there was no systematic deviation. 
The concentration of ZPP was determined with a direct-reading haemato-
fluorometer (Model 4000; Environmental Sciences Ass., Bedford, MA, U.S.A) after 
oxygenation of a 100 rrl blood sample by swirling on a shaker. The coefficient of 
variation of 15 analyses performed in the same samples on five successive days 
was 2.6% at a ZPP content of 95 rrmoVmol Hb and about 1.5% at concentrations 
of ZPP between 150 and 625 flIDol/mol Hb. 
Personal air sampling 
Air in the breathing zone was sampled by pumping air through a filter in a holder 
fixed to the lapel of the worker. The holder, with an opening of 6 mm diameter, 
contained a glass-fibre filter and was connected to an air sampling pump (Du Pont 
P 2500) by Tygon tubing. The flow rate was 2 Umin and the sampling time 3-4 
h. This method meets the criteria specified in a directive on inorganic lead issued 
by the European Community [EC (1982)]. 
Stationary air sampling 
SAS was carried out at fixed spots by pumping air through a holder containing a 
glass-fibre filter with a sampling pump (Du Pont P 4000). After dissolving in aqua 
regia, the Pb on the filters was determined by atomic absorption spectrophotometry 
(Varian Techtron AA 9751). Concentrations are reported as fIg/m'- The possible 
error in air sampling and the analysis amounted to about 10%. 
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Hand-washing 
Workers were invited to wash their hands with distilled water and lead-free soap 
just before lunch-time. The collected washing-water was filtered and Pb was 
determined in both the filtrate and insoluble fraction. 
Statistical analysis 
The decrease of the PbB level of each worker in time was tested with the rank 
correlation test of Spearman with p = 0.05 as level for statistical significance. The 
relation between PbB and ZPP in individuals was tested with linear regression 
analysis (p = 0.05). 
9.3 RESULTS 
During the survey (1982-1990), Pb and ZPP were determined in 563 blood samples 
collected from 99. workers. Because of the time of their employment or the low 
level of PbB, 22 workers were screened only once, whereas the others were 
screened more frequently (one worker was screened as many as 33 times). 
The ranges of Rsp~ of the PbB levels of 28 workers, screened seven times 
or more, are given in Table 9.1. Also presented are the numbers of these workers 
showing a statistically significant decrease of PbB during the time of the survey. 
Thirteen other workers have been screened three to six times. These numbers 
are too low for a Spearman rank correlation analysis. However, PbB levels of five 
workers showed a decreasing trend. Conditions were: at least five decreasing levels 
of PbB, successively in a period of more than a year, or all measurements decrea-
sing when only three or four screenings were available. 
PbB data of office workers are not shown. The values (n = 37) were lower than 
0.9 flmollL except two of 1.27 and 1.81 flmollL, respectively. 
The concentration of lead in the breathing zone of 20 workers was measured 
by PAS during four periods on two successive days (Table 9.2). Ten of the 
workers were employed in two shifts of about equal size whereas the others were 
working during day-time. Also the data of PAS measurements during removal of 
dross and during cleaning of the smelting department are shown. The concentra-
tions of Pb during SAS measurements presented in Table 9.2 refer to the places 
marked with a letter in Figure 9.1. 
The concentrations of lead in water collected after hand-washing are also given 
in Table 9.2. 
In the same week that PAS measurements were carried out, blood samples were 
collected. Table 9.3 shows the mean and range of the PbA and PbB levels that 
were measured. 
Linear regression of ZPP on PbB for 19 workers screened ten times or more, 
revealed a statistically significant relation for 17 of them (p = 0.05). In Figure 9.3 
four representative examples are plotted. 
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TABLE 9.1 DEVELOPMENT OF PbB LEVELS OF 28 WORKERS BETWEEN 1982-1990 
Department Number 
of 
workers 
Rspc:um:tn 
(range) 
Number of 
workers with 
significant 
decrease(\ 
Remarks 
Smelting 
Rolling 
Sawing 
Storehouse! 
forwarding 
Miscellaneous 
lead products 
Technical 
service 
Management 
support office 
a. P,50.05. 
6 
8 
3 
5 
2 
3 
.24/.72 
.18/.86 
.321.71 
.07/.61 
.021.60 
.79 
.28/.70 
b. One person showed a significant increase of PbB. 
3 
3 
o 
o 
b.c 
d 
c. One person showed an increase of PbB until 1983. and from then a signficant decrease. 
d. One person showed an increase of PbB until 1987. and from then a significant decrease. 
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Figure 9.3 PbB levels. )..lITlolIL (drawn line) and ZPP levels. )..lITlolfmol Hb (dotted line) of four 
workers. 
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TABLE 9.2 RESULTS OF PERSONAL AND STATIONARY AIR SAMPLING OF LEAD AND OF LEAD IN WASHING-WATER 
Job function! Number of Type of Number PbA (pglm') Percentage Department operator! sampling of of values Ph in washing-water (mg) 
Place of samples median range >MACa median range 
sampling 
Smelter 1,2,3,4 PAS 16 620 170-1970 100 15.2 4.1-102 
Shovel driver 5 PAS 4 680 570-750 100 11.1 
Removal drossb 3 PAS I 1800 100 
Other workb 3 PAS I 360 100 
Cleaningb 4 PAS I 610 100 
Other workb 4 PAS I 950 100 
Rolling master 6,9 PAS 8 55 40-60 0 7.8-8.6 
Rolling/sawing 7,10,11 PAS 12 95 60-110 0 18.1 9.7-26.8 
Sawing 12,13,14 PAS 12 300 200-380 100 3.3 3.1-11.8 
Storehouse 16,17,18,19 PAS 15 400 260-680 100 2.2 1.5-10.6 
Technical service 20,21,22 PAS II 320 210-920 100 30.6 9.5-59.0 
Smelting oven A' SAS 8 410 90-1620 88 
Refining OYcn B SAS 8 305 120-620 75 
Casting lead C SAS 7 160 80-240 57 
Rolling department D SAS 8 20 10·60 0 
Rolling department E SAS 8 60 20-80 0 
Filters F SAS 3 10 10-20 0 
Sawing department G SAS 4 200 180-2940d 100 
Charging shovel SAS 2 40-130 0 
Canteen SAS 4 35 20-50 0 
a. MAC: 150 pglm' (TWA-8 il). 
b. Sampling during the job indicated. 
c. Letters refer to Figure 9,1. 
d. Value of 2940 f-Iglm3 excluded from calculation of median. 
TABLE 9.3 MEAN AND RANGE OF LEVELS OF LEAD IN AIR AND IN BLOOD 
Department PbA (~g!m3)' PbB (~ol/L) 
Number Mean Range Number Mean Range 
of of 
workers workers 
Smelting 4 780 330-1350 3 2.76 2.44-3.30 
Rolling 5 70 40-100 5 1.90 1.09-2.79 
Sawing 3 280 220-330 1 3.10 
Storehouse 3 390 220-495 2 2.20 1.87-2.53 
a. TWA-8 h. 
9.4 DISCUSSION 
In 1982 the European Community issued a directive on the protection of workers 
from health risks of exposure to lead. It was implemented in the legislation of the 
Netherlands in 1988 [Ee (1982); Labour (1988)]. In Table 9.4 the measures 
described in the Directive are summarized. In this context environmental air 
monitoring and biological monitoring are the tools for health surveillance of 
workers occupationally exposed to lead. 
TABLE 9.4 ACTION LEVELS AND THRESHOLD LEVELS OF PbA AND PbB FOR 
OCCUPATIONALLY EXPOSED PERSONS 
Lead in air 
(llg/m3/ l 
>40 
>75 
a. TWA-40 h. 
and/or 
andlor 
Lead in blood 
(~ol/L) 
>1.4 
>2.:f 
>2.9 
b. Applies only to the worker concerned. 
c. Threshold level. 
Requirements 
Information to all workers 
Opportunity to undergo medical 
examination. Hygienic measures 
Information to all workers 
Opportunity to undergo medical 
examination. Additional hygienic measures 
Intensive medical cxaminationb 
If occurring twice within three 
months. withdrawal from exposure 
d. Acceptable. provided the level of S-aminolaevulinic acid in urine <20 mglg creatinine, of 
o~aminolacvulinic acid dehydratase in blood >6 European units or of zinc protoporphyrin in blood 
<.500 ~ollmol Hb. 
The knowledge of adverse health effects of Pb has increased considerably 
during the last decades. Effects on spermatogenesis [Koeter et at (1989)], on 
kidney function [Verschoor et at (1987)] and on the central and peripheral nervous 
system [Seppalainen (1988)] may occur at lower PbB levels than was assumed a 
few years ago. So the perrrrissible levels of PbB (3.4 flmollL) and of lead in 
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environmental air (150 jlglm', TWA-40 h) mentioned in the EC-Directive may not 
prevent the occurrence of health impairment. (By order of the European 
Community, Apostoli (1991) updated the data of the Directive. He proposed a 
reduction of the present permissible levels of PbA to 70 jlg/m' for male lead 
workers and to 35 jlglm' for female workers. The proposed biological limit values 
for PbB were 1.9 and 1.4 JlffiollL, respectively). 
The general policy of the management of the present plant is that measures to 
improve work conditions will also have a positive effect on the volume and quality 
of the production. Therefore, such measures are continuously carried out aiming 
to reduce the intake of lead by the workers. Between 1982 and 1990 the most 
important measures were the following. The year in brackets is the one in which 
the provision was introduced. 
- The ovens are exhaust ventilated at a rate of 20.000 m'/h (1988). 
- The smelting and refining ovens are equipped with covers and central exhaust 
ventilation. Ventilation at the rims was introduced in 1989. 
- Instead of being sawn, rolls of lead are cut into parts (1990). 
- During the working-day the stock of scrap-lead is sprinkled automatically every 
15 minutes (1988). 
- The changing room was rebuilt in 1985 and now has separated sections for 
personal and protective clothing. 
- No protective clothing is allowed in the canteen. 
- Smoking is prohibited, except in the canteen (1988). 
- Coffee and tea breaks are only allowed in the canteen, instead of distribution of 
drinks at the workplace (1988). 
- Eating and drinking during work is prohibited (1988). In the smelting department 
this was already prohibited in 1984. 
- Since 1982, workers of the smelting department are permitted to shower during 
working-time. Other workers are also allowed to shower at the plant but not 
during working-time. 
- Since 1984 workers engaged in removing dross use an air-stream helmet. 
- Workers on the platform near the smelting and refining ovens use a P2 filter-
mask. 
- In the smelting department protective clothing is supplied three times a week, in 
the other departments once a week (1983). 
Whether measures relating to personal hygiene are observed, depends on the 
worker himself. He is responsible for his own personal hygiene. In general such 
measures are reasonably well observed. If PbB of a new-comer becomes higher 
than 2.4 jlmollL, the consequences of the non-hygienic behaviour are pointed out 
to him. Newly arrived workers generally show an increase of PbB at first, which 
often stabilizes at a lower level after they get used to good hygienic working 
practice. 
95 
Statistical analysis of the results of PbB assays shows that between 1982 and 
1990 nine workers of a group of 28 showed a significant decrease of PbB (Table 
9.1). whereas five of a group of 13 other workers showed a decreasing trend. So, 
altogether the PbB level of 14 workers of a group of 41 declined. These were 
active in several departments. Therefore, it is not possible to point to the particular 
measures which contributed most to their decreased PbB. However, personal 
hygiene especially is considered an important factor with regard to the intake of 
Pb [Chavalitnitikul (1981); Ulenbelt (1990)]. Also, between 1982 and 1984,48 of 
the PbB levels measured were >2.9 J.1mollL, whereas between 1988 and 1990 this 
number decreased to 12. Overall, the PbB levels measured are comparable to those 
measured by Ulenbelt et aI. (1991) in 24 smelters and 13 refining workers in a 
similar type of plant. 
PAS and SAS measurements were carried out on two days with an average 
production of lead sheet in December 1984. PAS in the smelting department 
frequently showed extremely high Pb levels; all levels were higher than the limit 
value (Table 9.2). Stationary sampling indicated as the main sources the ovens and, 
in particular the removal of dross. As the latter is carried out manually, the worker 
is very close to the smelting oven. In the rolling department all levels of Pb were 
lower than the permissible limit value. In the sawing department, where all Pb 
levels were higher than the permissible limit, the circular saw was provided with 
ventilation equipment. However, without casing, ventilation is only effective when 
the capacity is very large, since the particles emitted have a high velocity. In the 
storehouse Pb levels were 2-3 times the permissible limit. This is unusual for 
places where finished lead products are stored. The Pb was supposed to originate 
from the sawing which was carried out in the same hall or from lead whirled up 
into the air by the fork lift trucks used in this room. Mechanics were exposed to 
PbA levels of 2-6 times the permissible limit. However, the ambulatory nature of 
the job made it difficult to establish a representative picture of their exposure. 
Whereas the PbA levels exceeded the limit value by 100-400% (with the 
exception of the rolling department), only one of the PbB levels was higher than 
the action value of 2.9 J.1mollL, and none exceeded the permissible limit (Table 
9.3). A clear relation between PbA and PbB is seldom observed [Alessio et a1. 
(1983); Booher (1988)]. PbB reflects mainly the deposits in two main tissue 
categories: one in blood and soft tissues (half-time 20-40 days), and another in 
bone (half-time about 10 years). The impact of the latter on the PbB level is 
relatively large after prolonged exposure, but small after a short exposure. Thus 
PbB reflects current exposure better in the initial stages of exposure than later on 
[Hemberg (1980)]. Furthermore, it has been recognized that in the lead industry 
personal protection devices will help to achieve lower PbB levels [Ulenbelt et a1. 
(1991)]. A negative trend between PbA and PbB was shown for people wearing 
an air-stream helmet and for those spitting during work, and a positive trend for 
smokers. These and other factors may affect the ratio between the actual 
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concentration of lead in environmental air and the ultimate intake. It is concluded 
that establishing PbA in relation to health effects has a limited purpose. 
The concentration of lead in water used for hand-washing furnished data on the 
possibility of oral uptake of Pb by hand-to-mouth contact (,finger-shunt'), also out 
of working time. Sampling was cartied out on the same days as the PAS and SAS 
measurements. The results indicate that uptake of lead by contaminated food and 
smoking of cigarettes may occur. In this respect, however, it should also be 
realized that in a plant like the present one, where thousands of tons of lead are 
processed each month, intake of amounts in the mg range or less may be 
inevitable. 
The assay of ZPP in blood has been used as a fast and inexpensive method to 
screen occupationally exposed workers with regard to their PbB level [Herber 
(1980); Wildt et al. (1987); Zwennis et al. (1990)]. However, to estimate PbB in 
an individual on the basis of his ZPP level, the relation between PbB and ZPP of 
a large cohort of lead workers is required. 
The PbB and ZPP levels of 19 workers who were screened at least 10 times 
over a period of several years, thus with relatively large intervals, showed a 
statistically significant relation for 17 of them (Figure 9.3). Using these data, the 
sensitivity and specificity of the ZPP analysis to establish a change in the PbB 
level of an individual was calculated. In this context, sensitivity and specificity are 
defined as the ability (in per cents) of the ZPP test to identify correctly an increase, 
respectively decrease of the PbB level in a sample. Altogether in 226 PbB and ZPP 
pairs sensitivity was 78.0% and specificity 68.0%. These results suggest that in the 
health surveillance of a single lead worker a change in the level of ZPP may 
possibly be used as an indicator for a change of PbB. An increment of ZPP, which 
will indicate an increment of PbB, will then require additional assay of the 
concentration of PbB. This approach can only be applied when the subject involved 
has been exposed to lead for a time sufficiently long to reach an equilibrium 
between the deposits. The procedure has to be worked out further but may 
facilitate and promote the frequent screening of lead workers. 
From this study it is concluded that the comprehensive measures cartied out to 
reduce exposure to lead have effected a general decline of the PbB levels. No 
particular measures can be indicated which led to this result. No relation between 
Pb levels in environmental air at the workplace and in blood has been established. 
Therefore, in this study the use of PbA in relation to health effects has only a 
limited meaning. 
Under conditions of prolonged exposure. a change in the level of ZPP of an 
individual worker may possibly be applied as an indicator of a change in the level 
of PbB. 
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9.5 SUMMARY 
Results are presented of a survey in a lead·recycling plant that produces mainly 
lead sheet. The survey covers the determination of lead and zinc protoporphyrin 
in blood of the workers over a period of ten years. At one occasion stationary air 
sampling and personal air sampling were carried out. The possibility of intake of 
Pb by 'finger shunt" was also considered. During the survey a programme of 
technical changes and hygienic measures was carried out with the goal of reducing 
the uptake of Pb by the workers. The effect of these measures, as reflected in PbB 
levels, indicated a general decline in the uptake. It is suggested that a change in the 
ZPP level of an individual worker exposed for prolonged periods may be applied 
as an indication of a change in PbB. 
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CHAPTER 10 
TOXICITY OF LEAD ACETATE TO FEMALE RABBITS AFTER 
CHRONIC SUBCUTANEOUS ADMINISTRATION 
I. BIOCHEMICAL AND CLINICAL EFFECTS' 
H. Falke" and W.C.M. Zwennis 
Abstract. The effect of chronic subcutaneous administration of lead acetate was 
studied in female rabbits. The low-dose group (15 animals) received three times 
a week 0.10-0.20 mg/kg body weight and the high-dose group (15 animals) 0.80-
l.20 mg/kg. The control group received the vehicle only. Concentrations of lead 
in blood in the low-dose group increased to ca. 400 J.Ig/L'" after 70 days and in 
the high-dose group to ca. 900 J.Ig/L after 110 days. After 7.5 months 8 animals of 
each group were sacrificed. The remaining rabbits were kept for an additional 4 
months without treatment. Blood lead concentrations decreased with a half-time of 
60-70 days. During exposure the gain in body weight was lower in the high-dose 
group than in the control group and the low-dose group. The high-dose group 
developed slight anaemia and low MCV, MCR and MCRC, and basophilic 
stippling of erythrocytes. These effects disappeared during recovery. ALAD activity 
in erythrocytes was very low during exposure in both exposed groups and did not 
reach control values during recovery. During exposure the concentrations of ZPP 
and ALAU increased, but only ALAU returned to normal during recovery. No 
other effects of lead on the composition of the urine were observed. No effects 
were observed on plasma urea and creatinine concentrations. In the high-dose 
group the concentration of ALAD in the liver decreased by 30%. During recovery 
this effect was no longer present. No effects were seen in cytochrome P-450 
content or cytochrome P-450-dependent enzyme activities. Lead was mainly stored 
in bones, but some also in several soft tissues. After recovery the concentrations 
in s6ft tissues decreased to a variable degree. In the high-dose group the relative 
weights of heart and liver increased. These effects disappeared during recovery. At 
400 J.Ig lead/L blood no adverse effects were observed that did occur at the high 
dose level. 
Key words: Lead - Rabbit - Chronic exposure - Biochemical effects - Clinical 
effects 
Published in Archives of Toxicology 64:522-529 (1990) . 
.. Present adress: Board for the Authorization of Pesticides. Wageningen, the Netherlands . 
... Note added: 100 I-lg lead corresponds to 0.48 JlITIol. 
101 
10.1 INTRODUCTION 
The rabbit is considered a very suitable animal model for lead intoxication with 
regard to haem synthesis and nephrotoxicity [Hass et al. (1964); Scharding and 
Oehme (1973); Chiba and Kikuchi (1974)]. In 1981. Spit et al. described changes 
in the proximal tubules of kidneys of rabbits that had been treated subcutaneously 
with lead acetate for 3 months, reSUlting in concentrations of lead in blood (PbB) 
of 500-600 flgIL during the last month. At this level no adverse effect of lead on 
the kidneys had been detected before. Therefore, it was decided to perform a 
second experiment in a somewhat different way, using additional parameters for 
kidney function that could possibly be implemented in a protocol for biological 
monitoring of lead workers. 
This is a report of an experiment of 11.5 months, including a recovery period 
of 4 months, in which female rabbits were treated subcutaneously with lead acetate 
in doses resulting in a PbB of 400 (low-dose) or >800 flgIL (high-dose). The PbB 
level of 400 flgIL was chosen because it is accepted by the WHO as a no-adverse-
effect level for lead workers, whereas a level of >800 flglL was chosen to yield 
clear effects. The study included kidney function tests, haematological and 
biochemical analyses and determination of lead in several organs at the end of 
exposure and after recovery. 
10.2 MATERIALS AND METHODS 
Animals 
Fifty-five young adult female rabbits (New Zealand White), weighing 2.5-2.8 kg, 
were obtained from ENKI-Konijnenfarm, Someren, Netherlands. The rabbits were 
caged individually in a room with constant temperature (18 ± 2°C) and relative 
humidity (50-70%). A 12-hour light-dark cycle was maintained. At the start of the 
study 45 rabbits were selected and divided into three groups of 15 animals each: 
a control group, a low-dose group (intended PbB 400 flgIL) and a high-dose group 
(intended PbB >800 flgIL). The rabbits were allocated to the various groups by 
computer randomization. A standard rabbit diet was provided ad libitum. Tap water 
was supplied ad libitum in macrolon bottles which were filled daily with fresh 
water and cleaned weekly. 
Test material 
Lead acetate (PbAc) was purchased from BDH Chemicals Ltd., Poole, England (N' 
10142). The material was stated to contain at least 99.5% lead acetate. 
Administration of test material 
Lead (Pb) was administered as a lead acetate solution in sterile 5% glucose 
solutions by subcutaneous injection in the neck of the animals. Fresh solutions 
were prepared every Monday. Control animals received the vehicle only. Solutions 
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prepared contained 0.20 mg lead acetate per ml for the low-dose group and 0.80 
mg/ml (initially), 1.0 mg/ml (after 7 weeks) and 1.20 mg/ml (after II weeks) for 
the high-dose group. 
The animals were injected three times a week, on Monday, Wednesday and 
Friday. The low-dose group received per injection 0.20 mglkg body weight, the 
high-dose group 0.80-1.20 mglkg. In order to keep PbB of the low-dose group at 
the intended 400 flglL, dosing was occasionally decreased to 0.15 mglkg or 0.10 
mglkg dependent on PbB measured in the previous week. During the recovery 
period no injections were given. 
Experimental design 
The exposure to Pb for the main group lasted 7.5 months. The recovery period 
lasted four months. Each animal was identified by a six-digit computer reference 
number and a number written in its left ear. The animals were distributed randomly 
in a cage rack. 
Body weight 
Individual body weights were recorded at the start of the study, then once a week 
and at termination of exposure and after the recovery period. 
Blood sampling 
Blood samples were collected from the central ear artery after rubbing the ear with 
xylene to stimulate the blood flow. Blood was collected in heparinized vacutainer 
tubes at day 0 and thereafter once a week for determination of the lead level. At 
days 0, 48, 97 and thereafter at approximately monthly intervals a second sample 
was taken for haematological and biocheniical analyses. 
Analysis of lead in blood 
Analysis of lead in blood was done by atomic absorption spectrometry (AAS) 
according to Schaller (1983). 
Analysis of lead in tissues 
At day 223 eight rabbits per group and at day 336 the animals that were allowed 
to recover were anaesthetized by intravenous injection of Nembutal followed by 
exsanguination from the abdominal aorta. Samples were taken from a number of 
tissues (see Results) for determination of lead. Lead was also determined in the 
remainders of each animal after homogenization in a Stephan Cutter. The 
concentration was determined by AAS after destruction with nitric acid and H,O,. 
Haematology 
Haematological parameters (see Results) were determined by conventional 
methods. 
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Clinical chemistry 
Blood samples for clinical chemistry were centrifuged for 15 minutes at 1250 g. 
In the plasma the concentrations of creatinine and urea were determined by 
conventional methods. The concentration of zinc protoporphyrin (ZPP) in blood 
was determined according to Blumberg et al. (1977). the activity of 8-amino-
laevulinic acid dehydratase (ALAD) in erythrocytes according to Burch and Siegel 
(1971). 
Urinalysis 
Urine was collected from individual animals at approximately monthly intervals. 
Until day 175 urine was collected by catheterization of the bladder. The bladder 
was emptied between 08.00 and 09.00 and the urine discarded. Further collections 
were made between 12.00 and 13.00 and between 16.00 and 17.00. These two 
portions of urine were pooled for analysis. From day 175 on, the rabbits were 
placed in metabolic cages for urine collection. After 1-3 days of acclimatization 
24-h urine samples were collected. Sample volume and pH were measured and 
after adjustment to pH 5 with nitric acid, the concentration of lead was determined 
according to the method used for the blood samples. Additionally, the following 
parameters were determined: creatinine, urea, 5-aminolaevulinic acid (ALAU) 
according to Davis and Andelman (1967). The kallikrein activity was measured 
with the slightly modified method for human urine using the chromogenic substrate 
S-2266 from KabiVitrum. N-acetylaminoglucosaminidase activity was determined 
according to Tucker et al. (1975) after desalting the urine samples over a Sephadex 
G-50 column. Protein concentrations were determined with the Bio-Rad protein kit 
using bovine serum albumin as a standard. The protein spectrum was estimated by 
SDS-PAGE. At the end of exposure and at the end of the recovery amino acid 
concentrations were measured by ion exchange chromotography, based on the 
method of Tutschek et al. (1977). 
Biochemistry of the liver 
Part of the liver of each animal was used for biochemical analysis. The tissue was 
weighed, collected in ice-cold isotonic (1.15%) KCl solution and cut into small 
pieces. The latter were washed once with cold isotonic KCl and subsequently 
homogenized in three volumes of cold KCl solution with a glass-teflon Potter type 
homogenizer. The homogenates were centrifuged for 15 minutes at 10,000 g and 
4°C to obtain the post-mitochondrial fraction. In this fraction the following 
measurements were made: total protein with the Bio-Rad protein kit using a 
Kjeldahl-calibrated post-mitochondrial rat liver fraction as a standard, cytochrome 
P-450 according to Schoene et al. (1972), aniline-4-hydroxylase (AR) activity 
according to Imai et al. (1966), aminopyrine-N-demethylase (APDM) activity 
according to Gram et aI. (1968), ALAD activity (ALAD-liver) by a modified 
method of Burch and Siegel (1971) for erythrocytes. 
104 
Statistical analysis 
Data on body weights, organ weights, haematology, clinical chemistry and 
biochemistry were evaluated by one-way analysis of (co-)variance, followed by 
Dunnett's multiple comparison test Data on reticulocytes and basophilic stippling 
were evaluated with the Mann-Whitney U test and the Fisher exact test, 
respectively, 
10,3 RESULTS 
Clinical signs 
During the study some animals, apparently infected with Pasteurella spp" died or 
were killed, Animals of the exposed groups developed subcutaneous nodules at the 
injection sites, Hardly any reactions of this kind were observed in the control 
group, The size of the nodules was dose-dependent, The nodules disappeared 
during recovery in about three months and were not observed at autopsy of the 
recovered animals. 
Blood lead concentrations (Figure ]0,/) 
On average, the low-dose group reached the intended PbB at about day 70 and was 
kept at this concentration for each animal through weekly adjustment of the amount 
of PbAc injected, The animals showed large variation in their response, Some 
animals never reached 400 flg lead/L blood while in others the amount of injected 
PbAc had to be decreased by 25% or sometimes even 50% to keep it on the 
intended concentration, The high-dose group passed 800 flg lead/L blood at about 
day 110 and stabilized at approximately 900 flg/L During recovery PbB gradually 
decreased until day 300, Thereafter PbB seemed to stabilize at approximately ISO 
flg/L in the low-dose group and 440 flg/L in the high-dose group, Mean PbB in the 
control group was almost always lower than 40 flg/L, 
Body weights (Figure 10,2) 
During the main study the high-dose group gained less weight than the other 
groups, This delay of growth became apparent after about day 80 when PbB was 
approximately 750 flg/L Due to intercurrent deaths the number of animals in the 
recovery phase was smalL The body weights of the animals selected for recovery 
were not representative of the mean body weights of the total group, Therefore, the 
apparent increase in body weights in the high-dose group after recovery cannot be 
attributed to the termination of exposure, The apparent decline of the body weights 
in the control group after termination of the exposure period was caused by the 
computer programme, which, accidentally, selected the heaviest animals in this 
group for killing, 
Haematology (Table ]0,1) 
Haemoglobin concentrations in the high-dose group were significantly lower than 
105 
EXPOSURE RECOVERY 
~ 1000 
.. 
z 
0 
;:: 800 ~ 
'" 
z 
w 
u 
Z 
0 600 u 
0 
~ 
w 
~ 
0 400 
0 
0 
~ 
w 
z 
~ 200 li 
0 
0 50 100 150 200 250 300 
DAYS IN STUDY 
Figure 10.1 Mean concentrations of lead in blood of female rabbits during exposure and recovery. 
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Figure 10.2 Mean body weights during exposure and recovery. Symbols and statistics as in Fig. 10.1. 
The data marked with * differ statistically from the control (* p <0.05. ** P <0.01). 
in controls from day 125 onwards. At that day the mean PbB was 865 ~gIL. 
During the recovery period the haemoglobin concentrations rapidly increased to 
control levels. Packed cell volumes in the high-dose group were somewhat lower 
than in the controls from day 125 onwards. The differences disappeared in the 
recovery period. Red blood cell counts were not influenced by lead. In the high-
dose group, red blood cell indices (MeV, MeR, MeRC) were clearly affected by 
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lead. MeV and MeR were depressed from day 97 (PbB 784 flg/L) and MeRe 
from day 125 (PbB 865 flglL). In the recovery period the effects on the red blood 
cell indices rapidly disappeared. Reticulocyte counts showed a tendency towards 
higher values in the high-dose group during the second half of the main study. but 
the difference was statistically significant only on day 216. Basophilic stippling of 
the erythrocytes was observed in most animals of the high-dose group from day 
125 onwards. This phenomenon gradually disappeared during the recovery period. 
No consistent differences in these haematological variables were observed between 
the control- and low-dose groups. 
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Figure 10.3 Mean aminolaevulinic acid dehydratase activity in erythrocytes during exposure and 
recovery. Symbols and statistics as in Figures 10.1 and 10.2. 
Clinical chemistry (Figures 10.3 and lOA) 
The mean activity of ALAD in the erythrocytes on day 48 was in the low-dose 
group 23.3% and in the high-dose group 13.4% of that in the controls. At that time 
mean PbB in the low-dose group was 349 flg/L and in the high-dose group 574 
flg/L. During the whole main study ALAD activity remained very low. In the 
recovery period the activities in both groups gradually increased (somewhat faster 
in the low-dose group than in the high-dose group) but never reached control 
values. At the end of the study, when PbB was 163 flglL, ALAD activity in the 
low-dose group was only 66% of that in the controls. ZPP in the high-dose group 
gradually increased after the start of the study. Mean ZPP in the low-dose group 
was consistently higher than in the controls but the difference was statistically 
significant only at day 48. During recovety ZPP in the high-dose group decreased 
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TABLE 10.1 HAEMATOLOGICAL EFFECTS OF LEAD ACETATE IN FEMALE RABBITS (MEAN AND (SEM)] 
Exposure (days in study) Recovery (days in study) 
Variable 0 48 97 125 153 181 216 244 272 300 328 
0 Haemoglobin control 7.7 7.8 8.1 8.1 8.2 8.1 7.8 7.5 7.8 7.8 7.7 00 
(mrnollL) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.2) (0.5) (0.3) (0.3) 
high dose 7.8 7.6 8.0 7.4** 7.5** 7.4** 7.2* 6.9* 7.6 7.7 7.9 
(0.2) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.2) (0.2) 
Haemalocrit control 0.388 0.386 0.384 0.391 0.391 0.387 0.371 0.349 0.365 0.377 0.381 
(L/L) (0.005) (0.005) (0.004) (0.005) (0.005) (0.004) (0.007) (0.012) (0.022) (0.015) (0.014) 
high dose 0.394 0.375 0.383 0.371 0.373 0.369* 0.358 0.342 0.359 0.375 0.383 
(0.007) (0.005) (0.007) (0.007) (0.007) (0.004) (0.007) (0.003) (0.003) (0.005) (0.006) 
Red blood control 5.1 5.1 5.3 5.4 5.2 5.2 5.3 4.9 5.4 5.5 5.3 
cell count (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.2) (0.4) (0.3) (0.3) 
( IO"IL) high dose 5.2 5.2 5.7 5.4 5.3 5.3 5.3 4.8 5.2 5.4 5.4 
(0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.2) (0.1) (0.1) (0.1) (0.2) 
MCV control 75.6 75.4 72.0 73.2 75.2 74.2 70.8 70.9 68.4 69.1 71.6 
(IL) (0.8) (1.4) (0.6) (0.7) (0.9) (0.8) (0.7) (1.2) (0.8) ( 1.6) (2.5) 
high dose 75.8 72.5 67.6** 68.7** 71.2** 69.7** 67.4** 71.0 68.9 69.7 70.8 
(1.0) ( 1.1) (1.0) (1.1) (1.2) (1.0) (0.8) (1.2) (1.2) (0.9) (1.1) 
MCH control 1.50 1.53 1.53 1.51 1.58 1.56 1.49 1.52 1.47 1.43 1.44 
(fmol) (0.02) (0.02) (0.01) (0.01) (0.02) (0.02) (0.01) (0.03) (0.02) (0.03) (0.03) 
high dose 1.50 1.46 1.42** 1,38** 1.43** 1.39** 1.35** 1.43 1.46 1.43 1.45 
(0.02) (0.02) (0.01) (0.02) (0.02) (0.02) (0.02) (0.03) (0.02) (0.02) (0.01) 
MCHC control 19.9 20.3 21.2 20.7 21.1 21.0 21.1 21.5 21.5 20.7 20.1 
(mrnollL) (0.1) (0.3) (0.2) (0.1) (0.1) (0.1) (0.1) (0.3) (0.0) (0.1) (0.3) 
high dose 19.9 20.2 21.1 20.1** 20.1** 19,9** 20.1 ** 20.1** 21.1 20.4 20.6 
(0.1) (0.2) (0.2) (0.1) (0.1) (0.1) (0.1) (0.2) (0.2) (0.2) (0.3) 
Reticulocytes control 15.3 20.4 30.0 28.2 21.9 19.6 29.2 28.8 28.8 26.3 13.8 
(1/1000) (2.3) (2.6) (4.9) (2.9) (3.3) (2.7) (3.2) (10.9) (10.3) (3.8) (4.3) 
high dose 16.7 20.3 27.1 33.2 27.5 27.1 44.3** 26.7 31.7 34.2 32.0* 
(2.6) (2.2) (3.5) (2.9) (3.7) (3.1) (3.8) (6.0) (6.1) (1.5) (3.7) 
Basophilic control nm nm 1/14 2114 1/14 2114 1/13 014 014 014 nrn 
stippling 
(fraction of high dose nrn nrn 6114 11114** 10/14** 11!l4** 13/14** 516* 316 216 nrn 
animals) 
Number of control 15 14 14 14 14 14 13 4 4 4 4 
animals high dose 15 15 14 14 14 14 14 6 6 6 5 
Statistics: ANDV A + Dunnett tests * p <0.05 ** p <0,01 two sided; for rcticulocytes: Mann/Whitney U test * p <0.05 ** P <0.02 two sided; 
for basophilic stippling: Fisher exact test * p <0.05 ** p <0.01; nm::: not measured 
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Figure lOA Mean zinc protoporphyrin concentrations during exposure and recovery. Symbols and 
statistics as in Figures 10.1 and 10.2. 
but did not reach control values at the end of the study. In the low-dose group ZPP 
completely returned to control values. Plasma urea and creatinine concentrations 
showed no differences with control values (data not shown). 
Urinalysis 
There were no Significant differences in mean urinary volumes between the three 
groups. ALAU of the high-dose group increased during the first part of the study 
and stabilized somewhat during the second half (Fig. 10.5). During the recovery 
period ALAU rapidly returned to control values. No significant increase was 
observed in the low-dose group. No differences were found between the groups in 
pH, urinary creatinine concentrations, kallikrein activity, protein concentrations, N-
acetylglucosaminidase activity, protein spectrum or amino acid concentrations (data 
not shown). Mean concentrations of lead in urine increased with increasing 
amounts of lead administered. The range in concentrations was very wide. 
Therefore, no statistical evaluation was performed. 
Biochemistry of the liver (Table 10.2) 
ALAD activity was decreased in the liver of the high-dose group at the end of the 
exposure phase, but was not affected in the low-dose group. The difference was 
no longer observed after the recovery phase. No differences were seen in 
concentrations of cytochrome P-4S0, AH, APDM or post-mitochondrial proteins. 
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Figure 10.5 Mean urinary aminolacvulinic acid concentrations during exposure and recovery. 
Symbols and statistics as in Figures 10.1 and 10.2. 
Lead distribution (Tables 10.3 and 1004) 
The concentrations of lead measured in several tissues at the end of the exposure 
phase increased with increasing amounts of lead administered, with the exception 
of skeletal muscle. In the control group relatively high levels were observed in 
lungs, kidneys and femur. The highest concentrations of lead in the low- and high-
dose groups were found in the femur, liver, kidneys and lungs. Relatively low 
concentrations were found in the other tissues but the increase as compared to the 
controls was usually ten times or more in the high-dose group. Very high 
concentrations were found in the subcutaneous nodules. After the recovery phase, 
the lead concentrations were generally lower than after the exposure phase, with 
the exception of the femur. The decrease in the other tissues was 30-50%, with the 
exception of the lungs, which showed very low concentrations of lead after the 
recovery phase. 
The total amount of lead in the body increased with dose. After the recovery 
phase a decrease of 20-30% was seen. Most of this lead seemed to reside in the 
skeleton. In this study the weight of the skeleton was estimated to be 5-10% of 
total body weight. Therefore, the lead content of the whole body and of several 
tissues are given for relative carcass weights of 5 and 10%. The other organs 
accounted for 1 % or less of total body burden. After recovery almost all lead in 
the rabbits seemed to be located in the skeleton. The total amount in the skeleton 
was even higher than at the end of the exposure phase. However, this might be an 
artefact due to the large scatter of the data and the small number of animals in the 
recovery group. 
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TABLE 10.2 EFFECTS OF LEAD ACETATE ON BIOCHEMICAL PARAMETERS IN THE 
LIVER OF FEMALE RABBITS [MEAN AND (SEM)] 
Day 222 Day 336 
cnd of cnd of 
exposure recovery 
Cytochrome P~450 control 0.53 0.33 
(~o1Jg protein) (0.05) (0.04) 
high dose 0.63 0.35 
(0.05) (0.03) 
Aniline hydroxylase control 0.223 0.224 
(U/g protein) (0.024) (0.022) 
high dose 0.213 0.194 
(0.011) (0.021) 
Aminopyrine N- control 1.08 1.22 
dcmcthybsc (0.11) (0.15) 
(U/g protein) high dose 1.08 1.06 
(0.05) (0.10) 
Aminolaevulinic control 0.37 0.29 
acid dehydratase (0.01) (0.03) 
U/g protein high dose 0.26' 0.27 
(0.01) (0.01) 
Number of animals control 8 4 
high dose 8 5 
Statistics: ANOVA + Dunnett tests. 
* p <0.01 two-sided. 
Organ weights 
Relative weights of heart and liver in the high-dose group were higher than in the 
control group. At the end of the recovery phase this difference was no longer 
observed (data not shown). No other differences in organ weights were observed. 
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~ TABLE 10.3 MEAN LEAD CONCENTRATION (MG/KG) IN THE CARCASS AND SEVERAL TISSUES OF RABBITS AFTER EXPOSURE TO 
'" LEAD ACETATE. IN BRACKETS THE RANGE OF VALUES OBSERVED 
Day 222 (end of exposure) Day 336 (end of recovery) 
Control Low dose High dose Control Low dose High dose 
Variable (n = 8) (n = 8) (n = 8) (n = 4) (n = 5) (n = 5) 
Carcass 0.21 3.37 18.40 0.65 2.39 9.09 
(0.14-0.43) (1.12-6.14) (8.74-35.15) (0.18-1.77) (1.49-3.49) (4.52-22.48) 
Femur 1.64 16.74 113.91 1.71 15.36 140.73 
(0.80-2.90) (13.00-22.40) (78.80-148.50) ( 1.08-2.52) (11.80-18.91) (117.69-158.41) 
Liver 0.15 3.48 8.74 1.13 1.62 5.76 
(0.00-0.32) (2.24-4.78) (4.47-12.56) (0.50-2.50) (0.80-2.70) (4.20-7.80) 
Kidneys 1.22 2.43 18.35 0.37 1.15 6.89 
(0.24-2.17) (1.81-3.11) (12.74-22.94) (0,02-1.28) (0.85-1.75) (4.48-13.70) 
Lungs 2.93 2.94 6.11 0.56 0.30 0.78 
( 1.50-6.40) (2.00-5.20) (3.50-7.00) (0.36-0.91 ) (0.04-0.69) (0.56-1.12) 
Brains 0.18 0.23 2.80 0.45 0.56 1.49 
(0.02-0.90) (0.11-0.64) (0.64-15.61) (0.29-0.75) (0.34-0.81) (0.88-2.84) 
Spleen 0.19 0.78 2.44 0.33 0.44 1.27 
(0.06-0.34) (0.30-1.38) (1.46-4.14) (0.23-0.43) (0.28-0.66) (0.50-2.46) 
Aorta 0.12 0.31 0.83 
(0.05-0.24) (0.14-0.72) (0.60-1.65) 
Pancreas 0.18 0.38 1.86 
(0.06-0.27) (0.17-0.61) (0.73-3.95) 
Thymus 0.09 0.11 0.22 
(0.05-0.12) (0.06-0.14) (0.16-0.36) 
Bladder 0.01 0.03 0.08 
(0.01-0.02) (0.02-0.30) (0.06-0.12) 
Muscle 0.06 0.12 om 
(0.03-0.12) (0.02-0.30) (0.05-0.11) 
Ovaries 0.06 0.23 1.70 
(0.00-0.13) (0.11-0.60) (0.82-4.35) 
Uterus 0.02 0.04 0.17 
(0.01-0.05) (0.00-0.15) (0.12-0.23) 
Subcutaneous 0.70 99.60 509.20 
nodulus (0.30- 1.1 0) (0.60-240.70) (392.0-648.2) 
No statistics done because of ycry large scatter of data. 
TABLE 10.4 MEAN LEAD CONTENT (MO) OF THE CARCASS AND SEVERAL TISSUES OF 
FEMALE RABBITS AFTER EXPOSURE TO LEAD ACETATE 
Day 222 (end of exposure) Day 336 (eod of recovery) 
Control Low dose High dose Control Low dose High dose 
Variable (0 ~ 8) (0 ~ 8) (0 ~ 8) (0 ~4) (0 ~ 5) (0 ~ 5) 
Whole body l.ll 16.97 78.55 1.29 13.14 52.22 
(calculated) 
Bone (cst. 10%) 0.83 8.54 49.66 0.80 8.11 77.26 
(est. 5%) 0.42 4.27 24.83 0.40 4.06 38.63 
Subcutaneous 
nodulus om 0.35 4.13 
Liver 0.01 0.34 0.96 0.11 0.15 0.77 
Kidney 0.02 0.05 0.34 0.00 0.02 0.18 
Lungs 0.04 0.04 0.10 0.01 0.01 0.02 
Blood (est. 7%) 0.01 0.14 0.31 0.01 0.06 0.17 
Muscle (est. 50%) 0.19 0.38 0.20 
Values calculated from the means in Table 10.3. 
Percentages given for some tissues arc estimated relative weights used for calculation. 
10.4 DISCUSSION 
The effects of exposure of female rabbits to lead for 7.5 months, resulting in 
concentrations of lead in blood equal to the WHO limit for lead workers (400 
JJg/L) and higher were investigated. The rabbits received lead by subcutaneous 
injections of lead acetate. This route circumvents the dietary effects on gastro-
intestinal lead absorption [Mahaffey (1983); Tsuchiya (1986)] and allows better 
control of concentrations of lead in blood. These advantages may be offset to some 
extent by the appearance at the injection sites of subcutaneous nodules 
accumulating significant amounts of lead. However, it appeared possible to keep 
the PbB level of the low-dose animals very close to the intended concentration of 
400 JJg/L when the dose of lead acetate was adjusted weekly, based on the PbB 
measured in the previous week. Animals receiving the same amount of lead 
showed very different responses with respect to their PbB values. Differences in 
release of lead from the nodules and in number of nodules might be among the 
causes of the different responses; differences between animals with respect to lead 
metabolism may also contribute to this phenomenon. 
Injection of 0.10-0.20 mg lead acetatelkg body weight three times a week was 
required for blood lead concentrations of 400 JJg/L (low-dose group) whereas 1.20 
mg lead acetatelkg resulted in mean lead levels of 900 JJglL (high-dose group). A 
similar result was described by Wibowo and Zielhuis (1980). In their experiment 
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doubling of the amount of lead given to rabbits (0.50 vs. 0.25 mg lead acetate. 
three times a week) resulted in a 20% rise of PbB. These rabbits also developed 
subcutaneous nodules at the injection sites [Zielhuis (1988)]. Rabbits of the high-
dose group stored approximately six times as much lead in their bones as did the 
animals of the low-dose group, and ten times as much in the subcutaneous nodules. 
In the recovery phase PbB decreased with a half-time of 60-70 days. This is 
much longer than the reported half-time for lead in human blood, which is 
approximately 20 days [Task Group (1976)]. Most probably this difference is due 
to slow leakage of lead from the nodules. After about 12 weeks of recovery PbB 
seemed to stabilize at approximately 40-50% of the concentration maintained in the 
exposure phase. Since this apparent stabilization was measured during an additional 
period of only four weeks no conclusions can be drawn as to the further course of 
PbB. 
At the end of the exposure phase lead concentrations were highest in the 
subcutaneous nodules and in bone. Other organs with relatively high lead 
concentrations were liver, kidneys, lungs, brain and spleen. With the exception of 
the lungs, this is in accordance with published results on lead accumulation in man 
and rat [Goyer (1981); Hejtmancik et al. (1982); Mahaffey (1983)]. No values for 
the concentration of lead in lungs were found in the literature. The organs were not 
perfused prior to collection, so part of the lead measured in the organs will have 
been erythrocyte-bound. After the recovery phase the lead content decreased in all 
tissues analysed except bone. In bone there even seemed to occur some further 
accumulation of lead in the high-dose group. Although an artefact cannot be 
excluded, reallocation of lead may have occurred during the recovery phase. 
The inhibitory effects of lead on haem synthesis are well known. Our results 
are in accordance with current knowledge. Effects were almost entirely limited to 
the high-dose group. From day 125 on the haemoglobin concentration decreased 
and the erythrocytes showed increased frequency of basophilic stippling. The 
effects On red blood cell indices were present already on day 97 (lowered MCV 
and MCH). These phenomena are considered to be the earliest signs of anaemia. 
No haematological effects were seen in the low-dose group. Wibowo and 
Zielhuis (1980) found no effect on haemoglobin concentration and haematocrit 
with a PbB of 500 and 600 ~glL. In adult people, effects on haemoglobin 
concentration are usually found at a PbB higher than 800 ~glL [Zielhuis (1977)]. 
During recovery the haematological values rapidly returned to control levels. 
Some biochemical parameters of haem synthesis showed larger effects of lead. 
ALAD was severely inhibited already after about 50 days in both the low- and 
high-dose group. However, indications of decreased haem synthesis (increased ZPP 
and ALAU and lowered haemoglobin concentration) were seen only in the high-
dose group. ZPP in the low-dose group was higher than in the controls during the 
whole main study, but the difference was statistically significant only at day 49. 
Therefore, the increase of ZPP in the low-dose group, if real, is much less 
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pronounced than the effect on ALAD. In female rabbits the effects seem to Occur 
at higher levels of PbB than in women. 
Inhibition of ALAD in liver required a much higher PbB than inhibition of this 
enzyme in erythrocytes. This is inversely related to the lead content of both 
'tissues'. In the low-dose group the lead content of the erythrocytes was 
approximately 0.8 mglkg whereas the livers of the same animals contained 3.5 
mg/kg. Nevertheless, erythrocyte ALAD activity was only 23% of control values 
while no inhibition was found in the liver. The difference may be caused by a 
different distribution of lead in the cell. In nucleated cells, including the liver 
parenchymal cell, lead is fixed in the nuclei by acidic non-histon proteins [Cherian 
and Nordberg (1981)]. Apparently, this fixation mechanism is able to keep 
cytoplasmatic lead concentrations low enough to prevent inhibition of liver ALAD, 
in spite of considerable concentrations of lead in tissues. Mature erythrocytes have 
lost their nuclei and thus a lead-inactivating mechanism, resulting in inhibition of 
erythrocyte ALAD at low PbB. The relatively small effect of lead on haemoglobin 
concentrations may be explained by the presence of a nucleus in the erythrocyte 
precursor (nortnoblasts) were most of the haemoglobin is synthesized. 
In summary, subcutaneous injection of lead acetate in female rabbits during a 
period of 7.5 months resulted in a number of effects, mainly in the high-dose 
animals. The only effects observed in the low-dose animals were a clear inhibition 
of ALAD and a marginal increase of ZPP in erythrocytes. Since in these animals 
the haemoglobin concentration was not affected, the effects apparently had no 
physiological consequences. Therefore, using various parameters at a level of 400 
jlg leadIL blood no adverse effects were observed. In particular, the kidney 
function was not affected. 
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CHAPTER 11 
GENERAL DISCUSSION AND CONCLUDING REMARKS 
In lead-processing industries in the Netherlands, an overall decline in the levels of 
exposure of the workers has been effected, among others, by improving working 
conditions. The increased attention of occupational physicians and hygienists, the 
more adequate legislation and the measures taken by the Directorate General of 
Labour contributed also to reduce the problem of disruption to health by 
occupational exposure to lead. So, nowadays, in industry intoxications by lead with 
pronounced clinical symptoms are seldomly encountered any more (personal 
communication, W.L.A.M. de Kort). However, in many lead workers levels of lead 
in blood (PbB) that may cause adverse effects still occur frequently (Chapter 4, 
Table 4.9), e.g. effects on the male reproduction system and on the central and 
peripheral nervous system. It implies that in many industries a 'lead problem', be 
it reduced, still exists, continuously requiring the vigilance of the authorities 
responsible, as well as of the employers, employees and trade unions. 
Vital information on the extent of lead exposure can be obtained from the lead 
content of the blood. Understandably, when biological monitoring (BM) of lead in 
blood is performed, the analytical quality of the assay, i.e. its accuracy and 
reproducibility, is of paramount importance. As is pointed out in the Lead Decree, 
issued by the Ministry of Social Affairs and Employment, the results of the 
analysis of PbB of an individual worker should be interpreted with respect to the 
so-called action levels and the limit values of PbB [Labour (1988)]. When these 
levels are exceeded, measures are required to reduce or to prevent further uptake 
of lead. This implies that results of the analysis of PbB may have great economical 
and social consequences for employees as well as for employers. When incorrectly 
high PbB values are reported, suggesting unacceptable levels of exposure, this may 
lead to unjustifiably drastic measures, such as costly technical changes or 
adaptations of processes. Ultimately the worker concerned may be unnecessarily 
removed from his job. On the other hand, if values are reported which are too low, 
necessary measures to decrease exposure will probably be omitted, possibly leading 
to undesirable and hazardous situations. 
The round robin exercises described in Chapter 3 indicate that in view of these 
considerations the performance of the analysis of PbB by the participating 
laboratories was, in general, insufficient with regard to precision (reproducibility) 
and accuracy (free from bias). In order to be assured of valid data, it is suggested 
that the assay of lead in biological samples for health surveillance purposes should 
be restricted to laboratories that have demonstrated proficiency in measurements 
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of low-level trace elements in this type of sample, and that carry out the analyses 
regularly. Versieck and Comelis (1980) and Versieck (1985) have shown that 
improved control of contamination and other factors resulted in considerably lower 
and more consistent reference values of metals in biological samples than were 
reported earlier. It is reasonable to assume that similar effects, resulting in 
generally more reliable results, will be achieved when such measures are applied 
on samples with increased levels of the metals, including lead. 
Of great importance in obtaining demonstrably more reliable results is also the 
continuous participation in external quality control programmes. This allows 
comparison of the skill of a laboratory with that of other participants and 
assessment of the reliability of the analytical method used. Satisfactory 
performance in such a programme will inspire confidence that the analysis of other 
samples also is carried out with comparable quality awareness. 
In daily routine, so-called internal quality control samples, should be analysed 
in the same series as the actual samples. The former are 'spiked' samples 
containing a known quantity of added lead. The results help in identifying any 
trends in the performance which may occur in course of time and to check 
intralaboratory precision and accuracy. 
Following the above recommendations may result in a coefficient of variation 
of the PbB analysis of 5-10% [Bullock et al. (1986)], instead of the values 
described in Chapter 3, which ranged from 10 to 36%. 
In many studies it has been established that lead is nephrotoxic and that it 
influences blood pressure. Effects on blood pressure have been established in lead 
workers at levels of PbB of about 2 ~molJL (Chapter 2). This is only marginally 
above the limit value for males of 1.9 ~molJL proposed by the Dutch Expert 
Committee on Occupational Standards [DECOS (1980)]. The aim of the study 
presented in Chapter 4 was to establish whether the levels of PbB that occur in 
lead workers in the Netherlands, make it desirable to include the routine 
measurement of blood pressure in health surveillance programmes. As is shown in 
the overview given in Chapter 4, in practice these levels of PbB were sometimes 
considerably higher than the proposed limit value. 
De Kort et al. (1987) observed an increase of systolic blood pressure of about 
1.8 mm Hg when PbB increases by 0.5 ~mol PblL. In view of this small effect, it 
is concluded that the present levels of PbB in the Netherlands, which probably will 
decline further in the future, would make it very difficult or even impossible to 
establish epidemiologically effects of lead on blood pressure in occupationally 
exposed workers. Only longitudinal prospective studies in large cohorts might 
possibly reveal such effects. 
Therefore, incidentally measuring blood pressure in lead workers with the aim 
of detecting an effect of lead exposure, serves no practical purpose and is not 
recommended. 
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Anaemia caused by exposure to lead only occurs as a result of high exposure 
levels. In the study presented in Chapter 5 a statistically significant linear relation 
between PbB and haemoglobin concentration in Dutch lead workers was observed. 
Over the range of PbB of 0-5 J.lmollL the average decrease in the level of Hb 
amounted to 0.28 mmollL. The upper limit of the 95% confidence interval 
amounted to a decrease of 0.59 mmollL. Although there is no clear consensus as 
to the exact dose-response relationship between PbB and the decrease of Hb 
[Moore and Goldberg (I985)]. these results may have implications for people 
having a low-to-normal Hb level (low-reference value is 8.6 mmollL) at the start 
of their work and who are highly exposed. 
There still is a number of occupational activities which may lead to levels of 
exposure of about 3 J.lmollL and higher. The demolition work described in Chapter 
8 is such an example. Also specific activities in the production of electric batteries 
and in the process of re-smelting scrap-lead presented in Chapter 9 appeared to 
result frequently in very high levels of exposure. These situations occur in practice 
notwithstanding interventions taken to decrease exposure and regular inspections 
by the occupational physicians responsible. In this respect it may be mentioned that 
Ulenbelt et al. (I990) have shown that the hygienic behaviour of workers in an 
electric battery factory was an important factor in the intake of lead. Hand-washing 
before visiting the toilet, spitting and nose blowing without using a handkerchief 
were considered examples of good hygienic behaviour. So, despite moderate levels 
of environmental concentrations of lead dust, due to carelessness avoidable 
additional uptake may occur, resulting ultimately in health impairment like 
anaemia. 
It is concluded that measurement of Hb is desirable in future lead workers to 
detect those at extra risk of developing anaemia. 
Exposure to lead may occur in various ways, with different consequences. A 
particular situation arises when the exposition involves an insoluble lead 
compound, such as lead chromate. The study presented in Chapter 6 shows that 
after inhalation of lead chromate dust by rats, the greater part forms a deposit in 
the lungs. In such a case PbB levels will reflect only that -small- part of the 
inhaled quantity of the compound that is absorbed into the blood. Because the 
deposit in the lungs is not accounted for, the PbB data give an underestimation of 
the actual intake and uptake in the body. 
These results suggest that inhalatory exposure of man to lead chromate may 
eventually result in little adverse systemic effects, in conformity with the low PbB 
level. However, there is uncertainty as to the health effect of the deposit in the 
lung tissues, among others in view of the suspected carcinogenicity of lead 
chromate. 
Health surveillance of workers exposed to lead chromate, but probably also of 
those exposed to other insoluble lead compounds, requires an approach different 
from that of workers exposed to metallic lead or soluble lead compounds. It is 
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desirable to estimate the total quantity of the compound taken up by the body and 
not to rely solely on PbB as the index of internal dose. Therefore, it is 
recommended that personal air sampling (PAS) is also carried out, systematically 
and frequently, to allow an estimate of the intake and thus of the deposit. The data 
obtained should be related to the MAC of lead chromate [MAC (1994)]. 
Exposure to lead will affect the synthesis of haemoglobin, and will result in the 
formation of another metalloporphyrin compound, viz., zinc protoporphyrin (ZPP), 
which then occurs at an elevated level in the blood. This effect shows great 
interindividual variation as has been demonstrated in Chapter 7. 
The determination of ZPP in relation to lead exposure has found two 
applications. Firstly, ZPP is applied frequently in biological-effect-monitoring 
(BEM). An increased concentration of ZPP in occupationally exposed people 
indicates an effect of lead on the haematopoietic system and is considered to reflect 
an 'active lead deposit' in the body. This has been discussed in Chapters 2 and 7. 
The other application of the assay of ZPP is as a simple and cheap pre-
screening method. Chapter 7 presents an investigation into the possibility of using 
ZPP to estimate whether PbB in a sample exceeds one of the action levels or the 
limit values of the EC-Directive. In that case additional determination of PbB 
would be required. However, the low specificity and sensitivity of ZPP at the first 
action level mentioned in the EC-Directive (PbB = 1.45 J.1IIlollL) makes it an 
inadequate substitute for the PbB measurement around this concentration. Because 
of the high proportion of workers with low to moderate exposure to lead, 
nowadays the applicability of ZPP for pre-screening individual workers has 
decreased. 
However, this does not rule out the use of ZPP in detecting an increased 
concentration of PbB in lead workers. An average increased concentration of ZPP 
in a group of people indicates almost with certainty an average increased level of 
PbB. Since anaemia induced by iron shortage also results in higher levels of ZPP, 
however, it is recommended in screening an individual for ZPP to concomitantly 
determine Hb. But neither in a group, nor on individual basis is it possible to 
estimate the actual level of PbB merely on the basis of ZPP measurement. 
The effects of occupational exposure to lead on PbB and ZPP in practical 
situations, is described in Chapters 8 and 9. There, the results are presented of BM 
of PbB and of BEM of ZPP in lead workers in two different working conditions. 
The data in Chapter 8 show that, despite the extremely heavy exposure (the time-
weighted average concentration in the breathing zone amounted to more than 100 
times the present MAC of 0.15 mg/m'), the PbB level of the workers did not 
exceed 5.5 flmollL. Apparently, after a more or less continuous exposure at this 
level, a plateau is reached with an equilibrium between uptake, deposition and 
excretion. The data suggest that the very high intake is reflected only partly in the 
level of PbB. 
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Essentially this result is in agreement with those of Skerfving (1993) who used 
available data. He established a curvilinear relationship between uptake of Pb 
(maximum 2.9 Ilmol/day) and PbB. which levelled off asymptotically at about 2.5-
4 Ilmol/L. Thus, the increase of PbB per unit increase of the concentration of Pb 
in air (PbA) gradually becomes smaller. 
This may have implications for establishing the 'true' intake of lead during 
heavy exposure. Under working conditions in which high levels of exposure are 
likely to occur, it is unwise to estimate exposure only by measuring PbB. 
Therefore, it is suggested that personal air sampling and determination of Pb in 
urine (Pb U) are also included. The latter has been recommended in particular to 
establish a severe exposure [Roots (1979)]. PAS and PbU data complement the 
results of the PbB analyses in decisions on managing the exposure. 
A low excretion of lead in urine in a situation of high intake will be a signal 
of the formation of a deposit in the body. This may require examination of the 
kidney function and further measures to control intake of lead. 
It appears from the results in Chapter 8 that induction of ZPP by lead exposure 
shows great differences between individuals when related to the PbB values 
reached. Similar results have been described in Chapter 7. The PbB levels of the 
workers increased to levels between 3.5 and 5.5 !Jffiol/L within a few weeks while 
the concentrations ofZPP reached values between 175 and lIDO Ilmol/mol Hb. The 
ratio of ZPP and PbB at the highest level of PbB of the workers varied between 
36 and 207. Because there is a time-lag in the formation of ZPP after exposure to 
lead, the levels of ZPP were probably still increasing during the following weeks. 
This indicates that not only the maximum allowable level of PbB, but also that of 
ZPP stated in the Lead Decree (500 Ilmol/mol Hb) in most cases has been 
exceeded grossly. 
The second study in a practical situation (Chapter 9) concerned a lead-recycling 
plant, where an extensive programme was initiated of hygienic and technical 
measures and of elaborate precautions to reduce the levels of PbB. Although this 
resulted in a general decline of exposure, the study made clear the difficulty of 
reaching a level of exposure that complies with the permissible level of PbB. 
More important from the health surveillance point of view was the observation 
made in this survey that it is difficult to demonstrate a decrease in intake of lead 
in chronically exposed subjects solely on basis of PbB data. Under conditions of 
chronic exposure, the level of PbB is determined by two sources: the absorbed lead 
originating from recently experienced exposure and, secondly. a continuously 
present 'background' built up over time, which is determined by the equilibrium 
of lead in the different compartments in the body (in addition to PbB, the deposits 
in soft tissues, trabeculae and, to a lesser extent, in compacta). It has been 
discussed in Chapter 2 that this background decreases only Slowly when exposure 
is reduced and that it may contribute considerably to the PbB level. This implies 
that, although technical measures as well as improved personal and work hygiene 
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may have resulted in a subst.antially decreased intake of lead, their actual effect on 
the PbB level of workers with a record of prolonged exposure is only reflected in 
the long term. Therefore, in addition to the assay of PbB, PAS will be required to 
monitor the short-term effect of these measures and the expected decline in intake 
of lead. 
In a group of 19 workers who were screened more than ten times for PbB and 
ZPP, 17 showed a statistically significant relation between these parameters. The 
workers had been chronically exposed to reasonably constant levels of Pb for 
several years and the PbB and ZPP screening had been performed at relatively long 
intervals. In 72% of the measurements, an increase or decrease of PbB resulted in 
a corresponding change of ZPP. In 18% of the cases an increase of ZPP went 
together with a decrease of PbB, thus yielding a false positive indication. Only 
10% of the measurements showed a false negative result (decreasing ZPP versus 
increasing PbB). This suggests that in workers exposed for a prolonged period, 
variations in the ZPP level of an individual may be used to establish changes in 
his PbB level. Such an approach might considerably simplify health surveillance 
of lead workers. 
An animal study was undertaken to see whether under conditions of long term 
exposure to lead, any physiological parameter would be affected in such a way that 
it might be considered indicative of the extent of exposure or of the total lead 
burden (Chapter 10). In this study two groups of female rabbits were exposed to 
lead acetate causing levels of PbB of about 1.9 and 4.3 ilffiollL, respectively, for 
7.5 months. Thereafter, a part of the animals was kept for 4 months without 
treatment. 
During exposure. gain in body weight was lower in the 'high-dose' group than 
in the 'low-dose' group, whereas the relative weights of heart and liver in the 
'high-dose' group increased. The first group also developed anaemia and effects 
on several other haematological parameters (inhibition of ALAD, increased levels 
of ZPP and ALAU). Also basophilic stippling and lowered MCV and MCH in red 
blood cells were observed. No haematological effects occurred in the 'low-dose' 
group, with exception of ALAD inhibition. In neither of the groups effects on 
kidney or liver function tests or on clinical parameters were observed. The 
experiment did not indicate any parameters that could possibly be applied in the 
health surveillance of lead workers. 
The objective of the present study on the labour conditions of workers in the lead-
processing industry was to investigate experimentally specific topics that could 
already be applied in health surveillance programmes, but which demanded a 
renewed evaluation. Further, it was considered desirable to pay attention to a 
number of topics that are recommended to become integrated parts of these 
programmes. In this context the aspects described in Chapters 3-10 have been 
investigated. The subjects vary greatly in character, but each in itself is considered 
124 
an essential element in health surveillance. The results of the studies, when applied 
in practical situations, will contribute to a more reliable health surveillance of 
people occupationally exposed to lead, and may help to prevent avoidable health 
risks. The following conclusions are drawn. 
- The results of the analysis of PbB may have radical consequences for people 
involved. In this respect it is essential that quality control of the assay of lead in 
blood constitutes an integrated part of health surveillance programmes. 
- Because high exposure to lead may induce anaemia, it is strongly advised that the 
potential occurrence of this effect in (future) lead workers is established. 
Therefore, measurement of haemoglobin should be a part of the pre-placement 
surveillance of these people. 
- In case of exposure to lead chromate or other insoluble lead compounds, one 
cannot rely on PbB measurements. Additional indicators of uptake are required 
to prevent the occurrence of health impairment. Therefore, establishment of the 
exposure by PAS should be included in the surveillance programme. 
- Due to its simplicity, the measurement of ZPP as (rough) indicator for PbB 
allows a frequent estimation of exposure. It is recommended that this screening 
should be incorporated into health surveillance. 
- During heavy exposure to lead the level of PbB does not increase corres-
pondingly. In these cases one should not rely solely on PbB as an indicator of 
body burden. In addition, the intake should be estimated by PAS and the uptake 
also by PbU. 
A protocol for health surveillance of occupationallly exposed lead workers in 
which these recommendations have been incorporated is suggested in the Annex. 
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ANNEX 
PROTOCOL FOR HEALTH SURVEILLANCE OF WORKERS 
EXPOSED TO LEAD 
INTRODUCTION 
In many countries the great number of people occupationally exposed to lead and 
the knowledge of the related risks to health, have led to the issuing of maximum 
permissible levels of PbB and PbA to ensure protection of workers (Table AI). 
In the Netherlands such regulations, just as other occupational health-based 
standards, are developed in the following three-step procedure. 
1. The Dutch Expert Committee on Occupational Standards (DECOS) advises in 
terms of exposure levels with respect to health effects. 
2. The Subcommittee on Occupational Exposure Limits of the Social and 
Economic Council (SOEL, the former National MAC-Commission) judges the 
advice of DECOS with regard to its social and economical implications. 
3. Finally, the Government lays down by rule, or decides, on the acceptable levels 
of exposure. 
In 1980, DECOS proposed permissible biological limit values of PbB for male and 
female lead workers. The Committee concluded that levels of PbB higher than 1.9 
flmol/L may lead to disturbed nerve conduction velocity (NCV) and/or a clearly 
increased level of zinc protoporphyrin (ZPP) in blood, the latter indicating the 
presence of an 'active' deposit of lead in the body. In view of the adverse effects 
of lead on the central nervous system of the foetus, for fertile women a permissible 
level of PbB of 1.4 flmol/L was proposed. In the proposal also the potential 
induction of chromosomal aberrations in lead workers was considered. 
In particular the effect on NCV was considered injurious to health. Health 
consequences of the increased level of ZPP were not clear, while the literature on 
the occurrence of chromosomal aberrations was conflicting. 
The Committee also proposed permissible levels of lead in environmental air 
at the workplace: for men of 60 flglm' and for women of 40 flgim' (TWA-8 h, 
particle size <5 flffi). It was emphasized, however, that the main criterion in health 
surveillance should be the level of PbB. 
Since the proposal of DECOS in 1980, no other health-based permissible levels of 
PbB and PbA have been issued by official bodies in the Netherlands. However, 
several recent studies, which are discussed in Chapter 2, have shown that adverse 
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TABLE Al STANDARDS AND GUIDELINES FOR LEAD IN BLOOD AND IN 
ENVIRONMENTAL AIR. AND FOR EFFECT PARAMETERS 
Status 
PbB PbA 
legally guide Effective 
(ll1ll01lL) (~g1m3) binding line Country since* Remarks 
1.9 60 + Netherl. 1980 Men PbA:TWA-8h 
1.4 40 + Women PbA:TWA-Sh 
ISO + Canada 1980 
0 + Germany 19S0 Fertile women may not be 
exposed to material 
containing >2% Pb 
1.9 + 1982* Men. and women above 
reproductive age 
1.4 + Women in reproductive age 
ALAU <6 mglg creatinine 
ZPP :00% raised 
(Recommended by WHO) 
50 + U.S.A. 1983 
3.4 ISO + E.C. 1988 
3.9 Prov. ALAU <20 mglg crcat 
or ZPP <500 ll1llollmol Hb 
or ALAD <6 EW'opean units 
ISO + U.S.A. 1987* Inorganic lead dust 
2.4 + U.S.A. 1987* PbU: 150 )lglg creatinine 
ZPP: I ~g1ml blood 
ISO + Belgium 1987* 
50 + Sweden 1989 Respirable dust of Pb and 
inorganic lead compounds 
100 + Finland 1989 
3.4 + Germany 1992' ALAU <15 mglg creatinine 
(men) 
1.4 Women <45 years: 
ALAU <6 mglg creatinine 
100 TWA-S h 
1000 STEL-30 min 
Exposure to Pb < MAC and 
< permissible level of PbB 
cannot exclude adverse 
effects to offspring 
ISO + U.K. 1993* TWA-8 h 
For abbreviations sec list on page 141. 
* The year indicated with * is the year that the guideline was issued. 
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health effects may occur at levels of exposure that in the recent past were 
considered without risks. In the light of these newly acquired insights, a re-
evaluation of the proposed levels by an expert group is recommended'. 
In 1982, the SOEL advised permissible biological levels of PbB for men and 
women of 2.9 and 2.4 flmollL, respectively, and a permissible level of PbA of 100 
flg/m'. These proposals should have taken effect in 1985 but were superseded by 
a Directive of the European Community (see below). Although the SOEL agreed 
with the opinions of the DECOS, the levels of PbB proposed by the laner were at 
that time considered not to be anainable in practice [SOEL (1982)]. However, they 
advised a further reduction of the permissible levels in the future. 
At present, health Burveillance of lead workers in the countries of the European 
Community is based on the requirements of an EC-Directive [EC (1982)]. This 
directive was implemented in the Dutch legislation as the 'Lead Decree' (,Het 
Loodbesluit') which took effect in 1988 [Labour (1988)]. It applies to work in 
which persons may be exposed to lead and aims at assessment and control of 
exposure and prevention of health impairment. However, the permissible limit 
values and the so-called 'action' levels for PbB and PbA defined in the decree 
(Table 9.3 in Chapter 9) were not based on published arguments. In view of 
current knowledge on the relation between exposure and occurrence of adverse 
health effects, as discussed in Chapter 2, these values and levels are considered too 
high. 
By order of the European Community the data of the EC-Directive were 
updated by Apostoli (1991). On the basis of recent studies the adverse effects of 
lead in adults were reconsidered. It was proposed to reduce the biological limit 
value of PbB for men to 2.4 flmollL and for women to 1.4 flmollL. Standards of 
PbA at the workplace were reduced to 70 and 35 flg/m' for men and woman, 
respectively. However, in the report no argumentation is given for these 
environmental air levels. It is emphasized further that the proposals are under 
discussion, now, and not accepted yet. 
Programmes for health surveillance of occupationally exposed workers are often 
based on the standards presented in Table AI. Generally, PbB andlor PbA are 
determined in these programmes and sometimes one or more effect parameters. 
Also more comprehensive programmes are available which cover additional aspects 
related to the health risks of occupational exposure. In the Lead Decree a protocol 
is described which is based on both the action and permissible levels of the EC-
Directive . 
• Recently. DEeOS started the procedure for updating the recommendations issued in 1980. 
129 
PROPOSAL OF A PROTOCOL 
Introductory remarks 
Health surveillance of lead workers is usually not performed on a regular basis. 
However, systematic collection of data in a longitudinal programme allows a more 
reliable assessment of exposure and earlier recognition of health impairment than 
incidental measurements [Zielhuis and Henderson (1986)]. 
The following protocol aims at obtaining a continuous and reliable insight into the 
exposure of workers in order to prevent the occurrence of early health impairment. 
It is based on that of Lerner (no year). In addition, the relevant results of the 
studies presented in Chapters 3·9 have been incorporated. Also several 
recommendations made in Publication P 170·1 [Labour (1988)] and in the 
Handbook of Occupational Hygiene [Harvey (1993)] have been taken into account. 
Alessio and Foa (1980) recommended that in health surveillance of lead workers 
two biological tests are used simultaneously. The first should indicate the internal 
dose or exposure as reflected in the concentration of PbB, the second should 
indicate an effect. 
Since it was argued before that the action values and permissible limit levels 
of PbB and PbA mentioned in the Lead Decree [Labour (1988)] are considered too 
high, the limit values proposed by DECOS (1980), i.e. PbB: 1.9 and 1.4 fImol/L 
and PbA: 60 and 40 fIg/m' for men and women, respectively, are adopted in the 
following protocol. A consequence of this is that the traditionally used biological 
effect parameters, like ALAU, CPU and to a smaller extent also ZPP, have become 
less important since they only respond at higher levels of PbB. They may have to 
be replaced by more sensitive parameters that have greater significance at lower 
levels of exposure, when available. 
In Chapter 8 it has been argued that on an individual basis the concentration 
of PbB cannot be derived from PbA. WHO (1980) also concluded that it is not 
possible to indicate a level of PbA which guarantees that the permissible level of 
PbB is not exceeded. Therefore, following DECOS (1980), in the following 
protocol PbB is the primary criterion for assessing exposure and preventing toxic 
effects, whereas PbA is used as a means to ascertain adherence to limit values. 
THE PROTOCOL (see also Table A2) 
A. PRE· PLACEMENT ASSESSMENT 
The following biological tests should be performed preferably prior to the 
commencement, but in any event within the first two weeks of the job. 
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TABLE A2 SCHEME OF HEALTH SURVEILLANCE 
New employees All employees 
Pre- Monthly PbA < PbA> PbB> Exposure 
placement for 4 limit limit limit to lead 
months value value value chromate 
A B C D 
PbB x x x x X 
ZPP' X X X X X 
ALAD' x x x x x 
p,N" x x x x x 
Hb x x x x 
Question-
naire x 
Medical 
examina-
tion x 
PAS x x x x x 
PbU 
EM' x x x 
For abbreviations sec list on page 141. 
A. Annually. on condition that PbS's of all workers arc <1.9 )JJ11ollL. 
B. At the decision of the occupational physician. 
C. Repetition of PbB, offered to the worker concerned within three months. 
D. Additional measurements 
d. One of these three BEM parameters. 
c. To identify sources of emission. 
Assay of lead in blood 
High 
exposure 
D 
x 
This analysis will reveal previous exposure in work or leisure time. On the 
condition that the analysis is performed before the first day of employment, it 
may also be used as a baseline value for further prospective studies. 
In the author's experience the assay of PbB by the method of Stoeppler et al. 
(1978) has proven to be reliable and applicable for the measurement of large 
series of samples. The precision of the method, expressed as the relative 
standard deviation in parallel determinations at different times, is about 5% 
and the detection limit about 0.05 /1mollL blood. Also, the procedure of Schaller 
(I 983) which uses extraction of the sample and flame atomic absorption 
spectrometry may be recommended (precision, is about 5%; detection limit 
0.07-0.25 /1mollL blood. 
The necessity of participation in an external quality control programme has been 
argued in Chapter 3. 
Determination of haemoglobin in blood (Chapter 5) 
Persons with a low-to-normal or a Hb-level below the reference value, who are 
potentially at risk of (further) developing anaemia, can thus be identified. This 
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applies in particular to workers who are likely to be significantly exposed to 
lead. Knowledge of the level of Hb also avoids a possibly wrong conclusion 
that an increased level of ZPP in blood actually resulting from anaemia is due 
to lead exposure (see Chapter 7). 
Determination of at least one of the following biological effect parameters 
Zinc protoporphyrin in blood (Chapter 7) 
It is recommended that PbB and ZPP are always determined jointly in a single 
blood sample. Recommended method of analysis: Blumberg et al. (1977). 
o-Aminolaevulinic acid dehydratase in blood 
References for the analysis of ALAD by the 'European Standardized Method' 
of Berlin et al. (1977) are given in Chapter 2. The precision of the method is 
about 3%. 
Pyrimidine 5' -nucleotidase in blood 
Details of the method of analysis and its application are given in Chapter 2. 
Of these three methods the assay of ZPP has found the most general application 
in health surveillance programmes. The analysis is cheap and easy to perform and 
the relation between PbB and ZPP has been studied extensively. However, as has 
been discussed above and in Chapter 7, at lower levels of exposure its meaning is 
limited. In those cases determination of ALAD or of P,N in blood is preferable. 
In Table A3 a summary is presented of reference values and available limit values 
of the parameters discussed in the proposed protocol. The reference values may 
give an indication of the levels that may be expected in non-exposed groups. 
However, it is strongly recommended that together with the screening of exposed 
workers, the levels in matched local control groups are established. 
PRE-PLACEMENT MEDICAL SURVEILLANCE 
Lerner (no year) and Labour (1988) recommend that in the medical surveillance 
of each worker to be employed attention should be given to the following issues. 
Determination of any past occupational exposure to lead. This may be achieved 
by analysis of PbB andlor by a questionnaire on occupational history. 
The physical status of the worker, to identify possible conditions that may be 
aggravated by exposure to lead. In this connection it is recommended that 
attention is given to 
• the blood and the haematopoietic system; 
• the nervous system; 
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• the kidneys; 
• the heart and the vascular system. 
The Directorate General of Labour has published the protocol 'Lead and its ion 
compounds' (Protocol S 30-8) giving particulars on the medical examination of 
workers exposed to lead and its ion compounds. 
TABLE A3 REFERENCE VALUES AND LIMIT VALUES OF PARAMETERS APPLIED IN 
THE PROPOSED PROTOCOL 
PbB (MffiollL) 
PbU (MffioJlmol creatinine) 
(MffiollL) 
ZPP (MffioJlmol Hb) 
ALAD (European units) 
PsN (International units) 
Hb (mmollL) 
PbA (~g/m3. <5 Mffi. TWA-8h1 
Lead chromate 
For abbreviations see list on page 141. 
Reference 
value 
38 ± 13 (men)f 
f 48 ± 16 (women) 
38.3' 
12 ± O.7h 
8.4-10.9i (men) 
7.3_9.Si (women) 
Limit 
value 
1.9b (men) 
1.4b (women in reproductive age) 
82' 
N.A. 
N.A. 
N.A. 
N.A. 
N.A. 
60b (men) 
40b (women in reproductive age) 
25k 
a. Based on a great number of PbB levels of non-occupationally exposed Dutch males established 
by MBL. 
b. DECOS (1980). 
c. Gerhardsson et al. (1992). 
d. ACGIH (1986). 
e. Zhang (1993). 
f. Wildt et a!. (1987). 
g. Berlin ct.!. (1977). 
h. Cook et aI. (1986). 
i. Local reference values. 
j. Particles <5 J-IIIl are considered respirable. 
k. TWA-15 min (MAC 1994). 
N.A. Not available. 
Identification of factors which may affect or contribute to exposure. As has 
been discussed before, poor personal or work hygiene like untidyness, smoking, 
eating and drinking during work, are often the most important factors 
determining intake of lead. 
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The ability of a subject to use a respiratory protective device when required. 
The physical status of a worker may restrict the use of a respirator mask. Facial 
hair e.g. may interfere with its proper fitting. 
Special attention should be given to the working conditions of pregnant and 
nursing women. Removal of women from work associated with exposure to 
lead in the early phase of pregnancy may be too late to prevent adverse effects 
to the central nervous system of the foetus. 
B. PERIODIC ASSESSMENT 
Periodic assessment aims at preventing the development of acute or chronic effects 
of lead. As has been discussed in Chapter 2, individuals may show different 
responses or symptoms and biological effects at similar levels of exposure. This 
implies that there is no level of PbB synonymous with lead poisoning. The 
diagnosis requires identification of early impairment, such as changes of nerve 
conduction velocity or kidney function. 
New employees 
New employees are subjected monthly to a programme of biological tests similar 
to that applied before employment. Along with this screening, levels of Pb in the 
breathing zone are also measured with PAS"'. When after four months the average 
of the PbB (and PbA measurements) are below the permissible limit values, the 
frequency of screening is reduced to once a year. It is assumed that exposure will 
not change significantly if the workplace of a subject and his work conditions 
remain the same. However, employment of a worker at another place or in another 
job requires that the monthly test programme is restarted [Labour (1988)]. 
Already employed workers 
When data of four PbA measurements, performed earlier in four successive 
quarters, are below the limit value (in this protocol 60 or 40 flglm' for male and 
female workers, respectively), and PbB of all workers is below the limit value (1.9 
and 1.4 flmoVL, for men and women, respectively), the worker concerned is 
subjected annually to the programme A shown in Table A2. 
When no measurements are available, PbA should be determined four times, 
each with an interval of three months. When the results of the three last results are 
below the limit value, a regimen similar as described above takes effect. 
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* Monitoring of lead in the breathing zone should be carried out according to the Dutch National 
fcntative Norm NVN 2938. 
The Lead Decree describes that when a PbA level exceeds the limit value the 
occupational physician decides on the necessity and time of repeating the 
assessment of the biological tests. 
Also, when a PbB level exceeds the limit value the employee is offered the 
opportunity to have the analysis of PbB repeated in newly obtained blood samples 
within three months. When the first result is confirmed, suspension of further 
exposure or transfer to a workplace with less exposure are indicated, together with 
repeated measurements of PbB until the latter has fallen below the permissible 
level. It is of essential importance that this step is followed by an investigation into 
the causes of the high exposure and that appropriate measures are taken to reduce 
further uptake. Counselling of the workers concerned may be required to obtain 
more insight into the causes of the inadmissible extent of exposure. Suspension of 
further exposure serves only a limited purpose if the causes of the high exposure 
are not eliminated. In Chapter 9 and below several work practices and procedures 
are described to avoid contamination of the workplace and the subsequent intake 
of lead. 
C. GENERAL CONSIDERATIONS 
The purpose of the following considerations is to improve further the quality and 
reliability of the proposed health surveillance programme. 
The protocol is applicable under conditions of more or less regular levels of 
exposure. However, in practice the conditions of exposure may vary in such a 
way that the application of the time-schedule suggested in the protocol will 
yield unsufficient insight into the actual intake of Pb. Under these 
circumstances it may be necessary to increase the frequency of the 
recommended measurements. The proper execution of the protocol depends on 
the actual circumstances and possibilities and rests with the occupational 
physician responsible and the management concerned. 
The annual screening discussed above, which is based on the directions of the 
Lead Decree, may imply a considerable risk that workers are exposed to 
unnoticed too high levels of Pb during the interval between two screenings. 
Therefore, contrary to these directions, it is suggested that the frequency of the 
screening is increased to several times a year. 
The Lead Decree requires that biological tests and medical surveillance are 
performed by or under the responsibility of an Occupational Hygiene Service. 
If work conditions do not change during subsequent employment, it is 
recommended that the medical examination is carried out once a year. 
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The biological tests should be carried out on persons who work in normal 
situations and who work during the usual time in the workplace [Harvey 
(1993)]. The situation at a plant in respect to exposure should not be based on 
results of BM measurements that are performed on workers with deviating 
work-time or work conditions. 
For analysis of PbB the time of sampling during the day is not critical. In order 
to correct for diurese and circadian rhythm, however, collection of urine and 
sampling of blood for BEM parameters should each time be performed at about 
the same time of the day. 
Although BM of lead provides an accessible measure for estimating exposure, 
interpretation of measured PbB levels should take into account the fact that they 
reflect only one point in time. Thus, if external exposure is highly variable in 
time and level, a single BM value may easily be misinterpreted. This should be 
taken into account when incidentally a large deviation from the usual exposure 
levels occurs. Under these conditions more frequent applications of the 
biological tests may be necessary. Also, when BM is carried out regularly, 
deviating higher results may indicate peaks in exposure which otherwise would 
not have been noticed. In Chapters 2 and 9 it is discussed that a decrease in 
exposure is not necessarily reflected, in the short term, in a lower level of PbB. 
When in a group of workers with similar tasks, PbB of one subject is 
permanently significantly higher than that of the others, this may indicate poor 
personal or work-hygienic behaviour of the worker concerned. The single high 
PbB level does not necessarily reflect a general high concentration of lead in 
environmental air. Results of BM should also be considered from this angle. 
In handling solid lead, the usual precautions with regard to personal hygiene, 
protective measures and cleanliness of the workplace usually prevent significant 
intake [Harvey (1993)]. In general, when personal hygiene is maintained, intake 
of lead by primary ingestion is considered negligible compared to intake by 
inhalation. 
In connection with the adverse effects of lead on a foetus, particularly during 
the first weeks of pregnancy (Chapter 2), it is recommended that fertile women 
do not experience exposure resulting in PbB levels exceeding the proposed limit 
value of 1.4 flmollL. The Dutch Government intends to insert a bill into the 
Lead Decree stating that pregnant and nursing women may not be obliged to 
work with lead and lead compounds when the possibility exists of uptake of 
lead in the body [Bill 14', Staatscourant 33, 1993]. 
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Because of the suspected carcinogenicity of lead chromate, it is proposed that 
health surveillance of lead workers who are exposed to this insoluble compound 
includes personal air sampling (Chapter 6). Very likely this applies also to 
exposure to other insoluble lead salts. In contrast with PbB, PAS will give 
information as to the actual intake of the compound and the presence of a 
deposit. The PAS-data may be interpreted on basis of the MAC-values stated 
in the MAC-list (1994). 
In particular types of work, heavy exposure to lead is almost inevitable. The 
results of the study presented in Chapter 8 suggest that the PbB levels of the 
workers concerned do not reflect ,this very high intake. Therefore, it is 
absolutely required that under such circumstances workers are also monitored 
regularly by PAS. 
When working conditions may lead to heavy exposure, as described in Chapter 
8, it is proposed to determine also PbU [Cf. Roots (1979)]. The PbU and PAS 
data will give additional information as to the intake and excretion of lead 
which cannot be derived from the PbB measurements only (see above). The 
results may also support decisions in managing the exposure. 
PbU should preferably be determined in 24-hour urine samples. However, 
collecting urine over a 24-hour period is difficult to realize in practice. When 
spot samples are used, interpretation of PbU data may require correction for the 
fluctuations of the Pb concentration caused by differences in the concentration 
of the urine. To this end PbU levels are often expressed per mol of creatinine' 
or at a certain urinary densiry, usually 1.020 [Kowal and Zirkes (1983)]. In 
principle, urine samples with levels of creatinine <4.4 and >26.5 mmollL, or 
with a density <1.015 and> 1.030, are considered inappropriate for establishing 
the correct excretion of Pb [Dell Orto et aJ. (1987)]. 
Persistently low PbU levels in combination with high levels of PbB may 
indicate a decreased capacity of the kidneys to excrete lead. Workers concerned 
should be medically examined [Lerner (no year)]. 
Data of BM and of BEM should be recorded numerically as well as in 
diagrams. The occupational physician should consider individual data of 
biological assessments as confidential. 
The Directorate General of Labour in the Netherlands generally follows the 
principle that exposure of workers should be prevented by intervention in the 
'" The quantity of creatinine excreted in urine per unit of time is grosso modo constant and 
largely independent of the volume of the urine. 
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transfer of dust from processes and sources to the worker. This goal may be 
reached by appropriate technical measures or by adaptation of processes, as 
well as by sufficient ventilation near the sources or the use of closed processes. 
Only when these measures do not result in acceptably low levels of exposure, 
should personal respiratory protective equipment be applied, but only 
temporarily. An exception is made for those situations in which exposure can 
only be prevented by personal protection [Labour (1988)]. 
In this strategy, personal protection is the last resort on the route from emission 
to intake of lead by workers. However, in view of the proposed large reduction 
of the permissible levels of PbB and PbA in this protocol, the use of these 
personal protection devices should temporarily be given a higher priority. 
Compared to the present situation, in many lead-processing industries a 
considerable further decline in the level of exposure is required to conform to 
the proposed biological limit values of PbB and the limit values of PbA. To 
pursue this goal in addition to addressing exposure by an adequate surveillance 
programme, the work procedures (and their inadequacy!) require the attention 
of the management and the occupational physician or hygienist responsible. 
In this respect, when appropriate the following aspects discussed by Harvey 
(1993) and those in Chapter 9 should be considered to control and reduce 
exposure. 
• Reduction of emission and transmission of lead-containing dust and aerosols 
in processes by improved exhaust ventilation as close to the sources as 
possible. Total enclosure of processes is to be preferred to exhaust 
ventilation. 
• Failure of temperature control, presence of dust on the floors and drying up 
of battery grids are examples of sources in battery plants resulting in 
avoidable uptake of lead. 
• Above 500°C, lead vapour may be given off. 
• Use of granulated instead of powdery compounds. 
• Substitution of lead-containing materials by lead-free materiaL 
• Application of sprinkler systems to wet particular stocks, floors, etc. 
• Avoidance of dry sweeping. 
• Availability of respirator protection devices. 
• Washing and changing facilities divided into a clean section without risk of 
exposure and a 'dirty' section where exposure may occur. It is important 
that the washing facilities are used by all workers before leaving the 
premises. 
• Canteen facilities should be situated in the clean section. Workers should 
change clothing before entering the canteen. 
• Information. instruction and training of the workers to effectively manage 
exposure and to impress on them the health risks of ignoring precautions. 
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ABBREVIATIONS 
aniline-4-hydroxylase 
o-aminolaevulinic acid 
o-aminolaevulinic acid dehydratase 
o-aminolaevulinic acid in urine 
aminopyrine-N-demethylase 
biological-effect monitoring 
biological monitoring 
coproporphyrin 
coproporphyrin in urine 
coefficient of variation 
European Community 
environmental monitoring 
i'thylenediaminetetraacetate-disodium salt 
haemoglobin 
mercury 
hydrogen peroxide 
potassium chloride 
maximum accepted average concentration during 
8 hours/day, and not more than 40 hours/week 
Medical Biological Laboratory 
mean corpuscular haemoglobin 
mean corpuscular haemoglobin concentration 
mean corpuscular volume 
personal air sampling 
lead 
lead in air 
lead in blood 
lead in urine 
pyrimidine 5' -nucleotidase 
sodium dodecylsulphate-polyacrylarnide gel-electrophoresis 
short-term exposure limit 
Nederlandse organisatie voar toegepast natuur-
wetenschappelijk onderzoek (Netherlands organization 
for applied scientific research) 
time-weighted average 
World Health Organization 
zinc protoporphyrin 
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UNITS AND CONVERSION FACTORS 
Molecular weight ZPP = 626 
Hb = 16,125 (Hb/4) 
creatinine = 113 
1 flIIlOI Pb = 207 flg 
100 flg Pb = 0.48 flIIlOI 
I flIIlol ZPP/mol Hb = 0.04 flg/g Hb 
1 flIIlol Pb/mol creatinine = 1.83 flg/g creatinine 
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SUMMARY 
During the last decades the industrial application of metallic lead and lead 
compounds has decreased considerably. In addition, present legislation and the 
measures taken by employers and trade unions to improve occupational hygiene 
have contributed to the disappearance of cases of overt intoxication of lead 
workers. On the other hand, the application of new and more sensitive 
(biochemical) tests, i.e. on neurological responsiveness and on renal metabolism, 
has made clear that health impairment by lead may already occur at levels of 
exposure which recently were considered harmless. 
The object of the studies presented in this thesis is to find conditions that can be 
applied to improve health surveillance of workers occupationally exposed to lead, 
in order to prevent tbe occurrence of adverse health effects, also in the long term. 
To this end, the topics indicated in the following paragraphs have been studied. 
In Chapter 2 a review is presented of the literature on health impairment induced 
by lead in man and on the methods which may be applied to estimate exposure. 
These are monitoring of lead in environmental air at the workplace (EM of PbA) 
and in the breathing zone of workers (personal air sampling, PAS) or biological 
monitoring (BM) of lead in blood (PbB) and of lead in urine (PbU). Also methods 
for routine assessment of effects of lead on the haematopoietic system (biological-
effect monitoring, BEM) are discussed. 
There is general consensus that the level of PbB is a measure of exposure to lead, 
and that it is also reflecting the body burden. To prevent adverse health effects in 
lead workers, in many countries maximum allowable levels of PbA andior PbB 
have been issued. In the European Community so-called 'action' levels and limit 
values of PbB and PbA are legally binding. When these levels or values are 
exceeded, particular measures must be carried out to prevent risks of (further) 
health impairment. Furthermore, the effect of technical and hygienic measures to 
reduce exposure of workers in lead-processing industries is often judged on the 
basis of a change of the PbB level. 
For either application the quality of the assay of PbB is of paramount 
importance. In Chapter 3 two interlaboratory surveys are described that gave 
insight into the quality of the analysis of PbB in the Netherlands. Almost all 
laboratories determining lead in blood more or less regularly at that point in time 
(1986/87), took part. The results of the assays performed by the greater part of the 
12 and 14 participants in these surveys, respectively, were insufficient in terms of 
precision and accuracy. The coefficient of variation (CV) of the average results 
ranged from 10 to 36%. 
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A CV of about 6% is attainable as appears from the results of an interlaboratory 
quality control programme organized in Great Britain. Therefore, it is proposed that 
laboratories analysing PbB within the frame-work of health surveillance of lead 
workers participate in a continuously running external quality control programme. 
The CV of the results, obtained over a longer period, should be lower than 10%. 
In several studies, a positive relation between PbB and blood pressure has been 
established. De Kort et al. (1987) estimated an increase of systolic blood pressure 
of about 1.8 mm mercury (Hg) and of diastolic blood pressure of I mm Hg per 0.5 
flmol increase of lead/L of blood (Chapter 4). In the general population the 
standard deviation of blood pressure varies between 15 and 25 mm Hg. To 
establish a statistically Significant effect of the size of 1.8 mm Hg, blood pressure 
should be measured in a cohort of at least 3200 people. The present levels of 
exposure in the Netherlands (P,o of PbB of Dutch lead workers, according to age, 
lies between 1.4 and 1.6 flmoVL; P,o of PbB of mediterranean lead workers 
between 1.8 and 2.2 flmoVL) do not justify such an investigation. The results also 
imply that occasional measurement of blood pressure of lead workers, for the 
purpose of establishing the effect of lead, has no practical meaning. 
In Chapter 5 a study is presented on the incidence of anaemia in 494 Dutch lead 
workers. A statistically significant linear relation between PbB and haemoglobin 
(Hb) was established with a decrease of the Hb level by 0.28 mmollL when PbB 
increased from 0 to 5 flmoVL. The upper limit of the 95% confidence interval 
amounted to a decrease of 0.59 mmoVL. These results suggest that occupational 
exposure to lead of people with a low-to-normal Hb value may lead to anaemia. 
Therefore, it is proposed that the assay of Hb is part of the pre-placement medical 
examination of new lead workers. 
When rats are exposed to lead chromate by inhalation, only a small fraction of this 
insoluble compound is absorbed into the blood, the greater part forming a deposit 
in lung tissue (Chapter 6). Extrapolation of these results to man implies that in 
case of exposure to lead chromate, the concentration of PbB represents an 
underestimation of the actual intake of the compound. Owing to the relatively low 
level of PbB, minor systemic effects will occur. However, it is desirable to obtain 
insight into the presence and magnitude of the deposit in the lungs, among others 
in view of the suspected carcinogenicity of lead chromate. Therefore, in addition 
to BM of PbB, also the intake, reflected in the concentration of PbA in the 
breathing zone of the workers, should be measured by PAS. This is apart from the 
recommendations to avoid exposure completely. 
An increased level of zinc protoporphyrin (ZPP) in blood generally reflects an 
effect of lead on the haematopoietic system. In Chapter 7 it is stated that the assay 
of ZPP in blood may be applied also to estimate whether the concentration of PbB 
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in that sample is higher or lower than one of the action levels or permissible values 
stated in the Lead Decree (Loodbesluit). The latter aims to protect workers to 
health risks of occupationally exposure to lead. Only when ZPP exceeds a 
predetermined level, does the concentration of PbB need to be determined to 
establish the correct value in the sample. The method, which may save cost and 
labour, is not applicable for the lowest action level of PbB (1.45 flmoVL) due to 
the low sensitivity and specificity of ZPP at low levels of exposures. 
In Chapter 8 a study is presented on the exposure to lead during demolition by 
flame-torch cutting of a steel structure coated with lead-based paint. The nine 
workers concerned showed levels of PbA in the breathing zone between 2 and 38 
mg/mo. These extremely high concentrations (the present MAC is 0.15 mg/m'), 
resulted in levels of PbB of 3.5-5.5 flmoVL, which suggests that at these levels the 
PbB values show a .saturation phenomenon and no longer fluctuate in accordance 
to exposure variations. Probably, at such very high intake the material is partly 
excreted in urine or deposited in the body. Therefore, it is proposed that under 
conditions of high exposure, the intake is not only estimated by determining PbB, 
but also by measuring PbU and by performing PAS measurements. 
The use of filtering facepieces was unsuitable for preventing uptake of lead dust 
and lead aerosols. Also dust filters, with a protection factor of JO to 12, only partly 
prevented the unwanted intake of lead. 
To reduce exposure to lead and to maintain a low level of exposure in a secondary 
lead smeltery joined to a rolling mill, a programme of hygienic measures and 
technical adaptations of the production process was carried out over several years 
(Chapter 9). As a result, PbB levels of thirteen employees out of a group of 28 
showed a statistically significant decline between 1982 and 1990. PbB levels of 
five out of thirteen others showed a declining trend. Also, the number of PbB 
levels >2.9 flmollL observed in workers decreased from 48 in the period 1982 -
1984 to 12 in 1988 - 1990. Specific technical or hygienic measures which resulted 
in this generally lower level of exposure could not be indicated. 
Over a period of several years 19 workers of the plant were screened for PbB 
and ZPP more than 10 times. In 17 of them levels of PbB and ZPP showed a 
statistically significant relation. This suggests that after prolonged exposure, 
resulting in an equilibrium of lead in the deposits, the ZPP of an individual lead 
worker may be used as an indicator of a change in the level of PbB. This approach 
would simplify health surveillance of lead workers considerably. 
In Chapter] 0 a study is presented on the effects of two concentrations of lead 
acetate injected subcutaneously in two groups of rabbits three times a week. The 
levels of PbB increased to about 1.9 and 4.3 flmoVL after 70 and 110 days, 
respectively, and were maintained at these levels during 7.5 months. Hereafter, a 
part of the animals was subjected to a recovery period of four months. This study 
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aimed at the identification. of any physiological criterion that might be used to 
indicate early health effects of lead exposure. 
The animals of both groups were subjected to a similar regimen. In the high-
exposed animals effects on the haematological system and on red blood cells were 
observed (anaemia, increased levels of ZPP and ALAU, basophilic stippling and 
lowered MCV and MCR). Gain in body weight was lower and relative weights of 
heart and liver increased. In both groups ALAD activity was very low. In neither 
of the groups effects on kidney function and on the haematopoietic system were 
observed which might be applicable as biological effect parameters in a programme 
for health surveillance of lead workers. 
The general discussion on the data from Chapters 3-10 and the concluding remarks 
are presented in Chapter 11. 
The results of the studies in Chapters 3-9 have been incorporated into a protocol 
for health surveillance of lead workers which is suggested in the Annex. The accent 
lies on prevention of adverse health effects by periodically assessing the exposure. 
Dependent on the workers involved and the extent and kind of exposure, the 
programme should be carried out monthly to annually. 
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SAMENVATTING 
De industriele toepassing van metallisch lood en loodverbindingen is in de loop 
van de laatste decennia aanzienlijk afgenomen. Daarnaast hebben wijzigingen van 
technische processen, alsmede wetgeving en maatregelen van werkgevers en 
vakbonden ertoe bijgedragen dat acute vergiftigingen van personen die in hun 
beroep worden blootgesteld aan lood. thans niet meer of nog slechts zelden 
voorkomen. Door de toepassing van nieuwe en gevoeliger (biochemische) 
bepalingsmethoden. zoals die welke het functioneren van het zenuwstelsel en van 
de nieren meten. is echter duidelijk geworden dat er bij blootstellingsniveaus die 
nog niet zo lang gel eden als risicoloos werden beschouwd toch gezondheidsschade 
kan optreden. 
Het doel van het onderzoek dat is beschreven in dit proefschrift was om informatie 
te verkrijgen die gebruikt zou kunnen worden om te komen tot een betere 
gezondheidsbewaking van personen die beroepsmatig aan lood worden bloot-
gesteld. Hierdoor zou het optreden van nadelige gezondheidseffecten worden 
voorkomen. ook op de langere termijn. In dit kader zijn de onderwerpen die in het 
volgende zijn aangegeven nader onderzocht. 
In Hoo/tis/uk 2 wordt een kort overzicht gegeven van de literatuur over 
gezondheidseffecten van lood. Tevens worden methoden beschreven waarmee de 
blootstelling kan worden geschat. Dit zijn 'monitoring' van lood in de lucht (PbA) 
op de werkplek en in inademingslucht (personal air sampling, PAS), alsmede 
biologische monitoring (BM) van lood in bloed (PbB) en van lood in urine (PbU). 
Tevens worden methoden besproken die worden gebruikt om routinematig effecten 
van lood op het bloedvormend systeem te bepalen (biologisch-effect monitoring, 
BEM). 
Het wordt algemeen aanvaard dat de concentratie van PbB een maat is voor de 
blootstelling en voor de opname van lood in het lichaam. Om nadelige 
gezondheidseffecten door beroepsmatige blootstelling te voorkomen, zijn in een 
groot aantal landen grenzen voor de maximaal toelaatbare concentraties van PbA 
en PbB vastgesteld. Ook in de Europese Gemeenschap zijn wetteIijk aanvaarde z.g. 
, actieniveaus' en grenswaarden voor PbA en PbB van kracht. In Nederland zijn 
deze opgenomen in het , Loodbesluit' . Bij overschrijding dienen bepaalde wei 
omschreven maatregelen te worden genomen om de blootstelling te verminderen 
en daarmee het (verder) optreden van gezondheidsrisico's te voorkomen. Het effect 
van deze maatregelen wordt vooral afgeleid uit de mate waarin deze lei den tot een 
verandering van de PbB waarde. Een en ander impliceert dat een juiste uitvoering 
van de PbB bepaIing van groot belang is, omdat het resultaat belangrijke 
consequenties kan hebben voor de betrokken werknemers en werkgevers. 
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In Hoofdstuk 3 worden twee vergelijkende onderzoeken beschreven naar de 
kwaliteit van de PbB bepaling zoals die in Nederland werd uitgevoerd. Aan deze 
onderzoeken werd deelgenomen door bijna alle laboratoria in Nederland (15-20) 
die de bepaling met een zekere regelmaat uitvoerden. 
De variatiecoefficienten (CV) van de gemiddelde resultaten van de 12, 
respectievelijk 14 deelnemers aan de onderzoeken varieerden tussen 10 en 36%. 
Een CV van ca. 6% is echter haalbaar, zoals blijkt uit de resultaten van een 
doorlopend programma voer kwaliteitsbewaking dat in Engeland is georganiseerd. 
Voor de meerderheid van de deelnemers aan het Nederlandse onderzoek waren de 
resultaten van hun loodbepalingen dan ook onvoldoende in termen van precisie en 
juistbeid. 
Voorgesteld wordt dat laboratoria waar bepalingen van lood in bloed worden 
uitgevoerd in het kader van de gezondheidsbewaking van loodwerkers, deelnemen 
aan een z.g. extern kwaliteitscontroleprogramma. De CV van de resultaten die 
daarin over een langere periode worden behaald, dient lager te zijn dan 10%. 
In de literatuur zijn verscheidene onderzoeken beschreven waarin een positieve 
relatie tussen PbB en de bloeddruk werd vastgesteld. De Kort e.a (1987) schatten 
de stijging van de systolische bloeddruk op ongeveer 1,8 mm kwik (Hg) per 0,5 
fjmol toename van lood/L bloed, en van de diastolische bloeddruk op ongeveer 1 
mm per 0,5 fjmollL (Hoofdstuk 4). In de algemene bevolking varieert de 
standaarddeviatie van de bloeddruk tussen 15 en 25 mm Hg. Om een statistisch 
significant effect ter grootte van 1,8 mm Hg aan te tonen, zou derhalve de 
bloeddruk van een cohort van 3200 personen onderzocht moeten worden. Afgezien 
van de vraag of in Nederland een dergelijk aantal personen bereid is deel te nemen, 
wordt een zo omvangrijk onderzoek niet gerechtvaardigd door de 
blootstellingsniveaus die in Nederland momenteel voorkomen (Pso voor PbB van 
Nederlandse loodwerkers, afhankelijk van leeftijd, tussen 1,4 en 1,6 fjmollL; voor 
mediterrane loodwerkers tussen 1,8 en 2,2 fjmollL). Dit houdt tevens in dat 
incidentele meting van de bloeddruk bij loodwerkers met het doel een effect van 
lood op de bloeddruk te meten, geen practische betekenis heeft. 
In Hoofdstuk 5 wordt een onderzoek beschreven naar de hemoglobine concentratie 
(Hb) bij 494 Nederlandse loodwerkers. Hierbij werd een statistisch significant 
lineair verband gevonden tussen PbB en Hb, met een afname van de Hb-
concentratie van 0,28 mmollL bij een toename van de PbB concentratie van 0 tot 
5 flIDollL. De bovengrens van het 95% betrouwbaarheidsintetval van deze afname 
bedroeg 0,59 mmollL. In twee groepen van respectievelijk 59 in Nederland 
werkzame Marokkaanse en 18 Turkse loodwerkers werd een dergelijk verband 
tusseh PbB en Hb niet gevonden. 
Het resultaat v~~r de Nederlandse populatie duidt erop dat de beroepsmatige 
blootstelling aan lood van personen die reeds een laag-tot-normale Hb-waarde 
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hebben, kan lei den tot bloedarmoede. Daarom wordt voargesteld de bepaling van 
Hb deel te laten uitmaken van het aanstellingsonderzoek van loodwerkers. 
Bij inhalatoire blootstelling van ratten aan load chromaat wordt slechts een klein 
deel van deze onoplosbare verbinding direct in het bloed opgenomen (Hoofdstuk 
6). Het grootste deel vormt een depot in het longweefseL Extrapolatie van deze 
resultaten naar de mens betekent dat bij blootstelling aan load chromaat met 
biologische monitoring van PbB een onderschatting van de blootsteIling wordt 
verkregen. Als gevolg van de lage concentratie van lood in bloed zullen ook de 
systemische effecten klein zijn. Toch is het gewenst dat inzicht wordt verkregen 
in de aanwezigheid en grootte van het depot in de longen, vooral in verband met 
de mogelijke carcinogeniteit van lood chromaat. Bij blootstelling aan deze 
verbinding dient daarom, als aanvulling op BM van PbB, oak de concentratie in 
de inademingslucht (PAS) gemeten te worden. Dit staat los van de aanbeveling dat 
blootstelling geheel voorkomen dient te worden. 
Bij blootstelling aan lood wijst een verhoogde concentratie van zink protoporfyrine 
in bloed (ZPP) bijna altijd op een effect op het bloedvormend systeem. In 
Hooftistuk 7 wordt beschreven dat met de eenvoudig uit te voeren meting van ZPP 
kan worden vastgesteld of PbB in een bloedmonster hoger of lager is dan een van 
de wettelijk vastgestelde actieniveaus of grenswaarden uit het Loodbesluit. Aileen 
als ZPP een vooraf gekozen, bepaalde waarde overschrijdt, dient alsnog de 
concentratie van lood in het monster bepaald te worden. Door de lage specificiteit 
en sensitiviteit van ZPP bij geringe blootstelling is de voorgestelde methode, die 
kosten en tijd bespaart, echter niet bruikbaar voor het eerste actieniveau (PbB = 
1,45 flIllollL). 
In Hoofdstuk 8 wordt een onderzoek beschreven naar de blootstelling aan lood bij 
het met snijbranders slopen van een met loodhoudende verf behandelde stalen 
constructie. Bij de negen betrokken personen werden in de ademzone loodwaarden 
gemeten tussen 2 en 38 mg/m'. Deze, in vergelijking met de huidige MAC (0,15 
mg/m'), zeer hoge concentraties leidden tot snel oplopende PbB waarden, die 
echter niet hoger stegen dan 3,5 - 5,5 IlmollL. Dit lijkt een aanwijzing dat deze 
concentraties een plateau weergeven, waarbij de extreem grote opname van lood 
slechts gedeeltelijk tot uiting komt in de PbB-waarde. De zeer hoge blootstelling 
leidt mogelijk tot een verhoogde uitscheiding in de urine of tot het optreden van 
depotvonning. Daarom wordt voorgesteld om in situaties met zeer emstige 
blootstelling, bijv. zoals beschreven in Hooftistuk 8, de opname van lood niet aileen 
te controleren door bepaling van PbB, maar ook door de concentratie van lood in 
de ademzone en in de urine te meten. 
Het gebruik van gelaatsmaskers, z.g. 'snuitjes', was onvoldoende om de opname 
van lood te voorkomen. Ook stoffilters met een beschermingsfactor van 10-12, 
voorkwamen de opname van lood slechts gedeeltelijk. 
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Teneinde de blootstelling van de werknemers te verminderen en vervolgens op een 
lager niveau te handhaven, werd in een secundaire loodsmelterij en -pletterij tussen 
1982 en 1990 een programma van wijzigingen in het productieproces en van 
arbeidshygienische maatregelen uitgevoerd (Hoofdstuk 9). In deze periode daalden 
de PbB waarden van 13 personen uit een groep van 28 werknemers statistisch 
significant. De PbB-waarden van vijf personen uit een groep van 13 anderen lieten 
een dalende trend zien. Terwijl tussen 1982 en 1984 nog 48 PbB waarden >2,9 
J.Imol/L werden gemeten, waren dit er tussen 1988 en 1990 nog maar 12. Welke 
maatregelen in het bijzonder tot de algemene vermindering van de blootstelling 
hadden bijgedragen, kon echter niet worden vastgesteld. 
In een peri ode van enkele jaren werd bij 19 personen meer dan tien keer PbB 
en ZPP gemeten. Bij 17 van hen was er een statistisch significant verband tussen 
beide parameters. Dit resultaat suggereert dat bij langdurig blootgestelde 
loodwerkers een stijging of daling van de individuele ZPP concentratie gebruikt 
kan worden als een indicatie voor een overeenkomstige verandering van de PbB 
waarde. Deze benadering. die nog verder uitgewerkt dient te worden, zou een 
aanzienlijke vereenvoudiging van het health surveillance programma betekenen. 
In Hoofdstuk 10 wordt een onderzoek beschreven waarin twee groepen konijnen 
gedurende 7,5 maanden door herhaalde subcutane injecties werden blootgesteld aan 
lood acetaat. PbB nam in de twee groepen respectievelijk toe tot circa 1,9 en 4,3 
J.Imol/L; deze concentraties werden gehandhaafd door wekelijks lood acetaat toe te 
dienen. Na de blootstellingsperiode onderging een deel van de dieren een 
'herstelperiode' van vier maanden waarin geen lood acetaat werd toegediend. In 
de haogst blootgestelde groep dieren werden effecten waargenomen op de 
haematopoese en op de rode bloedcellen (anemie, verhoogde concentratie van ZPP 
en ALAU, verlaagde MCV en MCR en basofiele stippeling). In beide groepen was 
de activiteit van ALAD sterk gedaald. In geen der groepen werden effecten op de 
nier- of leverfunctie of klinische afwijkingen gemeten. In de groep dieren met de 
laagste blootste1ling werden geen effecten waargenomen die gebruikt zouden 
kunnen worden als effect-parameters bij de gezondheidsbewaking van loodwerkers. 
De algemene discussie van de onderzoeken die zijn gepresenteerd in de 
Hoofdstukken 3-10 en de concJusies zijn vermeld in Hoofdstuk JJ. 
De resultaten van de onderzoeken in de Hoofdstukken 3-9 zijn verwerkt in een 
voorstel voor een protocol voor de gezondheidsbewaking van beroepsmatig aan 
lood blootgestelde personen dat wordt voorgesteld in de Annex. In het protocolligt 
het accent op preventie van gezondheidsrisico's door, aan de hand van een 
tijdschema, regelmatig de blootstelling te volgen. Afhankelijk van de werk-
omstandigheden en de mate en aard van de blootstelling is het protocol maandelijks 
tot jaarlijks toe te passen. 
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